Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
12313
volume 19 suppl
Severe Malaria
Recent data suggest that there
malaria is modest because were around 627 000 deaths
severe malaria has no from malaria worldwide in
Section 1: Epidemiology of severe features by which it can be 2012 (World Health
falciparum malaria Organization 2013). These
confidently distinguished
When an individual has been inoculated with a plasmo-dium from many other fatal febrile were deaths directly attribut-
parasite, a variety of clinical effects may follow, within the conditions in the absence of able to malaria (malaria also
sequence: laboratory tests (Snow et al. kills indirectly by reducing
Infection?asymptomatic parasitaemia?uncomplicated illness? 1992; Mudenda et al. 2011). birthweight and debilitating
severe malaria?death. (iii) Even when severe children with repeated infec-
Many factors influence the disease manifestations of the malaria is documented in a tions) and so would usually
infection and the likelihood of progression to the last two health facility, the diagnosis have been preceded by severe
categories. These factors include the species of the infecting may be missed or wrongly illness. With fewer than half
parasite, the levels of innate and acquired immunity of the host, applied to patients without of those who suffer severe
and the timing and efficacy of treatment, if any. malaria (Reyburn et al. 2004; malaria being able to reach a
Taylor health facility, and assum-ing
et al. 2004). Recent estimates a case-fatality rate of 90% at
based on verbal autopsies home and 20% in hos-pital
Plasmodium falciparum is the major cause of severe
suggest that there is a (Thwing et al. 2011), the
malaria
substantial mortality from global annual incidence of
Progression to severe and fatal disease is largely but not entirely malaria in older adults severe malaria can be
confined to P. falciparum infections; in this sec-tion and in most (Dhingra et al. 2010; Murray estimated at approximately 2
of this document, we will discuss severe malaria caused by P. et al. 2012), but this is not mil-lion cases. In parts of the
falciparum. Although they contrib-ute much less than P. borne out by hospital-based world where the transmission
falciparum to the global burden of severe malaria, both P. vivax studies or clin-ical of P. falciparum is intense and
and P. knowlesi can also cause severe disease and they do kill; observation (Lynch et al. stable, severe malaria is
these infections are discussed separately in Sections 13 and 14. 2012; White et al. 2012). mainly a disease of children
In endemic areas, severe from the first few months of
malaria is very unusual in life to the age of about 5
Problems in determining the epidemiology of severe years, becoming less common
malaria the elderly. [For discussion
of problems in malaria in older children and adults as
An accurate description of the incidence and distribution of diagnosis, see Section 9]. An specific acquired immunity
severe malaria requires identification of cases, and sev-eral alternative approach to gives increasing (although
factors make this problematic. (i) Malaria is most prevalent counting malaria deaths is to always incomplete)
where there is poverty and where methods of disease assume a contribution from protection. About 90% of the
identification, documentation and reporting are weakest. (ii) A malaria to all-cause mortality worlds severe and fatal
large proportion of severe malaria illnesses and deaths occur in based on data from countries malaria is estimated to affect
peoples homes without coming to the attention of a formal with very good diagnostic young children in sub-Sahara
health service: for children under 5 years of age, this proportion and reporting systems (Black Africa (Black et al. 2010). In
has been estimated at 90% in The Gambia (Greenwood et al. et al. 2010). Mathematical areas of lower endemicity,
1987) and at 49% more recently in Zambia (Mudenda et al. modelling can then be used severe malaria occurs in both
2011). Verbal autopsies have been used to identify causes of to pre-dict how various adults and children. Non-
death in community surveys, but their accuracy for measurable indices might immune travellers and
modify malaria mortality in migrant workers are
different countries. vulnerable to severe
i e o
Table 2 Outline bedside clinical classification of r p c
severe malaria in children in a high transmission e a
area d c l
o i
Group 1 Prostrate children (prostration is the c m s
inability to sit upright in a o a e
child normally able to do so n
or to drink in the case of s C a
children too young to sit).
Three subgroups of c o
increasing severity should i m p
be distinguished: o a a
Prostrate but fully conscious u i
s ( n
P
n t f
r
e h u
o
s e l
s
s
t
i s
r
b n t
a
u a i
t
t b m
e
i u
n l l
w
o i u
i
t t s
t
y )
h
i
n t R
i
o e
m
d s
p
e l p
a
i of i e
r gro t m
a up o
t 1 < g
o (ab l
r ove 1 o
y )*. 5 b
The % i
d se n
i incl 2 u
s ude r
t chil
o i
r dre
e r a
n
s wit
s h m (
any o b
( of r l
a the e a
c foll c
i owi c k
d ng: o w
o n a
t H v t
i a u e
c e l r
m s )
b i Jaundice
o
r o
g
e n Group 3 Children who require parenteral
l
a s treatment because of persistent
t o
vomiting but who lack any
h b specific clinical or laboratory
i w features of groups 1 or 2
i
n i (above)
n
g t
) < h *If parasite
: 5 i counts are
Mild sustained nasal flaring n immediately
and/or mild intercostal g available, a
/ a parasitaemia
indrawing (recession)
over 10%
Severe the presence of d should be
either marked indrawing l 2 included in
(recession) of the bony 4 group 2.
structure of the lower o - Children are
chest wall or deep r h defined as
(acidotic) breathing <12 years
Shock compensated or p old.
h
decompensated (see definition a e
above) e r
m i
Group 2 Children who, although able to be o
a
treated with oral antimalarials, d
t
require supervised
o
management because of the
c H
risk of clinical deterioration but
r a
who show none of the features
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
10 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Group 1 Adults at increased risk of dying immediately who require parenteral antimalarials and appropriate supportive therapy Prostrated or
obtunded adults (prostration is the inability to sit or to drink). Four subgroups of increasing
severity should be distinguished:
Prostrate but fully conscious
Prostrate with impaired consciousness but not in deep coma (GCS > 11)
Confusion and agitation (GCS > 11)
Coma (the inability to localise a painful stimulus) (GCS < 11)
Respiratory distress (acidotic breathing)
Mild sustained nasal flaring and/or mild intercostal indrawing (recession)
Severe the presence of either marked indrawing (recession) of the bony structure of the lower chest wall or deep
(acidotic) breathing
Shock (hypotension:systolic BP < 80 mmHg)
Anuria
Significant upper gastrointestinal haemorrhage
Group 2 Adults who, although able to be treated with oral ACTs, require supervised management because of the risk of clinical
deterioration but who show none of the features of group 1 (above)*. This group includes adults with any of the
following:
Haemoglobin <7 g/dl or haematocrit <20% One or
more convulsions within a 24-h period
Haemoglobinuria (blackwater)
Jaundice
Group 3 Adults who require parenteral treatment because of persistent vomiting but who lack any specific clinical or laboratory
features of groups 1 or 2 (above)
*If parasite counts are immediately available a parasitaemia over 4% should be included in group 2.
For epidemiological and research purposes, severe malaria is defined as one or more of the following, occurring in the absence of an identified
alternative cause, and in the presence of P. falciparum asexual parasitaemia:
Impaired consciousness: A Glasgow Coma Score <11 in adults or a Blantyre coma score <3 in children
Acidosis: A base deficit of >8 meq/l or, if unavailable, a plasma bicarbonate of <15 mM or venous plasma lactate
>5 mM. Severe acidosis manifests clinically as respiratory distress rapid, deep and laboured breathing
Hypoglycaemia: Blood or plasma glucose <2.2 mM (<40 mg/dl)
Severe malarial anaemia: A haemoglobin concentration <5 g/dl or a haematocrit of <15% in children <12 years of age (<7 g/dl and
<20%, respectively, in adults) together with a parasite count >10 000/ll
Renal impairment Plasma or serum creatinine >265 lM (3 mg/dl) or blood urea >20 mM
(acute kidney injury):
Jaundice: Plasma or serum bilirubin >50 lM (3 mg/dl) together with a parasite count >100 000/ll
Pulmonary oedema: Radiologically confirmed, or oxygen saturation <92% on room air with a respiratory rate >30/min, often
with chest indrawing and crepitations on auscultation
Significant bleeding: Including recurrent or prolonged bleeding from nose gums or venepuncture sites; haematemesis or melaena
Shock: Compensated shock is defined as capillary refill 3 s or temperature gradient on leg (mid to proximal limb),
but no hypotension. Decompensated shock is defined as systolic blood pressure <70 mm Hg in children
or <80 mm Hg in adults with evidence of impaired perfusion (cool peripheries or prolonged capillary refill)
Hyperparasitaemia: P. falciparum parasitaemia >10%
immediately at the point of at increased risk should be
pre-morbid and concomitant diseases, and access to appropriate care, but results of other lab- given the benefit of the
treatment. The patient must be assessed and treated without delay. oratory measures, if any, highest level of care
A practical bedside approach to the immediate assessment and may be available only after available. The attending
classification of children with suspected severe malaria is shown hours or days. The start of clinician should not worry
in Table 2 and for adults in Table 3. Tests such as the parasite treatment must not wait. As unduly about definitions; the
count, haematocrit and blood glucose may all be determined severe malaria is potentially severely ill patient
fatal, any patient considered
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 11
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
movements with deviation,
increased salivation or
abnormal respiratory
point where a clear response patterns.
Table 5 A coma scale for children (Blantyre coma scale). This scale is is obtained. A localising
for children, including those who have not learned to speak response must be
Prostration is the inability,
distinguished from a brisk
Best motor response Score
because of extreme
flexion response. The
localises painful stimulus* 2 weakness, to sit unassisted,
interpretation of appropriate
Withdraws limb from pain 1 in an adult or a child who is
cry is diffi-cult, some
Non-specific or absent response 0 normally able to do so. In
children are stoical, and the
Verbal response children not old enough to sit
Appropriate cry 2 appropriateness of verbal
up, pros-tration is defined as
Moan or inappropriate cry 1 response needs to be
the inability to breastfeed.
None 0 considered in the light of
Prostra-tion must always be
Eye movements other responses and the age
Directed (e.g. follows mothers face) 1
recorded directly and not
of the child. It is best to test
Not directed 0 based on history. Many
directed eye movement by
Total 05 patients who have a fever
asking the mother to move
and feel unwell prefer to lie
Unrousable coma 2. her face across the childs
or, in the case of children, to
*Painful stimulus: rub knuckles on patients sternum. field of vision, as the child
be carried but are capable of
Painful stimulus: firm pressure on thumbnail bed with horizon-tal may be less interested in
sitting if gently encouraged
pencil. looking at any other face or
to do so.
object.
requires immediate supportive care, and if severe malaria is a
Shock. Compensated shock
possibility, parenteral antimalarial drug treatment should be
is defined as capillary refill
started without delay. In summary - if in doubt, treat as severe Respiratory distress (acidotic
3 s or temperature gradient
malaria. breathing). Deep, laboured,
on leg (mid to proximal
Patients with a high parasite count (>4%) in a low noisy and often rapid
limb), but no hypotension
transmission setting but none of the clinical or laboratory breathing (Kussmauls
after adequate rehydration.
indicators of severe malaria should be monitored closely, breathing) with increased
Decompensated shock is
preferably in hospital for the first day of treatment. Although inspiratory and expiratory
defined as systolic blood
oral treatment with an artemisinin derivative is highly effective, chest excursion is the most
pres-sure <70 mm Hg in a
provided there is no vomiting (Luxem-burger et al. 1995), if important respiratory sign of
child and <80 mm Hg in an
there is any clinical doubt, treat-ment should be started with severe malaria. Patients with
adult, with cool peripheries
parenteral artesunate followed by an ACT. acidosis may sometimes have
(this assessment may vary
such deep laboured breathing
between observers) and
that their respiratory rates are
prolonged capillary refill 3
slow. In children, sustained
Impaired consciousness. Before the general use of coma scales, s after ade-quate rehydration.
nasal flaring and indrawing
the term cerebral malaria was used for patients with malaria Accurate blood pressure
(reces-sion) of the bony
who were unrousable, that is, unable to localise a painful measurement in young
structures of the lower chest
stimulus. This has been superseded by a Glasgow coma score of children depends on using
wall on inspiration should
less than 11 of 15 in adults (Teasdale & Jennett 1974) or a the correct sphygmo-
also be noted.
Blantyre coma score of less than 3 of 5 in children who are too manometer cuff size.
young to speak (Molyneux et al. 1989b; Newton et al. 1997a).
Multiple convulsions.
Many patients with malaria recover full consciousness after a
Generalised seizures are Pulmonary oedema is
convulsion, and so it is important to exclude transient post-ictal
common, particularly in suspected in any patient who
coma. Assessment for clinical management pur-poses should be
children, with severe develops tachypnoea
made immediately, but for classification, cerebral malaria is
malaria. Commonly, (respiratory rate >30/min),
coma which persists for > 1 h after a seizure irrespective of
convulsions, especially dyspnoea and hypoxia
anticonvulsant medications.
recurrent seizures, are subtle (oxygen saturation <92% on
(resulting in little or no room air) with
The Blantyre coma score (Table 5) requires careful local movement of limbs), and
standardisation. Care must be exercised in apply-ing the painful care should be taken to
stimuli; it is unkind and unnecessary to test responses repeatedly. detect minor manifestations
Testing should begin with a minimal stimulus, which should be
such as twitching of a digit,
increased only to the
repetitive jerky eye
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
12 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
severity of illness is different
in different populations and
age groups, and there has
AKIN criteria, but an been considerable debate
chest signs of diffuse wheeze or crepitations. It is con-firmed individuals previous values whether it should be included
radiologically. Abnormal bleeding is rare in severe malaria and are sel-dom available in at all in definitions of
may manifest by bleeding from the gums, nose, gastrointestinal malaria-endemic areas. As severity. In children in areas
tract or venepuncture sites. most patients with severe of unstable endemicity, a
malaria are children or peripheral parasitaemia of 4%
Jaundice. This is detected clinically by examining the sclera younger adults with normal or more (4% of circulat-ing
and/or mucosal surfaces of the mouth. Jaundice may occur in pre-morbid renal function, a red cells contain parasites)
adults with uncomplicated malaria so for a precise plasma creatinine over 265 lM carried an increased risk of
epidemiological classification of severe malaria jaundice is (3 mg/dl) is used as a death (Luxemburger et al.
defined as a combination of elevated plasma bilirubin (>50 lM criterion of severe malaria. 1995). A 4% parasitaemia in
or 3 mg/dl) together with a parasite count >100 000/ll. This corresponds to a GFR of non-immune children or
approximately <30 ml/min in adults should be considered
a man and <25 ml/min in a an indicator of high risk
Severe anaemia is suspected clinically from pale mucosal woman (eGFR requiring supervised manage-
surfaces and palms and confirmed by measurement of calculator: ment (Tables 2 and 3) but not
haemoglobin concentration or packed cell volume. Severe http://www.renal.org/egfrca by itself a criterion of severe
anaemia is defined as a haemoglobin <5 g/dl or a haemat-ocrit of lc for patients aged 18 years
malaria. In areas of stable
<15% in children (age <12 years) and a haemo-globin <7 g/dl or or more). This plasma
endemicity, parasita-emia
a haematocrit of <20% in adults. It should be specified whether creatinine level corresponds
thresholds should be derived
results are from a finger prick or venous sample. Finger prick approximately to a blood from local experience, but in
samples may underesti-mate the haemoglobin concentration by urea of 20 mM, a blood urea
the absence of local data, a
>1 g/dl if the fin-ger or ear lobe is squeezed during blood nitrogen of 57 mg/dl or parasitaemia >10% without
collection. Anaemia is common in malaria-endemic areas, blood urea of the other signs of severity
particu-larly in young children. To distinguish malaria-related
122 mg/dl, although patients described above indi-cates
anaemia from coincidental malaria for a precise epidemi-ological
with severe malaria may be severe malaria.
classification, severe anaemia is defined as above in combination
hypercatabolic and
with a parasite count >10 000/ll. It is difficult to distinguish
dehydrated which increase
chronic from acute anaemia. Chronic severe anaemia is common
the urea/ creatinine ratio. In
in areas of high malaria transmission, and areas with heavy
the past, acute kidney injury
hookworm burdens, and carries a better prognosis than rapidly Epidemiological and
has also been defined in terms
developing anaemia associated with an acute malaria infection. research definition of
of reduced urine output (<400
severe vivax malaria
ml in adults, <12 ml/kg/24 h
in children) despite rehydra- The criteria for severe vivax
Hypoglycaemia is a whole blood or plasma glucose con- tion, but this is much less malaria are the same as for
centration of <2.2 mM (<40 mg/dl). For screening pur-poses, useful as it requires accurate adults and children with
rapid tests are valuable, but their accuracy diminishes at blood monitoring and waiting 24 h. severe falciparum malaria
glucose concentrations below 3 mM and may be affected by low Oliguric renal failure rarely but with no parasitaemia
haematocrit. For research purposes, hypoglycaemia should be complicates P. falciparum density thresholds (and
confirmed on a venous sample measured with a glucose infection in young children. without the criterion of
analyser. Prognostically, a blood urea hyperparasitaemia) (see
measurement of >20 mM in Section 13). Although the
Acidosis is defined as a plasma bicarbonate concentration <15 children or adults with severe specificity is reduced without
mM or base excess below 8 meq/l. In the absence of laboratory malaria identifies a high-risk a parasitaemia threshold,
facilities, acidosis can be inferred from the presence of deep group with a mortality over parasite densities in vivax
breathing with a clear chest on ausculta-tion. Hyperlactataemia is 30% (Dondorp et al. 2005a, malaria are usually lower
defined as a plasma or whole blood lactate level >5 mM. 2010; Hanson et al. 2011a; than P. falciparum (almost
von Seidlein et al. 2012). always <2% of total red
Renal impairment or acute kidney injury is not well defined cells). The
from a single measurement. Changes in measures of glomerular
filtration rate are more important, and these are incorporated in
the widely used RIFLE and Hyperparasitaemia. The
relation of parasitaemia to
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 13
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
1 P. knowlesi
hyperparasitaemia
: Parasite density
a P. falciparum infection of >100 000/ll
mechanisms of severe disease may differ from those in fal- similar density. All the 2 Jaundice and parasite
ciparum malaria and are not clearly related to parasite bio-mass. severity manifestations listed density >20 000/ll
There is a 4- to 5-fold greater loss of uninfected red cells in P. for severe falciparum malaria Any patient with a
vivax infection relative to P. falciparum infec-tion at low parasite have been reported with P. knowlesi
densities, so P. vivax may cause severe anaemia at lower knowlesi malaria, except for parasitaemia of >20
parasitaemias. coma (see Section 14). 000/ll needs to be
Criteria for severe knowlesi observed very
malaria are the same as for carefully.
Epidemiological and research definition of severe
the definitions for adults and
knowlesi malaria
children with severe
Plasmodium knowlesi infections have a threefold higher risk of falciparum malaria but with
developing severe malaria than P. falciparum (Barber et al. lower parasitaemia cut-offs
2012). The risk of severe malaria is 28-fold greater with a for hyperparasitaemia and
parasitaemia >100 000/ll than the risk in jaundice as follows:
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
14 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
were comatose; in the same
series, 155 (62%) of the
children admitted had severe
bral malaria and metabolic anaemia (Allen et al. 1997).
acidosis. These may occur Among 6200 children
Section 3: Clinical features of severe separately or in any admitted to a rural hospital in
falciparum malaria in children
combination. The presence of Zambia, about 10% had
Most of the estimated 0.6 million malaria deaths every year impaired consciousness or severe malarial anaemia and
are in children up to 5 years old who live in areas of intense severe respiratory distress half as many had cerebral
transmission of P. falciparum, especially in sub-Saharan pre-dicted 84.4% of 64 malaria; but as the case-
Africa (World Health Organization 2013). deaths among 1844 children fatality rate in cere-bral
Severe malaria is rare in early infancy. Babies born to mothers admitted with malaria to a malaria was 19% and that of
who have malaria during pregnancy are at risk of having a lower district hospital in coastal severe malarial anaemia was
birthweight than the community average, usually as a result of Kenya. In this study, severe 9%, these two severe malaria
intrauterine growth retardation (see Section 5). Low birthweight anaemia was common but syndromes contributed
is associated with increased mortality from all causes in infancy rarely fatal unless approximately equally to the
(Steketee et al. 1996). In endemic areas neonates may have cord accompanied by impaired malaria-related mortality
blood and peripheral parasitaemia which usually disappears consciousness or severe (Biemba et al. 2000). In a
within hours or days. Congenital malaria (illness in the neonate respiratory distress (Marsh et prospective multicentre trial
resulting from malarial infection) is uncommon, but may present al. 1995). Hypoglycaemia comparing artesunate with
as fever, anaemia, and/or neonatal jaundice 10 30 days after and jaundice are additional quinine in childhood severe
delivery. This may mimic neonatal sepsis. Over the next few complications that may malaria conducted in 11
months of life, parasitaemia appears in an increasing proportion occur, usually in association centres in nine African
of children, the rate of increase in prevalence being a measure of with one or more of the countries, 5426 children were
transmission intensity. The great majority of infections are above syn-dromes. Both enrolled of whom 9.7% (527)
oligosymptomatic or symp-tomless and are reflected in the high hypoglycaemia and jaundice died. There were five highly
prevalence of asymp-tomatic parasitaemia among children in are associated with an significant independent
endemic areas. The likelihood of symptoms increases with the increased case-fatality rate predictors of mortality: base
density of parasitaemia, allowing statistical calculations of and were present in 31% and deficit [adjusted odds ratio
malaria-attributable morbidity (Smith et al. 1994). 16% of deaths, respectively, (AOR) 1.12, 95% CI 1.10
in the Kenya study. All of the 1.13], coma score (AOR 1.40,
deaths were among children 95% CI 1.341.45),
Importance of malaria as cause of severe disease and with coma or respi-ratory
mortality in older infants and children convulsions (AOR 1.72, 95%
distress. The pattern of CI 1.302.30), BUN (AOR
From the age of a few months onwards, infected infants may clinical events associated 1.02, 95% CI 1.021.03) and
develop severe disease. One study estimated that about one with death may be different chronic illness (AOR 2.12,
infection in a hundred progressed to cause complications (i.e. in the absence of hospital 95% CI 1.253.58) (von
became severe) in a population in The Gambia (Greenwood et treatment. In Nigeria, 46.5% Seidlein et al. 2012). The
al. 1991). These figures and the case-fatality rates of severe of 147 children with fatal relationships between 3 of
disease probably differ between populations dependent upon the P. falciparum infections had these predictors and their
transmission characteristics, health service provisions and cerebral malaria (Elesha et al. associated case fatalities are
availability, parasite drug sensitivities, and a variety of parasite 1993). In the Gambia, 43% of illustrated in Figure 1.
and host factors. Malaria is one of the three commonest rea-sons children admitted to hospi-tal
for admission to hospital and is a major cause of hospital death over a period of several years,
in children aged 15 years, in many ende-mic areas (Roca- and diagnosed as having
Feltrer et al. 2008; Black et al. 2010). severe malaria, were in coma Problems affecting the
diagnosis of severe
(Waller et al. 1995); the pro-
malaria in children
portion was similar 50%
in a series in Burkina Faso The difficulty of
Relative importance of different syndromes in fatal
(Modiano et al. 1995), but distinguishing clinically
malaria
considerably smaller in a between severe malaria and
Among the clinical syndromes that define severe malaria in series in Madang, Papua New pneumonia. Several studies
children (Tables 1 and 2), the most commonly encoun-tered fall Guinea, where of 249 have demon-strated the
into three main categories: severe anaemia, cere- children admitted to hospital problem of distinguishing
with severe malaria, 56 (22%) clinically between
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 15
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
impairm
ent and
metaboli
c
acidosis
alone or
in
combina
tion. The
sizes of
the ovals
are
Figure proporti
1 Data onal to
compile number
d from of cases.
prospect
ive
series of
severe
falciparu illnesses will also be
m accompanied by parasitaemia,
malaria yet have another cause. These
in 6189
children
illnesses include all of the
in syn-dromes that can be
studies caused by severe malaria,
conducte each of which can have other
d in causes. Vigilance for
Africa diagnoses other than malaria
and
pneumonia and malaria. In Malawi, of 471 children attending a (comorbidities), even in the
2605
hospital outpatient department who fulfilled the WHO clinical adults in presence of parasitaemia, is
definition for pneumonia, 449 (95%) also met the clinical studies important (Koram &
definition of malaria (Redd et al. 1992). Among Gambian conducte Molyneux 2007). Indicators
children with cough or breath-ing difficulty and a raised d in that malaria is a likely cause
South- of the presenting illness
respiratory rate, 38% had only malaria (parasitaemia with normal
East include high-density
chest radiograph) in the season of intense malaria transmission, Asia.
compared to 6% during the season of low malaria transmission Left side
parasitaemia and
(ODempsey et al. 1993). In Kenya, 200 children with fever, shows thrombocytopenia, although
cough, tachypnoea and additional features of respi-ratory the neither of these provide
distress, were compared with 26 children with def-inite prevalen diagnostic certainty (Figure
pneumonia (radiological consolidation, no parasitaemia) and 38 ce of 2). In the comatose patient,
different the presence of malarial
children with definite malaria (nor-mal chest radiograph, features
parasitaemia >100 000/ll); chest indrawing, unilateral signs and retinopathy is highly
of
crackles or wheeze were significantly associated with severe suggestive of a malarial
pneumonia, and pallor and deep breathing with malaria, but no falciparu aetiology of the illness [see
group of signs was entirely specific or sensitive for either m Section 8 (reti-nopathy)].
diagnosis (English et al. 1996a). malaria There have been few studies
by age, of the alternative causes of
and complicated febrile disease in
Venn
children in malar-ious
These observations indicate the need to consider and treat for diagram
both malaria and pneumonia in children with fever and chest s on the populations: in a recent
symptoms, in malarious areas, especially where either right hospital study in Malawi, of
radiological or microscopy facilities are not available (Bloland show the 513 children suspected to
mortalit have meningitis who had no
et al. 1991). [See Management of concomitant sepsis p104 for y in evidence of bacterial
discussion on the use of antibiotics in severe malaria] children
infection, 26% had PCR
and
adults evidence of at least one virus
The problem of diagnosis affects all syndromes that can
associate in the cerebrospinal fluid
resemble malaria. In a community with a high preva-lence of
asymptomatic parasitaemia, many febrile d with (Mallewa
manifest
ations of
et al. 2013). The
cerebral
and
development of bedside
renal diagnostic tests for
bacteraemias and viral infections would make an important individuals of all ages are presents with higher parasite
contribution to both epidemiology and patient care in more susceptible to severe burden, more com-plications
communities and peripheral hospitals in areas where incidental malaria (Otieno et al. 2006; and more frequent
P falciparum parasitaemia is common. Malamba et al. 2007; Imani comorbidity and carries a
et al. 2011). Severe malaria in higher case-fatality rate
Effects of HIV on childhood severe malaria. HIV-infected HIV co-infected patients (Hendriksen et al. 2012a).
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
16 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
cerebral malaria in 27
parasitaemic Malawian
children (Taylor et al. 2004)
causes. In most published compared autopsy evidence
Caution is needed when attributing complications to studies, the term cerebral of intracerebral parasite
P. falciparum infection, as HIV immunosuppression also malaria has been restricted to sequestration with ante-
increases susceptibility to many of the opportunistic infections the syndrome in which altered mortem clin-ical findings. In
that cause clinical illnesses that might be mis-takenly attributed consciousness, associated seven cases, autopsy revealed
to malaria in populations with a high prevalence of incidental with a malarial infec-tion, an alternative cause of death
parasitaemia. could not be attributed to and no intracerebral
convulsions, sedative drugs or sequestration, while in 20,
Strengthening the definition of severe malaria. These var-ious hypoglycaemia alone or to a there was intracerebral
considerations have led to increasing attempts to standardise the non-malarial cause. A child sequestration and no alterna-
definition of severe malaria in children, often fuelled by the need with loss of consciousness tive cause of death. Nineteen
to assess the efficacy or effec-tiveness of interventions (severe after a febrile convul-sion of the 20 with sequestered
malaria episodes being a primary endpoint) or to identify should not be considered to parasites had retinopathy
accurately patients to be recruited to pathogenesis or treatment have cerebral malaria unless before death, while none of
studies (severe malaria as enrolment criterion). The Severe coma persists for more than 1 those without intracranial
Malaria in African Children (SMAC) network aimed to quantify h after the convul-sion. parasites had retinopathy.
and describe severe malaria across a variety of epidemiologi-cal Similarly in a child with These results indicate (i) that
settings in order to design intervention studies with more precise malaria and hypoglycaemia the clinical diagnosis of CM
sample size estimates (Taylor et al. 2006a). The network enrolled who is comatose, diagnosis of is com-monly wrong and (ii)
20 333 parasitaemic children across five sites in sub-Saharan cerebral malaria cannot be that the presence of
Africa with differing malaria transmission characteristics and sustained if consciousness is retinopathy is highly
identified the incidence of various severe syndromes in these promptly restored by admin- suggestive of the presence of
diverse contexts. The programme to assess the malaria vaccine istration of glucose. Cerebral intracerebral parasite
RTS,S gave rise to a widely deliberated case definition of severe malaria is a clinical syn- sequestration, a characteristic
malaria to be used in identifying the primary end-point in the drome; the term is convenient histopathological feature of
Phase 3 multicentre trials (Vekemans et al. 2011). The definition for descriptive purposes. fatal CM. Several
included: presence of one or more clinical and/or laboratory descriptions of malarial
markers of disease severity; exclusion of four major The problem of diagnosis in retinopathy have been
comorbidities (pneumonia, men-ingitis, bacteraemia and cerebral malaria. Finding published in both children
gastroenteritis with severe dehy-dration); and a P. falciparum retinopathy improves and adults (Figure 2) (Lew-
parasitaemia density threshold (to maximise the specificity of the specificity. The syndrome of allen et al. 1996; Hero et al.
case defini-tion). This recommendation was largely based on a coma, commonly with 1997; Hien et al. 2003; Beare
prior analysis of 4583 well children and 1361 children admit-ted convulsions, that is the et al. 2004, 2006; Harding et
to a district hospital in Kenya (Bejon et al. 2007). The latter hallmark of cere-bral malaria al. 2006; Maude et al. 2009a).
study confirmed that increasing the parasita-emia threshold is like all other syndromes Retinopathy can be seen by
improved specificity but reduced sensitiv-ity of severe malaria that can complicate P. non-specialist clini-cians
diagnosis and that the malaria-attributable fraction of diagnoses falciparum infection, one that using direct or indirect
is considerably lower (61%) in areas of intense transmission than has a number of other ophthalmoscopy through
in areas of low or moderate transmission intensity (85%). possible causes. Some of dilated pupils, but training is
these are identifiable by required to achieve depend-
bedside examination or tests able results (Beare et al.
for example measles, 2002; Mohammed et al.
bacterial men-ingitis but 2011). Retinopathy can
Syndromes defining severe malaria in children many are not identifiable include any of four features.
immediately, if at all, in most Two of these are distinctive
Cerebral malaria (CM)
hospitals for example other and specific to malaria: these
Impaired consciousness. A number of different disease viral encephaliti-des, toxic are (i) patchy retinal
processes may affect consciousness in the child with malaria, syndromes, and intracranial whitening in the macula
including convulsions, hypoglycaemia, hyperpy-rexia, acidosis, vascular or mechan-ical (especially peri-foveal) and/or
severe anaemia and sedative drugs. How-ever, coma may events. Where asymptomatic in the peripheral retina; and
develop in the absence of any of these parasitaemia is common, (ii) white or orange dis-
attributing coma to malaria is colouration of retinal vessels.
problematic. A study of fatal Other features that may
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 17
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Figure 3 Manifestations and resolution of sequelae of cerebral malaria in children. Some sequelae of cerebral malaria (e.g. motor weakness and
spasticity), blindness or loss of speech are apparent on recovery from the coma, while others such as behaviour difficul-ties and epilepsy may not
appear until several weeks or months after discharge from hospital. Some deficits present on discharge such as generalised hypotonia, ataxia,
aphasia and blindness may resolve over the months following discharge. Thickness of shaded area corresponds approximately to relative (i.e. not
absolute) proportions.
of 132 cerebral malaria malaria (Figure 3). In Kenyan
this follow-up assessment, 68 (53%) had recovered fully, 18 survivors developed epilepsy children who had suffered
were mildly or moderately impaired, and 43 had severe ver-sus none of 264 controls malaria with impaired con-
neurological deficits (Dondorp et al. 2010). A smaller study of [odds ratio (OR) undefined; sciousness, reviewed at least
44 Ugandan children gave similar results; although neurological P < 0.0001]. In the same 42 months after exposure,
deficits were seen in 28.2% on discharge, rates decreased to study, 28 of 121 cerebral impairments in executive
9.5% at 3 months and 0% at 6 months (Boivin et al. 2007). Many malaria survivors developed functions, in particular the
patients with persistent neurological sequelae particularly new neurodisabilities, char- abil-ity to initiate, plan and
blindness, ataxia and central hypotonia also show considerable acterised by gross motor, carry out tasks, were
improvement with time (Schmutzhard & Gerstenbrand 1984; sensory or language deficits, significantly more common
Bondi 1992; John et al. 2008), but other severe neurological compared with two of 253 than in controls (Holding et
symptoms persist (Carter et al. 2005a), while others such as controls (OR 37.8, 95% CI al. 1999). Carter et al.
epilepsy and behaviour difficulties may develop after discharge 8.8161.8; P < 0.0001). A examined 152 children after
(Carter et al. 2004; Ngoun-gou et al. 2006a,b; Opoka et al. 2009; similar delayed manifestation cerebral malaria, 156 after
Birbeck et al. 2010a; Idro et al. 2010). Cortical blindness shows of epileptic seizures was malaria with multiple seizures
the most dramatic resolution; in the different series above, described in Uganda where and 179 controls, to identify
between 80 and 90% of children with cortical blindness the cumulative incidence of developmental impairments
recovered sight fully (Figure 3). seizures increased over time (Carter et al. 2004, 2005a,b,
with a total of two of 76 2006). Of children who
children (2.6%) reporting recovered from cerebral
seizures at 3 months, three of malaria 24% had deficits in at
Epilepsy developing after severe malaria. A retrospective study 74 children (4.1%) at 6 least one domain and 42% of
in Kenya identified epilepsy in 14/152 (9.2%) chil-dren who had months and 11 of 68 children those with impairments had
suffered cerebral malaria compared to 4/ 179 (2.2%) controls (16.2%) at 24 months multiple impairments.
(Carter et al. 2004), while in Mali, 5/101 (4.9%) survivors of (Opoka et al. 2009). Eighteen children (11.8%) of
cerebral malaria had epilepsy compared to 1/222 (0.5%) controls the cerebral malaria group, 14
(Ngoungou et al. 2006b). In a study in Malawi, 132 children with (9%) of the malaria with
retinop-athy-positive cerebral malaria and 264 age-matched, non- Longer term cognitive seizures group and four
comatose controls were followed up for a median of sequelae. Cognitive deficits (2.2%) of controls had
495 days (IQR 195819) (Birbeck et al. 2010b). Twelve are major sequelae of cerebral language impair-
20 2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
associated with increased
mortality (Crawley et al.
2000), and this inter-vention
but not identical, to those did not improve cognitive
ment (Carter et al. 2006). Language deficits (in compre-hension, predicting mortality. The outcome in survivors
syntax, pragmatics and word finding) and defi-cits in memory, main risk factors include (Abubakar et al. 2007). In a
attention, behaviour and motor skills were more pronounced in prolonged and repeated study to assess the memory
those with active epilepsy. Sim-ilar evidence of impaired seizures, deep and prolonged outcomes of cerebral malaria,
language development has been reported among 83 Malawian coma, and intracranial the number of seizures or
children after recovery from cerebral malaria with retinopathy hypertension (Molyneux et al. seizure duration did not
(Boivin et al. 2011). Other studies in Uganda and Senegal have 1989b; Brewster et al. 1990; independently predict
described similar cognitive deficits especially in working Crawley et al. 1996; van everyday memory (Kihara et
memory and attention (Boivin 2002; Boivin et al. 2007). Hensbroek et al. 1997; Idro et al. 2009). It is likely that
Although it has been reported, hearing loss has not been al. 2004). Others are male prolonged and recurrent
systematically examined as a sequela of severe malaria (Zhao & gender and higher admission seizures worsen an initial
Mackenzie 2011). These developmental impair-ments have been tempera-ture (Birbeck et al. neural injury that is partly
confirmed in more recent studies in Malawian children in whom 2010b); age younger than 3 responsible for the seizures
malaria retinopathy was used as an inclusion criterion to improve years (Molyneux et al. 1989b) themselves. Intracra-nial
on the diagnos-tic accuracy of cerebral malaria. In this cohort, up and a biphasic clinical course hypertension may lead to
to one-third (42/132; 32%) of children who survived cere-bral characterised by recovery of reduced cerebral perfusion
malaria developed epilepsy or new neurobehavioural consciousness followed by pressure, and impaired
impairments (Birbeck et al. 2010b; Boivin et al. 2011). Adverse recurrent convulsions and nutrient and oxygen delivery
outcomes appeared to develop sequentially, with motor, sensory coma (Brewster et al. 1990). that result in global ischaemic
or language deficits being evident initially, followed by The prevalence of sequelae injury and death, and contrib-
disruptive behaviour at a median of increases with worsening ute to clinical features
depth of coma on admission. suggesting herniation and
150 days and lastly epilepsy at a median period of about 300 In a cohort of 143 surviving brain-stem compression
days. Post-cerebral malaria epilepsy manifested as localisation- Kenyan children, 5/6 (83%) (Walker et al. 1992; Newton
related epilepsy with focal motor, complex partial, focal with with admission Blantyre et al. 1997b). There remains
secondary generalisation, multifocal or generalised tonic clonic Coma Score 0 had uncertainty how important
seizures (Birbeck et al. 2010b). impairments compared to these processes are overall as
5/18 (28%) of those with a a cause of brain damage and
Abnormal behaviour. Preliminary studies suggest that some score of 1 and 24/119 (20%) death in cerebral malaria (see
children recovering from cerebral malaria may develop of those with score 2 (Idro et pathophysiology Section 7
behavioural abnormalities including hyperactiv-ity, al. 2006b). Children who for discussion of raised
impulsiveness and inattentiveness or conduct disor-ders such were later found to have intracranial pressure, and
as aggressive, self-injurious and destructive behaviour. These impairments had a slower pathol-ogy Section 8 for
defects are particularly seen in patients with other severe recovery from coma, with a autopsy findings).
sequelae (Idro et al. 2010; Boivin et al. 2011). In the study of median time to full
Malawian children, disruptive behaviour fulfilling the DSM IV consciousness about
criteria for attention deficit and hyperactivity disorder was
described in 14/132 (10.6%) after a median follow-up period of 8 h longer than those without
495 (IQR 195819) days (Birbeck et al. 2010b). The impairments. Although Syndromes defining
pathogenesis is still poorly understood, and more detailed repeated seizures feature severe malaria in children
descriptions are awaited. The findings from all these studies prominently as a risk factor
Metabolic acidosis
suggest that (i) brain damage after cerebral malaria in children is for sequelae, the role of
more common than was originally thought; (ii) sequelae can take seizures in the causation of In many severe disease states,
many forms including defects of movement and coordination, brain injury is not clear; it is including severe malaria, the
cognitive and behavioural impairments and epilepsy; and (iii) possible that the seizures presence of acidaemia is
many of these sequelae are not evident at the time of discharge them-selves are a associated with a high case
from hospital (Figure 3). manifestation of brain injury. fatality (Stacpoole et al.
Although high-dose 1994). Acidaemia is a
prophylactic phenobarbitone manifesta-tion of severe
malaria, whether there is
Prognostic factors for neurological sequelae. Prognostic factors significantly reduced seizures
associated with neurological sequelae are similar, in cerebral malaria, it was altered
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 21
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
2012).
60
50
40
30
20
10
Mortality (%)
30
20
Gastrointestinal symptoms.
Nausea, vomiting (2030%
Acid base disturbances. of patients), abdominal pain,
respiratory distress syndrome (ARDS) (Taylor et al. 2012b; Acidosis is a major cause of which may be colicky and
Hanson et al. 2013). Patients with severe malaria are more death from severe malaria, severe, and diarrhoea (10
vulnerable than those with sepsis to volume overload and and the degree of acidosis is 20% of patients), which may
readily develop ARDS. Hyper-parasitaemia, renal failure, and the single most powerful be watery but does not
pregnancy are predis-posing factors. Hypoglycaemia and prognostic indicator (Day et contain blood or pus cells, all
metabolic acidosis are commonly associated. The first indication al. 1996b; Hanson et al. occur in adults with severe
of impending pulmonary oedema is usually an increase in the 2012). Acidotic breathing malaria and may lead to
respiratory rate, which precedes the development of other chest (hyper-ventilation, misdiagnosis of enteric
signs. Without good facilities for emergency radiography, it may Kussmauls breathing) is a infections. Patients who
be difficult to differentiate acute pulmonary oedema from poor prognostic sign although consis-tently vomit tablets
aspiration bronchopneumonia and metabolic acidosis, although it must be distinguished from should be transferred to a
in acidosis, ausculta-tion of the chest is often normal. Metabolic pulmonary oedema and place where parenteral
acidosis and pulmonary oedema may also occur together. neurogenic hyperventilation. treatment can be given unless
Although pulmonary oedema may develop at any stage of the Metabolic aci-dosis may intrarec-tal artemisinin
acute illness, it tends to occur later than the other acute develop in severely ill derivatives are available and
manifestations of malaria (Brooks et al. 1969). Hypoxia may patients as a result of can be given.
cause convulsions and deteriora-tion in the level of microcirculatory obstruction
consciousness, and the patient may die within a few hours. combined with hepatic dys-
function, in patients who are Hypoglycaemia.
shocked or are in renal Hypoglycaemia is an
failure. Hyperlactataemia important compli-cation of
Cardiovascular abnormalities, shock (algid with a high lactate/pyruvate falciparum malaria and its
treatment (White
malaria). The blood pressure of patients with malaria is usually ratio indicates an ischaemic
at the lower end of the normal range, although most patients are basis for the lactic acidosis et al. 1983a). Often
warm and well perfused. Approxi-mately 10% of patients with (Pukrittayakamee et al. 2002). hypoglycaemia is not
severe malaria are consid-ered clinically to be in shock Other unidentified organic suspected clini-cally so blood
(Dondorp et al. 2005a). Severe hypotension [systolic blood ions also contribute (Dondorp glucose concentrations must
pressure less than et al. 2004a). Clinically, there always be checked in
80 mmHg (10.7 kPa) in adults in the supine position] with is no distinction between the severely ill patients. The
features of circulatory failure (cold, clammy, cya-notic skin, metabolic acidosis incidence of hypo-glycaemia
constricted peripheral veins, prolonged capil-lary refill time) is consequent upon at presentation has fallen as
seen in patients with pulmonary oedema, metabolic acidosis, microcirculatory obstruction, use of quinine has declined.
bacteraemia (see below) and following massive gastrointestinal hepatic dysfunction, and renal In conscious patients,
haemorrhage or splenic rupture. Dehydration may also contribute impairment. On admis-sion hypoglycaemia may pres-ent
to hypoten-sion, and some patients may be admitted severely plasma lactate may be high with classical symptoms of
anxiety, breathlessness, a
dehy-drated, hypotensive and oliguric having endured high fever for various reasons including
recent seizures and very high feeling of coldness,
and inadequate fluid intake for several days. How-ever, most
catecholamine levels, which tachycardia and
adult patients with severe malaria are not sig-nificantly
lightheadedness and signs of
dehydrated or hypovolaemic, and fluid resuscitation needs to be usually fall rapidly (Day et al.
autonomic overactivity
performed carefully to avoid fluid overload and pulmonary 2000a,b). Sustained elevation
(sweating, or goose-flesh).
oedema (Hanson et al. 2013). Myocardial dysfunction, of plasma lactate carries a
More severe signs include
ventricular failure and cardiac arrhythmias are very rarely poor prognosis, whereas
coma, deteriorating
observed in severe malaria, despite the sequestration of rapidly resolving
consciousness, abnormal
parasitised erythro-cytes in the myocardial vessels and the hyperlactataemia carries a
posturing (decerebrate or
marked cardiac effects of many antimalarial drugs (Bethell et al. good prognosis. If possible,
decorticate rigidity, muscle
1996). The clinical picture of algid malaria (shock in severe plasma concentra-tions
spasms, pouting, stertorous
malaria) resembles that of septic shock, and indeed, in many should be checked 4 h after
breathing and opisthotonos)
patients (but certainly not all), there is concomitant bacteraemia. admission and after adequate
and generalised convulsions.
rehydration.
The diagnosis of
hypoglycaemia may be
overlooked
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 33
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
that are involved and the
severity of their dysfunction.
Mortality is increased in the
Peripheral leucocytosis. The elderly and also in pregnant
because all these clinical features are also typical of total white count is normal in women. While the qual-ity of
severe malaria per se. the majority of patients intensive care support is an
In severe malaria, many of the usual diagnostic features of (median approximately 8000/ important determinant of
hypoglycaemia may be absent and the diagnosis may be ll). Neutrophil leucocytosis outcome, by far the most
overlooked. Sweating is an inconstant sign, the pupils are may occur in severe falcipa- important factor is the spe-
frequently not dilated, the breathing may be cyclical or stertorous rum malaria, even in the cific antimalarial drug
and deep, and there may be abnormal pos-turing of the arms and absence of detectable treatment. Treatment must be
legs. There is usually a deteriora-tion in the level of secondary bacterial infection. given as early as possible in
consciousness. Following treatment with intravenous 50% Approximately 25% of the evolution of a potentially
glucose, clinical improvement is very variable from no patients have a total white lethal infection. Artesunate
apparent change to a change in the respiratory pattern and a count on admission over 12 reduces the mortality of
lightening of coma. Hypo-glycaemia complicates malaria in 000/ll (Hien et al. 1996). severe malaria in adults by
three clinical settings which may overlap: in patients with severe Leucocytosis is associated one-third compared with qui-
disease espe-cially young children, in pregnant women and in with poor progno-sis. nine (Newton et al. 2003;
patients given quinine. Quinine-induced hyperinsulinaemia is a Leukaemoid reactions have Dondorp et al. 2005a; Phu
common contributing cause of hypoglycaemia particu-larly in been reported (Stein 1987). et al. 2010). Many studies
pregnant women (White et al. 1983a; Das et al. 1988), and have examined prognostic
hypoglycaemia in this context may be recur-rent as glucose fac-tors (Newton et al. 2013).
administration stimulates further hyperin-sulinaemia. Peripheral Differences in predictive fac-
Hypoglycaemia develops during treatment of malaria gangrene/rhabdomyolysis. tors are explained by the
significantly more commonly in patients (adults and children) There are many reports of different patient populations;
treated with quinine than those treated with artesunate (Dondorp symmetrical peripheral for example, parasite density
et al. 2005b, 2010) or arteme-ther (Hien et al. 1996). gangrene occurring in acute is clearly an important
Hypoglycaemia unrelated to qui-nine is associated with acidosis malaria, both falciparum and determinant of outcome in
in severe malaria in adults and children and carries a poor vivax. Many of these have acute falciparum malaria; yet
prognosis. It is a direct result of the disease process (anaerobic followed the treatment of within strictly defined severe
glycolysis the Pasteur effect). severe falciparum malaria, falciparum malaria, the
and in some there has been density of parasitaemia has
associated coagulop-athy much less prognostic value.
(Alkizim et al. 2011). Delay in administering
Complicating and associated infections. Other severe and life- Generalised myalgia, antimalarials is clearly a
myoglo-binuria and major determinant of
threatening infections may arise in patients with severe
histological evidence of progression to severe disease,
falciparum malaria. In some cases, there are com-plicating
inflammatory skeletal muscle but once severe disease has
infections: for example, aspiration bronchopneu-monia in
necrosis have been reported developed, outcomes are
patients who have had generalised convulsions; urinary tract
(De Silva independent of the duration of
infections in patients with indwelling ure-thral catheters; infected
decubitus ulcers in patients with prolonged coma; and infection et al. 1988), but skeletal preceding illness. Dangerous
around intravenous cann-ulae. Nosocomial infection is an muscle damage sufficient to anteced-ent factors for the
important contributor to death in patients who remain seriously cause renal failure appears development of severe
to be rare. Biochemical evi- falciparum malaria include
ill for several days. In a recent study in Vietnam in a setting with
dence of muscle damage is splenectomy, pregnancy,
good intensive care facilities, nosocomial infection was consid-
much more common corticosteroid or cytotoxic
ered to contribute to a fatal outcome in 12 of the 37 deaths in the
(Miller et al. 1989). drug use,
370 adults enrolled in a clinical trial com-paring artesunate and
artemether (Phu et al. 2010). Bacteraemia may coexist with immunosuppression, lack of
severe falciparum malaria without an evident focus. Unlike previ-ous malaria exposure
children in Africa, among whom the causative organisms are Outcome and prognostic and, to a much lesser extent,
indices in adults lapsed immunity.
usually enteric bacteria, in Vietnam only one case of Gram-
negative septicaemia was detected in 500 adult patients on
The prognosis in severe
admis-sion with strictly defined severe malaria (Parry; personal
malaria is determined by the
communication).
number of vital organ systems
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
34 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
with >50% mortality. This
loose relationship differs
according to age and intensity
deep laboured breathing of malaria transmission. In
Clinical indicators. Any degree of central nervous system (reflecting acidosis, areas of higher transmission,
dysfunction carries an increased mortality. Confusion, agitation, pulmonary oedema or the mortality associated with
obtundation are all risk factors. In the large SEAQUAMAT study aspiration pneumonia) often this parasitaemia would be
(N = 1461, 563 with cerebral malaria), unrousable coma or termed respira-tory distress considerably lower. In non-
cerebral malaria identifies a subgroup of immune subjects, parasitae-
(GCS < 11) carried a 37% mortality in adults treated with patients at high risk of dying mias over 4% are considered
quinine and 30% in those treated with artesunate. In earlier independent of cerebral sufficiently dangerous to
series, mortality with quinine treatment was lower malaria. Respiratory dis-tress warrant closely supervised
approximately 20%. This is because mortality in comatose of this kind is usually a late treatment (Tables 2 and 3)
patients is very much determined by other vital organ sign in adults. Signifi-cant (Luxemburger et al. 1995). In
dysfunction. In patients with pure cerebral malaria, that is, no bleeding is associated with an endemic areas, the thresh-old
other vital organ dysfunction, the case fatality is <10%. Marked, increased risk of dying but is is higher. The prognostic
often violent, agitation in young adults may precede rapid unusual. Jaundice carries a value of the parasite count
deterioration. Convul-sions often progress to coma, but even poor prognosis only if may be improved
with rapid recov-ery, convulsions define a group at increased combined with other evidence considerably by assessing the
risk in areas of low or unstable transmission (Wattanagoon et al. of severe disease. stage of parasite development
1994). However, although cerebral malaria is undoubt-edly a in the peripheral blood film;
very important severe manifestation of malaria, patients of all Laboratory indices. at any parasitaemia, prognosis
ages may die without cerebral involve-ment. Laboratory indicators of poor worsens if there is a predomi-
prog-nosis reflect the size of nance of more mature parasite
During the past three decades in Vietnam and Thai-land, the the parasite burden (parasite stages. In general, if more
clinical pattern of severe malaria has changed. Over two decades count, stage of parasite than 50% of the peripheral
ago, cerebral malaria was the predomi-nant manifestation of development, neutrophil pig- blood parasites are at the tiny
severe malaria, whereas today the combination of jaundice and ment), the degree of ring stage (where the
renal failure is more com-mon. The incidence of convulsions in microvascular obstruction diameter of the nucleus is less
cerebral malaria has also declined from 50% to <20% (Warrell et (lactate, bicarbonate) and the than half the diameter of the
al. 1982). Renal impairment is an indicator of severity, and the extent of vital organ rim of cytoplasm), then the
prognosis of acute renal failure is worsened by coexis-tent dysfunction or damage (urea, prog-nosis is relatively good,
jaundice (Trang et al. 1992).The prognosis of cere-bral malaria is creatinine, glucose, bilirubin, whereas if more than 20% of
worsened considerably if there is also renal failure. The signs of transaminas-es, haemoglobin, the parasites contain visible
acidosis or uraemia represent a late stage in the progression of platelet count). The pigment (i.e. mature
the disease. Oliguria or anuria are usually present, but may not prognostic value of the trophozoites or schizonts),
have been recorded. Measurement of blood urea or creatinine is parasite count, as a measure then the prognosis is
often the only method of diagnosis. In adults, severe anaemia is of parasite burden, depends relatively bad (Silamut &
less prominent than it is in children. The prog-nosis of severe on the age and degree of White 1993). Assessment of
anaemia in the absence of other severe manifestations of malaria background immunity of the peripheral blood polymor-
is good, probably because it often represents acute on chronic patient. The classical work of phonuclear leucocyte pigment
anaemia or a protracted course of illness. For this reason, recent Field in Malaya (an area of proved to be a rapid and fairly
large randomised trials have used a stricter threshold relatively low seasonal accurate prognostic indicator
(haematocrit <20% plus parasitaemia 100 000/ll) than in the transmission) first charac- in Vietnamese adults (Nguyen
current docu-ment (where the parasitaemia threshold is 10 000/ll) terised the relationship et al. 1995). As in children,
as a criterion of severe falciparum malaria (Hien et al. 1996; between parasitaemia and recent studies in adults have
Dondorp et al. 2010; Phu et al. 2010). Many studies have progno-sis (Field & Niven shown the prognostic value of
emphasised the prognostic importance of acidosis, reflected as 1937; Field 1949). There was measuring plasma PfHRP2
acidotic breathing or measured as arterial pH, base deficit, a correlation between parasite concentrations as a surrogate
plasma bicarbonate concentration, or as arterial, venous, or CSF counts and prognosis with a measure of the parasite
lactate concentration (Day et al. 1996b; Hanson et al. 2010; significant increase in burden (Desakorn et al. 2005;
White et al. 2013a). Rapid mortality with parasitaemias Dondorp
over 2%. In Fields original
series, a parasitaemia over et al. 2005b). This has
500 000/ll was associated substantially better predictive
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 35
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
the Glasgow Coma Score (GCS
02). Bicarbonate-based CAM
score (04) is calculated as the
bicarbonate score (02) plus the
Table 7 Derivation of the Coma GCS (02). Respiratory rate-
value than the parasite count (Fox et al. 2013; Hendrik-sen et al. Acidosis Malaria (CAM) Score.
based CAM score (04) is
2013c). Several prognostic scores have been developed and their Bicarbonate-Based CAM Score
calculated as the respiratory score
and Respiratory Rate-Based
performance characteristics assessed. These scores are useful for CAM Score (Assessed at (02) plus the GCS score (02)
rapid bedside assessments and triage. Acidosis (base deficit) and Hospital Admission) (Hanson et al. 2010).
cerebral malaria (mea-sured as Glasgow Coma Score) are the
main independent predictors of outcome. Score
Based on data from 868 South-East Asian adults with severe Variable 0 (Normal)
malaria, Hanson et al. (2010) developed a simple 5-point Coma
Base deficit <2
Acidosis Malaria (CAM) score derived from these two variables
GCS 15
(Table 7). Mortality increased steadily with increasing score. A Bicarbonate score 24
CAM score <2 predicted survival with a positive predictive value Respiratory rate score <20
(PPV) of 95.8% [95% confidence interval (CI), 9397.7%]. Of
the 14 of 331 patients who died with a CAM score <2, 11 (79%) CAM score
had renal failure and death occurred late after hospital admission
1
(median, 108 h; range, 40-360 h). Substitu-tion of plasma
2
bicarbonate as the measure of acidosis only slightly reduced the 3
prognostic value of the model. Use of respiratory rate was 4
inferior, but a score <2 still predicted survival with a PPV of
92.2% (95% CI 89.1 94.7%). CAM score (04) is calculated as
the base deficit score (02) plus
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
36 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
malaria is poor.
In areas of intense, stable
transmission severe or com-
unrecognised, and cerebral plicated disease with the
effects may be mistakenly exception of severe anaemia
Section 5: Severe malaria in pregnancy is uncommon in pregnancy,
attributed to malaria.
In areas of low transmission, falciparum malaria is an important Hypoglycaemia in late and malaria is unusual as a
cause of maternal mortality (Desai et al. 2007; Rijken et al. pregnancy commonly recurs direct cause of maternal
2012a). Severe malaria in late preg-nancy is a devastating and after correction by death. The main presentation
fulminant disease with a high mortality for both mother and fetus intravenous glucose therapy. of severe malaria is severe
that is very difficult to manage, requiring close liason between anaemia. This is often multi-
physicians, obstetricians and paediatricians. The case fatality is factorial with a further
Acute pulmonary oedema
sub-stantially higher in the second half of pregnancy than in non- reduction in haematocrit as a
pregnant adults, and with quinine treatment often reached 50% Pregnant patients with severe result of pregnancy-
(Looareesuwan et al. 1985; Mengistu falciparum malaria are par- associated anaemia, iron and
et al. 2006). Reduced host-defence mechanisms and extensive ticularly prone to develop nutri-tional deficiency and
parasite sequestration in the placenta both contribute to the acute pulmonary oedema. The sometimes folate deficiency
increased risk. Severe malaria is an important cause of abortion, first signs are an increase in (Flem-ing 1989). With
stillbirth, premature deliv-ery and fetal death (Desai et al. 2007; respiratory rate, which pre- increasing success of malaria
McGready et al. 2012b). In travellers from non-endemic areas cedes the development of control measures,
and resi-dents of low transmission areas who have little or no chest signs. Dyspnoea and transmission intensities are
background immunity, pregnancy increases the risk that a hypoxia may be present on falling and this may result in
P.falciparum infection will develop into severe malaria. Any of admission or develop sud- an increase in the risk of
the syndromes observed in non-preg-nant adults may occur in denly several days after maternal severe malaria. HIV
pregnant women, but two manifestations are particularly admission to hospital. Acute infection and malaria
common: hypoglycaemia and pulmonary oedema (White et al. pul-monary oedema often synergise in their harmful
1983b; Looareesu-wan et al. 1987). The anaemia of severe develops immediately after effects on pregnancy. Severe
malaria com-pounds pre-existing pregnancy-related anaemia delivery and may occur at any malaria increases the risk of
(Phillips et al. 1986a; Fleming 1989). Fetal distress is usual, and time in the first week post- vertical transmission of HIV
fetal death is common. After delivery post-partum haem-orrhage partum. Women who are infection, as does the
is common, and there is a high risk of puer-peral sepsis. If the severely anaemic or fluid- presence placental
fetus does survive, there is intra-uterine growth retardation. overloaded when they go into parasitaemia at parturition.
labour may develop acute Menendez et al. (2008)
pulmonary oedema after conducted a prospective
separation of the placenta. autopsy study between
Severe anaemia is October 2002 and December
Hypoglycaemia associated with maternal 2004 on the causes of
morbidity, an increased risk maternal death in a tertiary-
Hypoglycaemia is a common presenting feature of severe
of post-partum haemorrhage level referral hospital in
malaria in pregnancy (Looareesuwan et al. 1985). Qui-nine is
and peri-natal mortality. Maputo, Mozambique: 65 of
particularly dangerous in pregnancy because it causes marked
hyperinsulinaemia. In the past, hypo-glycaemia developed during the 139 women (46.8%) who
the course of quinine treat-ment in 50% of pregnant women with Premature labour died were HIV-positive.
cerebral malaria (White et al. 1983b). Artesunate reduces the Severe malaria was
mortality of severe malaria in adults by 35%, does not cause Symptomatic falciparum responsible for 14 (10.1%) of
hypo-glycaemia and is therefore the treatment of choice in all malaria commonly induces the maternal deaths.
trimesters of pregnancy (World Health Organization 2010a). uter-ine contractions and this
Hypoglycaemia may be associated with lactic acidosis in may precipitate premature
fulminant multisystem disease, or it may be an isolated labour. The frequency and
complication. Hypoglycaemia may be asymp-tomatic or may intensity of contractions are
present with sweating, behaviour change, altered consciousness related to the height of fever
(Looareesuwan et al. 1985).
or convulsions. There may be associated foetal bradycardia or
Fetal distress is usual. The
other signs of fetal distress. Asymptomatic hypoglycaemia is
foetal prognosis in premature
commonly
labour associated with severe
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 37
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Acidosis is an important cause of death from severe malaria and Pulmonary oedema. Acute Acute Kidney Injury is a
results from accumulation of organic acids including lactic acid respiratory distress syndrome frequent feature of severe
(Day et al. 2000b). This may be com-pounded by ketoacidosis in (ARDS) is a feared malaria. Oliguric renal
children or acute renal failure in adults. Acidotic breathing, a complication in adults with failure is common in adults
major cause of respiratory distress, is a sign of poor prognosis in severe falci-parum malaria, with severe falciparum
malaria (Marsh et al. 1995). It is often followed by circulatory and it may also develop in malaria, but rare in children.
failure refractory to volume expansion or inotropic drugs and acute vivax malaria. It behaves clinically and
ultimately by respiratory arrest. The plasma concentrations of Significantly increased pathologically as acute
bicarbon-ate or lactate are among the best biochemical pulmonary capillary per- tubular necrosis.
prognostica-tors for death in severe malaria as they rise in meability develops after start Hypertension and significant
proportion to disease severity (Krishna et al. 1994; Hanson et al. of antimalarial treatment in proteinuria never occur. The
2010; von Seidlein et al. 2012) (see Section 10). Lactic aci-dosis up to a third of patients pathogenesis is still unclear,
is caused by the combination of anaerobic glycolysis in tissues (Taylor et al. 2012b). As with but reduced microcirculatory
where sequestered parasites interfere with micro-circulatory ARDS in other settings the flow as well as inflammation
flow, lactate production by the malaria para-sites, and a failure of pathogenesis is not fully likely contribute
hepatic and renal lactate clearance. Although hypovolaemia has under-stood, although (Nguansangiam et al. 2007).
been considered a contributor to hyperlactataemia, recent studies inflammatory mediated Acute renal failure may
question its causative increased capillary occur with multiple vital
permeability or endothelial organ dysfunction (carrying
damage is a central feature. a high
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 41
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
of malaria before the
introduction of control
measures, which suggests that
pathological interpretations. these genetic disorders con-
mortality) or may develop as other disease manifestations Plasma PfHRP2 concentra- fer a survival advantage in the
resolve. In survivors, urine flow resumes in a median of 4 tions, which can be used to presence of malaria. Indi-
days, and serum creatinine levels return to normal in a estimate the number of viduals who are homozygous
mean of 17 days (Trang et al. 1992). Early haemofiltration or sequestered P. falciparum for the sickle cell gene suffer
dialysis considerably improve the prognosis, particularly in parasites which release this from sickle cell disease,
acute hypercatabolic renal failure (Phu et al. 2002). protein, can distinguish which confers a reduced life
Although a variety of glomerular abnormalities have been between severe malaria and expectancy, whereas the
reported associated with malaria, the clinical features, urine severe other febrile illnesses heterozygous sickle cell car-
sediment (not active), and natural history of acute kidney with incidental parasitaemia rier does not suffer from the
injury do not suggest significant glomerulonephritis. (Hendriksen et al. 2012b, haemoglobinopathy and in
2013c; Seydel et al. 2012). addition is protected from
Severe jaundice is associated with P. falciparum infec-tions; it is HIV transmission and severe malaria. These
more common among adults than among chil-dren, and results progression may be contrast-ing clinical effects
from a combination of haemolysis, hepatocyte injury and accelerated by malaria have resulted in a balanced
cholestasis. Jaundice is often accompanied by renal impairment. (Kublin et al. 2005; Abu- polymor-phism during
Liver blood flow is reduced in severe malaria (Molyneux et al. Raddad et al. 2006), whereas evolution (Williams 2012).
1989a; Puk-rittayakamee et al. 1992), and hepatic conversely, HIV infection
gluconeogenesis is impaired (White et al. 1983a,b; White et al. increases the incidence of Several different malaria
1987a,b; Taylor et al. 1988; Day et al. 2000a,b). Hepatic clinical malaria, severe protective mechanisms have
dysfunc-tion contributes to hypoglycaemia, metabolic acidosis malaria and malaria-related been identified: these include
and impaired drug metabolism. mortality in adults with decreased parasite growth at
deteriorating immune status low oxygen tensions (Hb AS),
(Whitworth et al. 2000; reduced cytoadherence (Hb
Interactions with bacterial infections and HIV/AIDS. Kublin et al. 2005; Chalwe et AC, CC, AS), reduced
Bacteraemia, especially with Gram-negative bacteria, may al. 2009). In children with invasion (ovalocytosis),
complicate severe malaria, particularly in children. African severe falciparum malaria, reduced parasite densities
children with slide-proven severe malaria have a 4.6 7.8% HIV-AIDS increases the (G6PD deficiency) and
prevalence of concomitant bacteraemia (Berkley et al. 2005; severity, number of reduced multiplication at high
Bronzan et al. 2007). Given the limited sen-sitivity of blood complications and mortality. densities (HbAE). The
culture (Gilman et al. 1975), the real number of children with (Patnaik et al. 2005; Berkley underlying mechanism has
malaria who have bacterial septicaemia could be twice as high. et al. 2009; Hendriksen et al. been worked out in detail for
Falciparum malaria has been estimated to account for more than 2012a). HbAS and HbS. In parasitised
half of invasive bacterial disease in children living in malaria- red blood cell with these
endemic areas (Scott et al. 2011). Parasite digestive vac-uoles, haemoglo-bins, the trafficking
containing malaria pigment, are rapidly phagocy-tosed by of PfEMP1 and other proteins
Other host factors
polymorphonuclear granulocytes and cause a state of functional to the red blood cell surface is
neutrophil exhaustion. This blunts their microbicidal activity Many of the common disturbed (Cyrklaff et al.
upon bacterial challenge and may well contribute to the enhanced inherited red cell disorders 2011), causing aberrant knob
susceptibility of severe malaria patients to invasive bacterial confer a relative protection formation leading to reduced
infections (Dasari et al. 2011). Inhibition of neutrophil oxidative against the development of cyto-adherence of the
burst by induction of haem oxygenase (Cunnington severe malaria, and there is infected erythrocyte (Cholera
strong evidence that malaria et al. 2008). Most of the
et al. 2012a,b), and quenching of nitric oxide (Yeo et al. has been the direct cause of haemoglobinopathies are
2009), a key anti-Salmonella mediator, are also hypothesised their evolutionary persistence. associated with a reduced risk
to increase the risk of bacteraemia in malaria. Increased The geographical of severe malaria, but HbAS
translocation of bacteria across the distributions of sickle cell has also been associated
intestinal lining may also be an important contributor. There is disease, hae-moglobins C and consistently with reduced risk
extensive misdiagnosis of severe malaria in children who have E, ovalocytosis, the of uncom-plicated malaria
severe sepsis (septicaemia, pneumonia, thalassaemias and glucose-6- (Taylor et al. 2012a).
meningitis) and incidental parasitaemia (Reyburn et al. 2004). phosphate dehydrogenase
This has confounded clinical studies and (G6PD) deficiency match that
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
42 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
9a). The developmental
staging of parasites within a
vessel on brain smears
suggests that they arrive,
(a)
Section 8: Pathology of severe falciparum adhere and subse-quently
malaria develop in a synchronous
manner and do not detach
Pathology studies based on post-mortem and biopsy material are
once adherent (Silamut et al.
essential for a better understanding of the pathophysiology of
1999; Milner et al. 2012a,
severe Plasmodium falciparum malaria. Two large autopsy
White et al. 2013b). In
studies (one from Vietnam and the other from Malawi)
addition to cytoadhesion of
conducted over the past twenty years have used detailed
parasitised erythrocytes to
clinicopathological corre-lation with histological, ultrastructural
microvascular endothelium,
and immunohisto-chemical features and are now applying more
factors that contribute to
advanced molecular pathological techniques to the investigation
microvascular sequestration
of fatal malaria. However, several fundamental questions
in the brain include a
regarding the pathophysiology of fatal malaria remain
reduction in RBC
controversial, such as the mode of death in malaria patients, and
deformability (Don-dorp et al.
the factors causing coma in cerebral malaria. There are very few
2004b), clumping of PRBC or
pathology reports of fatal vivax malaria (see Section 13).
adhesion via platelet/von
(b)
Willebrand factor strings
(Bridges et al. 2010) and/or
The pathological features of cerebral malaria rosette formation (Ho et al.
1991; Chotiva-nich et al.
Sequestration. The predominant histopathological fea-ture of 2000).
human cerebral malaria (CM) is the sequestration of erythrocytes
containing Plasmodium falciparum troph-ozoites and schizonts
in the capillaries and post-capillary venules of the brain, first
recognised over a century ago (Marchiafava & Bignami 1892).
Parasitised red blood cells (PRBC) sequester and reduce the
diameter or com-pletely fill the vascular lumen (Figures 7 and 8).
Although sequestration is extensive in most cases of CM, the
degree and intensity differ between organs and within areas of
the brain.
Figure 7 Sequestration of
Sequestration in cerebral microvessels tends to be more parasitised erythrocytes in
intense in the cerebral cortex, where vascularity is greater in the cerebral microvessels in post-
grey matter than in the midbrain or brainstem. mortem brain tissue from fatal
cases of cere-bral malaria.
The degree of sequestration measured histologically varies with Packing of small calibre
duration of illness prior to death and with treat-ment. However, capillaries and post-capil-lary
the measurement of sequestration using histology on brain venules is demonstrated in this
sections (Aikawa et al. 1990; Pong-ponratn et al. 1991; Taylor et section of cerebral cortex
al. 2004; Dorovini-Zis (a). Margination in larger calibre
venules due to cytoadherence can
et al. 2011; Ponsford et al. 2012), brain smears (Silamut et al. also be demonstrated (b with
1999; Milner et al. 2012a) or by electron micros-copy inset) (haematoxylin and eosin,
(Pongponratn et al. 2003) (Figure 8) confirms that high levels 9400).
are significantly associated with ante-mortem coma.
Significantly more PRBC sequestration is seen in the brain of
cerebral malaria patients compared to cases both without The microvascular
neurological complications and without clinical evidence of distribution of sequestration
cerebral sequestration (i.e. malarial retinopathy), in both adult is not uniform and vessels
and paediatric cases, regard-less of brain area, time from may contain many parasites
treatment to death or type of treatment (Pongponratn et al. in one segment, but adjacent
2003; Dorovini-Zis areas or neighbouring vessels
et al. 2011). may only demonstrate
occasional parasites (Figure
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 43
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
(a)
association of ICAM-1
binding phenotype with clini-
cal risk of cerebral malaria
suggest that this is a major
receptor for sequestration in
the brain during CM (Och-ola
et al. 2011). Using molecular
pathological methods of PCR
and RT-PCR from autopsy
tissues, the genotype of
parasites sequestered in
different organs shows a nar-
rower spectrum than
circulating parasites,
(b) implying some selection of
binding parasite phenotypes
(Montgomery
Figure 8 Transmission electron micrograph of a cerebral venule
showing marginated cytoadherent parasitised erythrocytes, and et al. 2006; Milner et al.
uninfected erythrocytes within the narrowed vascular lumen. Tight 2012b). However, no specific
interactions of the endothelium with parasitised red blood cells as well
as between parasitised red blood cells and unin-fected red blood cells
have been seen at this level. Focal perivas-cular oedema is present in the
Virchow-Robbins space.
(Bar = 100 lm, courtesy of Prof Emsri Pongponratn, Mahidol
University and Prof David Ferguson, Oxford University).
(a) (b)
(a) (b)
Figure 11 MRI imaging of the brain in paediatric cerebral malaria. Severe brain swelling occurred in this patient with effacement of the 4th
ventricle, prepontine cistern and brainstem compression and tonsillar herniation (a); and normal child of similar age for com-parison (b).
Pictures supplied by Dr Sam Kampondeni.
ischaemic damage in 4, all of been reported in African chil-
in the brain, are commonly found in survivors, suggest-ing that whom suffered from neuro- dren, although the specificity
in common with sequestration haemorrhages are not solely logical sequelae (Newton et of the clinical signs is unclear
sufficient to cause mortality. However, unlike sequestration, the al. 1994). The pattern of (Pongponratn et al. 1991; Idro
number of haemorrhages is not quantitatively linked to the injury was consistent with a et al. 2005a; Seydel et al.
presence of coma pre-mortem. critical reduction in perfu- 2011). In other words it has
sion pressure, and the been unclear if the brainstem
convalescent scans showed clinical signs resulted from
cerebral atrophy. Acute CT brainstem compression or
Brain swelling and oedema findings in Malawian intrinsic dysfunction related
At autopsy, the brain may be swollen or normal in adults, children included cerebral to the disease process. Histo-
whereas brain swelling is universal in African children (Potchen oedema and acute brain logical evidence of oedema is
et al. 2010; Dorovini-Zis et al. 2011) (Figure 12a). Adult patients infarctions. In 11 children seen in over 60% of adult
with coma may have no evidence of brain swelling either with subsequent neurological cases (Medana et al. 2011),
radiographically before death or at autopsy. Computerised sequelae who had CT scans and most if not all paediatric
tomography (CT) in Indian adults with cerebral malaria showed 718 months after the initial cases (Dorovini-Zis et al.
that brain swelling occurred but was not related to coma depth or illness, 5/11 had focal and 2011) (Figure 12b). Much of
fatal outcome (Mohanty et al. 2011). CT and magnetic resonance multifocal lobar atrophy the increase in cerebral
imaging (MRI) data in paediatric cases demon-strate oedema correlating with regions of volume in adults in the acute
commonly in cerebral malaria patients with a strong association the brain affected by focal phase of illness can be
with outcome (Figure 11) (Seydel et al. 2011; Potchen et al. seizures during the acute quantitatively explained by
2012). In a study of Nigerian children, the post-mortem findings illness (Potchen et al. 2010). the intravascular load of
suggested gross cerebral oedema and raised intracranial pressure sequestered parasites and
in four of seven cases with petechial haemorrhages and small Evidence for raised uninfected erythrocytes
areas of focal necrosis (Walker et al. 1992). Com-puted intracranial pressure and (White et al. 2013b).
tomography of the brain in 14 Kenyan children recovering from subsequent frank brainstem Congestion of microvessels
cerebral malaria with raised intracranial pressures revealed herniation is uncommon in with PRBC and uninfected
evidence of brain swelling in 6 and of adults. Clinical and RBC is associated
radiological evidence for significantly with coma
brainstem herniation as a (Ponsford et al. 2012), but the
mode of death in CM has degree and patterns
46 2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
(a)
(b)
(b)
(c)
Axonal injury
Acute axonal injury, detected both morphologically
as swollen axonal sheaths and bulbs, or on immunohisto-
chemistry by accumulation of beta-amyloid precursor protein, is
found in post-mortem studies of CM patients in both adult and
paediatric cases (Medana et al. 2002, Dorovini-Zis et al. 2011)
(Figure 14). This likely repre-sents a reversible but final
common pathway to neurolog-ical impairment in CM.
Platelet deposition
(b)
Lung pathology
tion is significantly associated with poorer prognosis in children is seen in combination with Respiratory distress is a
and adults, and it has been noted that in HIV-infected children malaria retinopathy (Beare common feature of severe
with fatal malaria, there is a lack of monocyte sequestration in et al. 2004, 2011; Taylor et falci-parum malaria in both
the brain (Grimwade et al. 2004; Berg et al. 2008). Where the al. 2004; Birbeck et al. children and adults (Taylor &
opportunity to exam-ine potential differences due to treatment 2010a; Dorovini-Zis et al. White 2002; Taylor et al.
has presented, no differences in the type or degree of brainstem 2011; Milner et al. 2012a). 2006c). Metabolic acidosis is
neuro-pathology were found in adult patients treated with dif- The Malawi autopsy study the most important cause of
ferent drugs (artemether versus quinine) (Hien et al. 2003). showed that approximately respiratory distress, but many
25% of clinically diagnosed other factors may contribute
Quantitative neuropathological examination using mul- CM cases did not have to it, including severe
tivariate analysis in Vietnamese cases of CM shows that the evidence of malaria parasite anaemia, pulmonary oedema
presence of coma before death was associated with the sequestration in the cerebral and aspiration pneu-monia.
neuropathological features of PRBC sequestration, micro- microvascu-lature and had Frank pulmonary oedema is
vascular congestion and axonal injury. Observed seques-tration other causes of death (Taylor more common in adults than
in brain microvessels was associated with time to death (i.e. et al. 2004). This large children and is a poor
duration of treatment), admission Glasgow Coma Score and proportion of patients in prognostic sign, although it is
density of peripheral parasitaemia. In African children, cerebral which the clinical case less common with improved
malaria was confirmed using a pathological cut-off of more than definition failed has ventilation
21% of cerebral vessels showing sequestration at post-mortem implications for both the
(Taylor et al. 2004; Milner et al. 2012a). The sensitivity of reliability of verbal autopsy
diagnosis of malaria increases, and the prognosis worsens, when (Snow et al. 1992) and the
coma interpretation of treatment or
vaccine trials.
Parasitised erythrocytes sequestered in alveolar
capillaries alongside host lymphocytes and
monocytes (b) are demonstrated in most patients
Figure 18 Examples
(c) of the pathology (H&E 9 100). Immunohistochemistry with anti-
(a) (b) CD68 (c) shows both intralveolar macrophages
(d) found in the lung
and type 2 pneumocytes and an increase in
during Plasmodium
circulating monocytes in alveolar capillaries,
falciparum malaria.
many of which contain phagocytosed malaria
Patchy pulmonary
pigment (H&E 9 400). In paediatric cerebral
oedema (a) with
malaria, the amount of pigment within
pigment deposition
macrophages is significantly greater than in non-
can be seen
CM patients. A case of pyogenic pneumonia (d)
commonly in adults
is dem-onstrated as the cause of death in a
and in about 40% of
patient who recovered from cerebral malaria but
paediatric cases
died later (H&E 9 400).
(H&E 9 100).
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 51
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
include thickened alveolar
septa showing monocytes
and neutrophils (often
Figure 19 Manifestations of contain-ing phagocytised
Plasmodium falciparum malaria particles of malaria pigment),
(a)
infection in the kidneys are patchy intra-alveolar
shown. Histology demonstrating
haemorrhage and pulmonary
sequestration of parasitised
erythrocytes (a) in both oedema. In individual adult
glomerular (arrowheads) and cases, hyaline membrane
peritubular capillaries. There is formation can be seen as an
associated tubular epithelial cell indicator of diffuse alveolar
swelling and degeneration damage; this pattern has not
consistent with acute tubular
been observed in children.
necrosis (ATN) (H&E staining
9200). A transmis-sion electron Pyogenic con-solidation may
micrograph (b) shows be found in some cases,
sequestered PRBC, unin-fected indicating that pneumonia
red cells (RBC), and was the true diagnosis in a
mononuclear leucocytes (M) in a patient with inci-dental
peritubular capillary. The parasitaemia whose illness
proximal tubular cell is separated
was mistakenly attrib-uted to
by the basement membrane (BM)
and is rich in mitochondria (Mi) malaria, or it may be a
(b) (Scale bar = 2 lm, courtesy of secondary complication of
Prof Emsri Pongponratn). Fibrin coma, convulsions or
thrombi within glomerular intubation in patients
capillaries (c) indicative of suffering from cerebral
microang-iopathic changes are
malaria.
seen in approximately 40% of
classic paedi-atric cerebral
malaria cases.
Renal pathology
weight with associated Renal failure is a common
pulmonary oedema on clinical manifestation of
section-ing. Pleural or severe falciparum malaria in
intrapulmonary punctuate adults, but it is uncommon in
haemorrhages can be seen in chil-dren (Trang et al. 1992;
adults (these are common in Mehta et al. 2001; Dondorp et
many organs in adults with al. 2005a). There is a clinical
fatal malaria). In contrast, association between jaundice
haem-orrhages outside of the and acute renal failure in
brain in paediatric cases have adults (Day et al. 2000a).
(c)
not been found. Alveolar Patients may have shock,
capillaries may show seques- anaemia and other
tration of PRBC, causing complications potentially
congestion of pulmonary reducing renal oxygenation. A
capil-laries, and there is study of renal blood flow and
sometimes associated intra- haemodynamics in
alveolar haemorrhage. The Vietnamese patients with
degree of host leucocyte severe malaria showed only a
response is greater in the lung small decrease in renal
than the brain, with
monocytes, neu-trophils and
lymphocytes seen in alveolar
capillaries (Duarte et al.
1985; MacPherson et al.
1985). In some cases, the
inflammatory response
and ICU level care for adult patients (Brooks et al. 1969). Adult
resembles a pneumoni-tis
patients may develop radiological and clin-ical signs of acute
(Figure 18).
respiratory distress syndrome (ARDS). At autopsy, the lungs may
be normal or increased in
The pathological features
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
52 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Tiny ring Ring form, width <1/2 of diameter of the nucleus 12, round at one side of cytoplasm No
Small ring Ring form, width 1/2 of diameter of the nucleus 12, round at one side of cytoplasm No
Large ring Ring form, width diameter of the nucleus 12, round or elongated No
Early trophozoite Spherical 12, inside cytoplasm Faint, pale brown
Middle trophozoite Spherical, enlarged, stained dark 12, pale inside cytoplasm Brown, clumps
Late trophozoite Spherical, 1/2 of host RBC, stained dark 12, pale inside cytoplasm Dark brown clumps
Early schizont Spherical, >1/2 of the host RBC, stained dark 35, irregular, inside cytoplasm Dark brown clumps
Late schizont Spherical, nearly fills the host RBC, stained dark >5, round or oval, inside cytoplasm Dark brown clumps
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
56 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Figure 23 Plasmodium falciparum in the thin blood smear: stages of asexual parasite development (Silamut et al. 1999). Pigment-con-taining
trophozoites and schizonts is sequestered and so rarely seen on peripheral blood smears. Finding these mature stages comprise >20% of peripheral
blood parasites carries a poor prognosis in severe falciparum malaria.
Kenyan study calculated that
among children under 2 years
can present with a low old with severe disease and
parasites in the first 24 h of the 48 h asexual life cycle are parasite count, high over 2500 parasites/ll, the
usually visible (Figure 23 and Tables 8 and 9). Sexual stages of counts without signs or malaria-attributable fraction
the parasites (gametocytes) may also be seen but do not symptoms of severity are of severe disease exceeded
indicate acute infection, as their period of matura-tion and associated with increased 85% in moderate- and low
subsequent clearance is considerably slower than that of risk. In a low transmission transmission areas, but 61%
asexual stages. setting a peripheral blood in a high transmission area
Patients with uncomplicated malaria without clinical severity slide showing 4% (Bejon et al. 2007). In
symptoms have on average lower peripheral blood parasitaemias infected RBCs (around children with cerebral
than patients with severe disease. As an example, one study from 150 000/ll) without signs malaria, parasitaemias in
Thailand found a geo-metric mean parasitaemia of 62 574/ll (50 of severity is associated excess of 1 000 000/ll were
09578 144/ ll) in hospitalised patients with uncomplicated with a mortality of around significantly associated with a
disease, versus 206 395/ll (156 458272 332/ll) in patients with 3% (Luxemburger et al. fatal outcome (Moly-neux et
severe disease (Dondorp et al. 2005b). However, within the 1997). al. 1989b). Both histidine-rich
patient group with severe disease, peripheral blood parasitaemia protein 2 (Pf HRP2) and
varies greatly and is only a weak predictor of mortality in In areas of high malaria malaria pigment
falciparum malaria. This is because the less pathogenic transmission, children may phagocytosed by monocytes
circulating stages can be counted in the peripheral blood slide, tol-erate higher levels of clear more slowly than
whereas the more pathogenic sequestered mature parasitised parasitaemia without severe malaria parasites and indicate
erythrocytes are not seen. As a consequence of sequestration, two symp-toms, and low level recent infection in a parasite
identical peripheral blood parasite counts can represent a 100- parasitaemia can be detected negative patient, which is a
fold difference in sequestered parasite biomass (White & Krishna in a high proportion of not uncommon scenario in
1989). The clinician should thus not be reasssured by the asymptomatic children. The patients that have been pre-
laboratory reporting a low peripheral blood parasite count when probabil-ity that a severe treated with antimalarial
the patient has symptoms of severe disease. Although severe febrile illness is attributable drugs before hospital
malaria to malaria increases with admission (Day et al. 1996a).
higher parasitaemias. A
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 57
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Table 9 Criteria for identifying developmental stages of Plasmodium falciparum in thick blood smears as assessed by light microscopy modified
from Silamut et al. (1999)
Stage
development Cytoplasm Nucleus Pigment
(a) (b)
(c) (d)
Figure 26 Simulated total first-dose exposure levels (AUC012 h) of (a) artesunate and (b) DHA after the standard 2.4 mg/kg parent-eral dosing
in children at different body weights (ref is Hendriksen et al. 2013b). Simulated total first-dose exposure levels (AUC0 12 h) of (c) artesunate
and (d) DHA after the suggested adjusted dose regimen (Table 3). Open circles represent median values, and bars indicate the 25th75th
percentiles of simulations (1000 simulations at each body weight). The broken line represents the median
exposure for the largest weight group (i.e. 700 and 1230 h ng/ml for artesunate and DHA, respectively). ARS, artesunate; AUC012 h, area under
the concentrationtime curve from time points 012 h; (DHA, dihydroartemisinin).
were found to be similar for
Table 10 Bodyweight- i.m. and i.v. artesunate
take oral medications reliably, parenteral (intramuscular) adjusted i.m. artesunate dosing (Nealon et al. 2002), whereas
artesunate is also the drug of choice. If injections cannot be regimen for children that
provides similar exposure to
rec-tal artesunate needs to be
given, then rectal artesunate is indicated in young children, but that in adults receiving 2.4 given at fourfold higher doses
not in older children (>6 y) and adults until further evi-dence of mg/kg to reach similar
safety is obtained. bioavailability (Ilett et al.
Dose i.m. 2002a). Other for-mulations
Weight (kg) (mg)
Drug treatment. Severe malaria is a medical emergency. After are in development. This dose
rapid clinical assessment and confirmation of the diagnosis, full 67 20 is unchanged in renal
doses of parenteral antimalarial treatment should be started 89 25 impairment, liver
without delay with any effective anti-malarial first available. 1011 30 dysfunction, pre-treatment,
Artesunate (i.v. or i.m.) is the treatment of choice, artemether 1213 35 and the elderly. Any
(i.m.) is second choice, and quinine (i.v. or i.m.) is third choice. 1416 40
uncertainties over the safety
1720 50
Artesunate should be given in a dose of 2.43 mg/kg BW 2125
of artemisinins to
60
preferably by intravenous route or by intramuscular injec-tion on
admission (time = 0), then at 12 h and 24 h, then once a day until *For children <14 kg dilute
the patient can reliably take oral medica-tion. As children require to 10 mg/ml, for children 14
higher doses to achieve equivalent exposures to adults kg dilute to 20 mg/ml.
(Hendriksen et al. 2013b) (Figure 26, Table 10), a simple Divide over both thighs.
recommendation is to give parenteral artesunate at a dose of 3
mg/kg to patients <20 kg, and 2.4 mg/kg for heavier patients. All and given by intravenous or
the large clinical trials have been performed with one artesunate intramuscular injection. The
formulation, in which a lyophilised powder of artesunic acid is pharmacological properties,
dissolved first in 1 ml 5% sodium bicarbonate, and this solution notably the bioavailability of
is then diluted with 5% dextrose or 0.9% sodium chloride the active metabolite DHA,
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 77
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
patient has had impaired
consciousness, because of an
increased incidence of
followed by a full course of neuropsychiatric
the developing fetus are outweighed in severe malaria by their oral antimalarial treatment, complications associated with
enormous life-saving benefit and better safety profile in once the patient can tolerate mefloquine following
pregnancy. oral therapy. The previously cerebral malaria (Nguyen et
Artemether 3.2 mg/kg BW should be given by intra-muscular recommended options for al. 1996).
injection to the anterior thigh on admission then 1.6 mg/kg BW follow-on oral treatment are
daily thereafter until the patient can reliably take oral medication. as follows (World Health *Doxycycline is preferred
This dose is unchanged in renal impairment, liver dysfunction, Organization 2010a): to other tetracyclines because
pre-treatment, infants, children and the elderly. Intramuscular 1 artemether
lumefantrine
plus it can be given once daily and
arteme-ther is, however, absorbed very slowly in patients with does not accumulate in renal
acute malaria (Hien et al. 2003) and also with great vari-ability in 2 artesunate plus amodiaquine failure. Where available,
children with severe malaria (Mithwani et al. 2004). The 3 dihydroartemisinin
piperaquine
plus clindamycin should be
generally recommended regimen for intramus-cular artemotil substituted in children up to
4 artesunate plus sulphadoxine
pyrimethamine age of 7 years and pregnant
(available only in India) is a larger initial dose of 4.8 mg/kg
followed by the same maintenance dose of 1.6 mg/kg BW daily 5 artesunate plus clindamycin women because doxycycline
or doxycycline*
thereafter, until the patient can reliably take oral medication (Li should not be given to these
et al. 2004). 6 quinine plus clindamycin or
doxycycline groups.
Most countries have their
Quinine 20 mg dihydrochloride salt/kg BW on admis-sion (4-h own first-line treatment pol-
IV infusion or divided IM injection 10 mg salt/kg given into icy for uncomplicated
each anterior thigh). This is followed by 10 mg/kg BW every 8 h. malaria this should be
The intravenous infusion rate should not exceed 5 mg salt/kg given in full as follow-on
BW per hour. therapy after initial parenteral
treatment for severe malaria.
Follow-on treatment. Parenteral antimalarials in the treatment of The only caveat is that
severe malaria should be given for a mini-mum of 24 h, once mefloquine should be
started (irrespective of the patients ability to tolerate oral avoided as a component of
medication earlier). This should be follow-on therapy if the
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
78 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
2011a,b).
Epidemiology of complicated
and severe vivax malaria
Section 13: Severe vivax malaria In the only modern autopsy
Outside of Africa, P. vivax series, at least four of 17
Plasmodium falciparum causes the majority of severe and fatal (23.5%) vivax-associated
causes almost half of all
malaria cases and has overshadowed the public health deaths in Brazil were attribut-
importance of vivax malaria (Baird 2007; Price malaria cases, with 70390
million clinical infections able to alternative causes,
et al. 2007). Plasmodium vivax is less pathogenic than P. including meningitis and yel-
each year (Price et al. 2007).
falciparum in otherwise healthy patients, but can cause low fever (Lacerda et al.
In countries endemic for both
complicated and severe disease (Price et al. 2007, 2009; Baird 2012). This proportion is
major Plasmodium species, P.
2009; Bassat & Alonso 2011; Anstey et al. 2012). In the malaria similar to the 23% of P.
therapy era, acute mortality during vivax infection can account
for up to 38% of patients falciparum-associated deaths
P. vivax therapy of neurosyphilis averaged 510% over-all attributable to other non-
hospitalised with malaria
(Swellengrebel & De Buck 1938) and up to 1014% with the falciparum aetiologies at
(Buck et al. 1983; Gopinathan
Madagascar strain (James 1933), but these were debilitated autopsy in Malawi (Taylor et
& Subramanian 1986;
patients with a fatal underlying disease. Plas-modium vivax al. 2004). An additional 41%
Maitland et al. 1997; Carrara
infection has been associated with severe and fatal disease in of the Brazilian fatal vivax
et al. 2006; Tjitra et al. 2008).
endemic areas, including Indonesia (Barcus et al. 2007; Tjitra et cases had major underly-ing
In Indonesian Papua, P. vivax
al. 2008; Lampah et al. 2011; Nurleila et al. 2012), Papua New comorbidities contributing to
accounted for 24% of malaria
Guinea (Genton et al. 2008; Manning et al. 2011), India (Kochar death at autopsy (Lac-erda et
admissions in all age groups,
et al. 2010; Yadav et al. 2012), Brazil (Andrade et al. 2010; al. 2012), an association also
but 47% (415/887) of infants
Lacerda et al. 2012), Venezuela (Rodriguez-Morales recognised in the early
(Tjitra et al. 2008). The need
for hospitalisation indicates literature (James 1925;
et al. 2008), Thailand (Luxemburger et al. 1997), Malay-sia Kitchen 1949a). The popu-
significant morbidity and at
(Barber et al. 2012) and Sudan (Mahgoub et al. 2012). Severe lation-based risk of severe
least moderately severe
manifestations associated with P. vivax infection in these series and fatal disease is not well
disease (Anstey et al. 2012).
include severe anaemia, respira-tory distress and acute lung defined. In Indonesian Papua,
This ranges from vomiting
injury (ALI), acute kidney injury (AKI), splenic rupture, where transmission is high,
and inability to tolerate oral
metabolic acidosis, jaun-dice, multiorgan dysfunction, shock and the risk of severe disease and
rarely coma. ther-apy, through to
prostration and those with death from P. vivax was
P. vivax also causes substantial morbidity, particularly severe estimated at 1 in 270 and 1 in
disease mani-festations
anaemia (Genton et al. 2008; Tjitra et al. 2008; Poespoprodjo 3959 clinical infections,
fulfilling the severity criteria
et al. 2009; Price et al. 2009; Manning et al. 2011; Nurleila et respectively, compared to
described earlier for
al. 2012) and low birthweight (Nosten et al. 1999; estimates for P. falciparum of
falciparum malaria (Section
Poespoprodjo et al. 2008; Rijken 1 in 185 and 1 in 1742,
2). The risk of severe dis-ease
et al. 2012a). While many recent series report PCR exclu-sion of respectively (Tjitra et al.
from single P.vivax infections
mixed Plasmodium infection, investigation for concurrent 2008). Mortality rates in
is very low in other-wise
infections or comorbidities has been mostly incomplete. those hospitalised in
healthy adults and older
Evidence is strong that P. vivax can cause severe anaemia (Price Indonesian Papua with
children without
et al. 2009; Douglas et al. 2012), acute respiratory distress microscopy-diagnosed P.
comorbidities, with ready
syndrome (ARDS) (Tan et al. 2008; Valecha et al. 2009; Taylor et vivax were reported as 0.8
access to early diagnosis and
al. 2012b), splenic rupture (Imbert et al. 2009) and in some areas 1.6%, similar to that of P.
effective treatment. (Price et
acute kid-ney injury (Chung et al. 2008; Kute et al. 2012b; Sinha falciparum infection (1.6
al. 2009; Anstey et al. 2012).
et al. 2012). For other reported severe malaria syn-dromes, the 2.2%) (Barcus et al. 2007;
In endemic areas, the risk of
extent to which they are attributable to Tjitra et al. 2008; Price et al.
severe disease is asso-ciated
P. vivax is not yet clear: infectious and non-infectious with young age, higher 2009). The adjusted odds
comorbidities may be additive or synergistic contributors to ratio of death from severe
transmission intensity, early
severe disease or alternative causes (Kitchen 1949b; Anstey et anaemia in Papua was 5.9 for
and frequent relapse, less
al. 2009; Price et al. 2009; Lampah et al. 2011; Anstey et al. those with P. falciparum and
access to early diagnosis and
2012; Barber et al. 2012; Lacerda 4.4 for those with P. vivax
treatment and/or greater
et al. 2012). However, the presence of comorbidities does not prevalence of comorbidities infection. Case-fatality
exclude a key role for P. vivax in the pathophysiol-ogy of severe including bacterial co-
disease.
infections and malnutrition
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
82 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
severe illness (Lanca et al.
2012). Such comorbidities are
in malaria-endemic regions,
Other comorbidities. Acute and their contribution to
rates in Indian children hospitalised with PCR-confirmed P. and chronic infectious and severe and fatal disease in P.
vivax mono-infection (3.9%) were also comparable to that seen non-infectious vivax infection is probably
in PCR-confirmed P. falciparum infection (3.2%) (Kochar et al. comorbidities probably underesti-mated (Anstey et al.
2010). In marked contrast, sub-stantially lower vivax mortality contribute to severe and 2009; Price et al. 2009;
(0.22%) has been reported in children hospitalised in Thailand fatal disease in P. vivax Anstey et al. 2012).
(Wattana-goon et al. 1994), and only one of 1000 sequential infection (Anstey
adult admissions with strictly defined severe malaria in Viet-nam et al. 2009; Price et al. 2009;
had P. vivax malaria (TT Hien, personal communi-cation). Anstey et al. 2012; Lacerda et
Furthermore, in contrast to the reports from some parts India, al. 2012). Haemodynamic
acute kidney injury from vivax malaria is very unusual in South- effects of the systemic Severe malaria syndromes
East Asia. The mortality of vivax malaria in low transmission inflammatory response to P. Series of severe vivax
areas is uncertain with some recent case series reporting vivax and anaemia may con- malaria have described a
significant mortality and other series reporting very low tribute to decompensation of broad range of severe
mortalities. Thus, whereas the spectrum of falciparum malaria concurrent acute and chronic manifestations in children
severity in relationship to age and transmission intensity appears disease and subsequent death, and adults, using criteria
similar across the world, there appear to be marked differences in whereas otherwise healthy developed for severe
the reported severity of vivax malaria between different areas. children and adults may make falciparum malaria.
an uncomplicated recovery
(James 1925; Kitchen 1949a). Severe anaemia. The major
In the Manaus (Brazil) severe manifestation in most
autopsy series, 10 of the 13 P. series of vivax malaria in
Vulnerable groups
vivax-associated deaths had children is severe anaemia,
Young children. In co-endemic areas, morbidity, includ-ing concurrent comorbidities, defined as a haemoglobin
severe disease from P. vivax, usually occurs at a younger age including pneumo-nia, concentration of <5 g/dl in
than from P. falciparum (Michon et al. 2007; Tjitra et al. 2008; emphysema, diabetes, children and <7 g/dl in adults
Kochar et al. 2010; Lin et al. 2010). Most severe disease in haemorrhagic stroke, decom- (Luxemburger et al. 1997;
children, especially severe anaemia, is reported from high pensated cirrhosis and Rodriguez-Morales et al.
transmission areas in chil-dren under 5 years (Genton et al. 2008; congestive heart failure 2008; Tjitra et al. 2008; Poe-
Tjitra et al. 2008; Poespoprodjo et al. 2009; Alexandre et al. (Lacerda et al. 2012). HIV co- spoprodjo et al. 2009;
2010; Kochar et al. 2010; Lanca et al. 2012). This risk is high-est infection was found in one Alexandre et al. 2010;
in infancy (Douglas et al. 2013). In Indonesian Papua, more case (Lacerda et al. 2012). Kochar
infants are hospitalised with vivax malaria than fal-ciparum HIV infection is a risk factor et al. 2010). There are few
malaria (Tjitra et al. 2008; Poespoprodjo et al. 2009) including a for severe disease and death data on the confounding
2.4-fold higher proportion with severe anaemia if hospitalised in P. falciparum infection effects of other causes and
with vivax compared with falcipa-rum malaria (Tjitra et al. (Bejon et al. 2007; Berkley et the effect of successive
2008). Infant risk starts in ute-ro, with P. vivax infection in al. 2009), but the risk in P. episodes of malaria caused
pregnancy associated with abortion, low birthweight, congenital vivax infection is not yet by reinfection and relapses.
malaria (Poe-spoprodjo et al. 2011) and a greater risk of clinical known. In the United States, Despite these limitations,
dis-ease and severe anaemia in the neonatal period deaths from P. vivax have the association between
occurred in patients with pre- vivax infection and severe
(Poespoprodjo et al. 2009; Lanca et al. 2012).
existing cardiac disease anaemia is strong,
(Stoppacher & Adams 2003). particularly in infancy
Among 24 P. vivax-infected (Michon et al. 2007;
Malnutrition. As in falciparum malaria (Berkley et al. 2009),
Genton et al. 2008; Tjitra et
malnutrition is a likely major contributor to severe disease in P. Brazilian children requiring
intensive care admission, al. 2008; Ladeia-Andrade
vivax infection. In India, malnutrition was found in 69% of
25% had concomitant acute et al. 2009; Poespoprodjo
children with severe vivax malaria and 75% of the vivax-
et al. 2009; Lin et al. 2010;
associated deaths (Kochar et al. 2010). In Brazil, 17% of vivax- gastroenteri-tis, and in total,
58% had a concurrent acute Douglas et al. 2013). Among
infected children requiring intensive care admission had patients presenting to hospital
malnutrition (Lanca et al. 2012). or chronic comorbidity that in Indonesian Papua,
may have contributed to
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 83
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
more frequent in children
hospitalised with falciparum
malaria (18%) than those with
appears less common than in vivax malaria (11%);
where transmission of malaria is high, the adjusted falciparum malaria, but has however, this ratio was
population fraction of severe anaemia attributable to also been reported in adult reversed in children younger
P. falciparum was 15.1% compared to 5.8% for P. vivax and severe vivax malaria than 5 years (2% and 15%,
5.9% for mixed infections. The fraction of severe anaemia (Lampah et al. 2011). In the respectively) (Kochar et al.
attributable to P. vivax was highest in infancy, when it rose to Brazilian autopsy series, 88% 2010).
30.4% compared to 20.5% for P. falcipa-rum. (Douglas et al. had respiratory distress prior
2013). In Brazil, 9% of children up to 14 years old requiring to death, again mostly
intensive care unit admission with vivax malaria had severe appearing after the start of Both hypoxaemia and
anaemia, but there were no deaths (Lanca et al. 2012). Even in antimalarial drug treatment. metabolic acidosis have been
adults, severe anaemia can be a common manifestation of severe ARDS and/ or lung oedema described in children with P
vivax disease. In Indonesian Papua, 10% of all adults hospita- was identified as the vivax-associated respiratory
lised with P. vivax infections between 2005 and 2007 had a commonest compli-cation distress (Kochar et al. 2010;
haemoglobin <5 g/dl (Tjitra et al. 2008). In other series from contributing to death, Lanca et al. 2012). The rela-
India and Brazil, severe anaemia accounted for almost a third of occurring in 35%, and in tive contributions of
all cases of severe adult vivax malaria (Kochar et al. 2009; three of the four patients in metabolic acidosis, lung
Andrade et al. 2010). Con-versely, in a hypoendemic region of whom P vivax was injury, pneumonia, sepsis and
north-western Thai-land, none of 1978 adults and children >5 considered the direct cause of severe anaemia to the
years diagnosed with acute vivax malaria over a 3-year period death (Lacerda et al. 2012). In respiratory distress associated
required hospitalisation for severe anaemia or blood transfusion two of the latter cases, lung with P. vivax in children is
(Luxemburger et al. 1997). Infection with gastrointestinal oedema occurred in unclear. Respiratory distress
helminths can cause anaemia through chronic blood loss. While conjunction with other major was the commonest
mixed infections with hook-worm and P. falciparum cause an pathology (one each with complication (67%) among
additive reduction in haemoglobin in preschool children coma/encephalitis and splenic Brazilian children admitted
(Brooker et al. 2007), in the one study co-infection with rupture (Lacerda et al. 2012). for intensive care with severe
hookworm, Ascaris and Trichuris in Brazil attenuated the disease associated with P.
reduction in hae-moglobin associated with vivax malaria (Melo Respiratory distress is also vivax, with 12.5% overall
et al. 2010). a common manifestation in having strictly defined ARDS
most series of severe (Lanca et al. 2012); none
paediatric vivax malaria died. One child with
(Gen-ton et al. 2008; Tjitra et respiratory distress (6%) had
al. 2008; Kochar et al. 2010; pneumonia and empyema
Acute lung injury (ALI) and respiratory distress. Acute lung Yadav et al. 2012). As in identified as the underlying
injury (ALI) and acute respiratory distress syndrome (ARDS) are adults, definitions used for cause (Lanca et al. 2012).
well-recognised complications of P. vivax malaria. Initial reports respiratory distress vary One of 65 Indian children
were of cases mostly managed in non-endemic country hospitals, considerably between series with PCR-confirmed severe
with a very low case-fatality rate and with the majority occurring (Taylor et al. 2006c), vivax malaria had pulmonary
after com-mencement of antimalarial drug treatment (Taylor et complicating comparisons. oedema in association with
al. 2012b). In a single case report from India, ARDS arising pre- Respi-ratory distress occurred multiorgan dys-function
treatment in vivax malaria had a fatal outcome (Vale-cha et al. more frequently in vivax (Kochar et al. 2010).
2009). More recently reported ALI/ARDS in adults have mostly malaria (60%) than
been part of larger series of severe vivax malaria from endemic falciparum malaria (41%) in
settings, generally with less-clearly defined ARDS criteria, Papua New Guinean children, Acute kidney injury.
occurring as part of multi-ple organ dysfunction/failure (Kochar and with substantially higher Evidence of acute kidney
et al. 2005, 2009; Alexandre et al. 2010; Andrade et al. 2010; proportions than those injury (AKI) has been
Lacerda reported in hospitalised reported in several series
children in Indonesia Papua, a of adult vivax malaria and
not in others (Kochar et al.
et al. 2012). Clinical ARDS/respiratory failure occurred in 10 reflection of broader
2005; Chung
32% of patients with severe vivax malaria and had case-fatality inclusion criteria. In
rates of 5067% (Kochar et al. 2005, 2009; Alexandre et al. Indonesian Papua, rates were
2010; Andrade et al. 2010), much higher than the very low similar between P. vivax
fatality rate seen in reports of single-organ ARDS (Taylor et al. (2.3%) and P. falciparum
2012b). Lactic acidosis (2.5%) (Tjitra et al. 2008). In
India, respiratory distress was
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
84 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
sangioproliferative and
membranoproliferative
glomerulo-nephritis from P.
been reported in children malariae (Gilles &
et al. 2008; Kochar et al. 2009; Alexandre et al. 2010; Andrade et from north-west India with Hendrickse 1960, 1963 ; van
al. 2010; Kute et al. 2012b; Sinha et al. 2012). There appear to be PCR-confirmed P. vivax Velthuysen & Florquin 2000)
geographical differences in risk and severity, with little or no mono-infection-associated has also been reported in
vivax-associated AKI being reported in returned travellers (Tan AKI, with all deaths having association with P. vivax
et al. 2008) or from some vivax-endemic areas, such as Thailand associated multiorgan infections (Bircan et al. 1997;
(Luxemburg-er et al. 1997; Piyaphanee et al. 2007) and Vietnam dysfunction (Kochar et al. David et al. 2009). Acute
(Hien et al. 1996). AKI is reported, but is rarely severe, in 2010). In contrast, in Vietnam glomerulonephritis in malaria
Korean cases of vivax malaria (Chung et al. 2008). Across and Thai-land, where the two (of any species) is very rare,
northern India, severe dialysis-requiring AKI and/ or AKI-related infections have similar so the pathological role of
death is increasingly reported (Prakash prevalence, excluding P.vivax in these latter cases
massive haemolysis in G6PD remains uncertain.
et al. 2003; Kochar et al. 2005, 2009; Kute et al. 2012a, b; Sinha deficiency, AKI in paediatric
et al. 2012), but only the Rajasthan series was P. vivax mono- vivax malaria is not seen (TT
infection confirmed by PCR. AKI in PCR-confirmed mono- Hien, NJ White; personal Shock and multiorgan
infection has also been reported from Brazil (Alexandre et al. communication). The reasons dysfunction. Shock has been
2010; Andrade et al. 2010; Lacerda et al. 2012). No population- for these substan-tial asso-ciated with adult
based data on risk of AKI have been reported from any region. differences are unclear. (Kochar et al. 2005, 2009;
It is unclear why there are such marked differences in the Other P. vivax series have Song et al. 2007; Alexandre et
apparent incidence of renal complications between differ-ent reported AKI associated al. 2010; Barber et al. 2012)
areas. with thrombotic and pae-diatric (Kochar et al.
In those series reporting AKI in vivax malaria, this was most microangiopathy (Saharan et 2010; Kaushik et al. 2012) P.
commonly associated with multiorgan dysfunction and was a risk al. 2008; Sinha et al. 2012) vivax infections usually as
factor for fatal outcome (Kute et al. 2012b). Shock was also a in both adults and children, part of multiple organ
common association. Renal biopsies in four patients with vivax- and hae-molytic-uraemic dysfunction. Culture of blood
associated AKI reported patchy cortical necrosis in three cases syndrome (HUS) in children and other fluids was not
and acute tubular necrosis in the other (Kute et al. 2012b). The (Sharma et al. 1993). In the reported, and bacterial co-
pre-sentations reported frequently mimicked AKI seen with largest series (four adults infection and bacterial sepsis
sepsis and/or shock, but the contribution of concomitant bacterial and five children), persistent are possible synergistic or
sepsis to these syndromes is not known. In the Brazilian autopsy vivax-associated AKI was alternative causes. Shock was
series of deaths associated with associated with present in 54% of Brazilian
thrombocytopenia, bleeding, children requiring ICU
P. vivax infection, all six cases with AKI were associated with anaemia, splenomeg-aly, admission in Brazil in which
pre-existing comorbidities predisposing to AKI or multiorgan with schistocytes on negative pre-antibiotic blood
dysfunction (heart failure, sickle cell haemo-lytic crisis, chronic peripheral film in 77% cultures were reported;
liver disease) or alternative aetiologies (primaquine-induced (Sinha et al. 2012); one of however, 38% of these had an
haemolysis or yellow fever) (Lacer-da et al. 2012). AKI, with the patients with identified additional
varying definitions, has also been reported increasingly as a schistocytes had infectious comorbidity
manifestation of severe vivax malaria in children (Kochar et al. concomitant coma (Sinha et potentially contributing to
2010; Manning et al. 2011; Jat et al. 2012; Kaushik et al. 2012; al. 2012). Biopsies showed shock (Lanca et al. 2012).
Yadav et al. 2012) occurring in 315% of severe cases in these universal ischaemia and
series, usually as part of multiorgan dysfunction. This contrasts endothelial injury and
with severe falciparum malaria, in which acute kidney injury is arteriolar thrombi in two Bacterial co-infection and
markedly less common and is less severe among children than in cases, consistent with bacteraemia. The
adults (Anstey et al. 1996; Hien et al. 1996; Weber et al. 1999; thrombotic micro- bacteraemia risk in severe P.
Dondorp et al. 2008b). In paediatric series describing both severe angiopathy (Sinha et al. vivax infection has not been
falciparum and severe vivax malaria, renal impairment occurred 2012). Fatal AKI associated studied sys-tematically. A
with a lower (Kochar et al. 2010) or similar (Manning et al. with crescentic large prospective blood
2011; Yadav et al. 2012) frequency in those with glomerulonephritis (Patel et culture and malaria
P. vivax infection. Mortality rates of up to 30% have al. 2012) and nephrotic microscopy study in Kolkata,
syndrome (more commonly India, showed that 6 of 89
associated with me- uncomplicated vivax malaria
cases [6.7% (95%
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 85
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
(Lampah et al. 2011), similar
to that occasionally seen
following coma in
reported complete, falciparum malaria (Nguyen
CI: 3.113.9%)] had concomitant bacteraemia, with 5/6 (83%) of systematic microbiological et al. 1996).
the bacteria isolated being Gram-negative (one S. typhi, one S. and radiological
paratyphi A, three other enterobacteria-ceae) (Bhattacharya et al. investigation to exclude Other, rarer, neurological
2013). Of the two cases of Salmonella bacteraemia reported from bacterial and viral infection complications reported in
Thailand in associ-ation with PCR-confirmed P. vivax mono- and other causes of coma. association with P. vivax
infection, one patient had multiorgan dysfunction (renal failure, Such studies are needed. In infection include facial
jaun-dice and hypotension), with concurrent serogroup D Sal- autopsies in two Brazilian diplegia (Kochar et al. 2007;
monella bacteraemia, and the other uncomplicated, children with vivax- Sim et al. 2010), acute
P. vivax case had non-typhoidal Salmonella bacteraemia associated coma, inflammatory polyneuropathy
(Piyaphanee et al. 2007). Gram-positive (Streptococcus encephalitis was identified (Chakravarty et al. 2004),
pneumoniae) bacteraemia has also been reported in asso-ciation in one (Lanca et al. 2012) acute dissemi-nated
with hypotension in adult vivax malaria (Barber et al. 2012). and could not be excluded in encephalomyelitis (Koibuchi
the other (Lacerda et al. et al. 2003) and ante-rior
Coma and other vivax-associated neurological complica-tions. 2012). In a prospective ischaemic optic neuropathy
Coma is much less common in vivax than falcipa-rum malaria. series of 24 cases of coma (Flowe et al. 2011). As in
Over 100 cases of P. vivax mono-infection in adults and children associated with P. vivax many of these observations
associated with coma have been described in reports or series infection diagnosed by and associations, causality is
from 1921 to 2011; how-ever, only studies in the last 15 years microscopy, 75% had PCR uncertain. While not seen in a
have been able to exclude mixed species infection with P. evidence of P. falciparum series of uncomplicated adult
falciparum by PCR methods (Beg et al. 2002; Kochar et al. 2005; (co)infection or other vivax malaria in Bangladesh
Thap-a et al. 2007; Sarkar & Bhattacharya 2008; Harish & Gupta bacterial or non-infective (Abu Sayeed et al. 2011),
2009; Kasliwal et al. 2009; Kochar et al. 2009; Parakh et al. causes of coma; almost all cases of retinal haemorrhages
2009; Thapa et al. 2009; Kochar et al. 2010; Lampah et al. 2011; PCR-confirmed cases of in pure vivax malaria have
Tanwar et al. 2011). In Indo-nesian Papua, coma associated with coma in P. vivax mono- been described elsewhere
PCR-confirmed infection in this series were without central nervous
in young adults with low system complications (Choi
P. vivax mono-infection (and without overt comorbidi-ties) parasitaemia, no other organ et al. 2004; Lee
occurred 23 times less frequently than with falcipa-rum malaria dysfunction and good et al. 2010b).
and was estimated as occurring in one in 29 500 infections outcomes (Lampah et al.
(Lampah et al. 2011). In Thailand, the risk of hospitalisation with 2011). Plasmodium vivax Splenic rupture and
impaired consciousness with microscopy-diagnosed P. vivax -associated coma has been infarction. Splenic rupture is
(not-PCR-confirmed) was 1 in 858 infections, with the risk being associated with thrombotic a life-threatening but
15.2-fold less than that with P. falciparum (Luxemburger et al. thrombocytopenic purpura probably under-reported
1997). In over 1000 prospectively studied patients with severe in one (Sinha et al. 2012), complication in adults
malaria studied in a specialist unit in Vietnam, one patient (with but not another series (Moses 1945; Kapland et al.
coma) had vivax malaria (TT Hien, per-sonal communication). (Lampah et al. 2011). Other 1946; Kitchen 1949a; Lubitz
Most other reports of coma in association with PCR-confirmed P. adult series with 1949; Imbert et al. 2009;
vivax mono-infection have been from the Indian subcontinent; Lacerda et al. 2012). In a
however, denominators of the surveillance and population-based P. vivax mono-infection have systematic review of 55 cases
risks were not reported. Only one case with no identified described coma in associ- of malaria-associated splenic
alternative aetiology has been reported from South Amer-ica, a ation with multiorgan rupture, the mortality rate
PCR-confirmed P. vivax mono-infection (Lacerda et al. 2012). dysfunction (Kochar et al. was 22%, with
2005, 2009). A post-malarial P. vivax accounting for
No reports of coma in vivax malaria, including those with neurological syndrome with approximately half of all
PCR-confirmed P. vivax mono-infection, have tremor and myoclonus has cases (Imbert et al. 2009). In
also been reported after the 2012 Brazilian P. vivax
recovery from PCR- autopsy series, three patients
confirmed P. vivax coma (18%) had splenic rupture,
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
86 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
2011; Liu et al. 2012),
through transpla-cental
infection in utero or during
small series from India delivery (Poespoprodjo et al.
all adults, two of whom also had pulmonary oedema (Lacerda (Kochar et al. 2005; Nayak et 2011; Rijken et al. 2012a). In
et al. 2012). Of the four deaths considered directly caused by al. 2009) with poor pregnancy Papua, P. vivax con-genital
P. vivax, splenic rupture occurred in two (Lacerda et al. 2012). outcomes but again with no infection (alone or mixed)
maternal deaths. In all occurred in 1.6 per 1000 live
Other complications. Jaundice is common in both adult [36 endemic regions, less severe births (Poespoprodjo et al.
57%; (Kochar et al. 2005, 2009; Alexandre et al. 2010; Andrade vivax-associated maternal 2011); congenital malaria was
et al. 2010)] and paediatric (Alexandre et al. 2010; Kochar et al. anaemia is common, being independently associated with
2010; Jat et al. 2012; Lanca et al. 2012) series of severe vivax approximately twice as likely low birth-weight and was
malaria, often in association with other severe manifestations. in pregnant women infected mostly asymptomatic at birth
However, in Brazilian children, jaundice did not predict need for with P. vivax than without (Poe-spoprodjo et al. 2011).
ICU admission (Lanca et al. 2012). Severe epistaxis associated (Nosten et al. 1999; Like congenital falciparum
with thrombocytopenia requiring blood and platelet transfusions Poespoprodjo et al. 2008). malaria (Poespoprodjo et al.
was reported in 5% of adults with severe vivax malaria (Kochar 2010), congenital vivax
et al. 2009), and throm-bocytopenia was associated with other malaria can cause severe
severe manifesta-tions (Kochar et al. 2005; Kochar et al. 2009; Effects on fetus and neonate. illness mimicking neonatal
Andrade et al. 2010; Alexandre et al. 2010). Fatal pulmonary Plasmodium vivax infec-tion sepsis (Del Punta et al. 2010).
haemorrhage and haematemesis have been reported (Jat et al. in pregnancy causes a
2012). Hypoglycaemia (blood glucose <2.2 mM or <40 mg/dl) reduction in birthweight
(World Health Organization 2010a) was found in 12.5% of (med-ian 108 g) (Nosten et al.
Severe and fatal
children with vivax malaria requir-ing admission to intensive 1999; Poespoprodjo et al. complications of primaquine
care unit in Brazil (Lanca 2008; Rijken et al. 2012a)
approximately 70% of that Morbidity and mortality
et al. 2012). Less common disease associations with P. vivax observed following maternal secondary to adverse effects
include haemoglobinuria in the absence of G6PD deficiency falciparum malaria (median of primaquine are likely to be
(Kochar et al. 2010) and peripheral gangrene (Raghunandan et 150192 g). With low underestimated in populations
al. 2012). Acalculous chole-cystitis has been described in both birthweight contributing to with unmonitored use of
adults and children (Curley et al. 2011), with gall bladder wall greater infant mortality primaquine and high
oedema and periportal oedema described in 32% and 35% of 34 (Luxemburger et al. 2001), P. prevalence of G6PD
vivax malaria patients undergoing CT scanning for abdominal vivax in pregnancy is thus deficiency (Baird &
pain (Kim et al. 2010). Series from the 1940s reported patients responsible for substantial Surjadjaja 2010). Primaqu-
with acute lower abdominal pain associated with vivax malaria, indirect mor-tality in the first ine-induced haemolysis in
but not with splenomegaly, mimicking appendicitis and other year of life. A single episode patients with G6PD
acute surgical conditions (Most & Hayman 1946; Kitchen of P. vivax infection in the deficiency can cause life-
1949b). first trimester also increases threatening AKI and severe
risk of mis-carriage 2.7-fold anaemia, accounting for 8%
and fourfold with of P. vivax-associated
asymptomatic and intensive care admissions in
symptomatic malaria, Brazil (Lanca et al. 2012) and
Vivax malaria in pregnancy respectively (McGready et al. 12% of deaths in the Manaus
Effects on mother. In contrast to P. falciparum, 2012b), a rate approximating autopsy series (Lacerda et al.
P. vivax rarely causes severe malaria in pregnant women (Nosten that with P. falciparum 2012). Severe haemolysis
et al. 1999; Poespoprodjo et al. 2008; McGready et al. 2012a,b; (McGready et al. 2012b). results from multiple dosing
Rijken et al. 2012a), and in a large series from the Thailand in radical treatment regimens.
Myanmar border, no maternal deaths were associated with vivax Congenital malaria. Overall, 14 deaths from pri-
malaria over a 25-year period (McGready et al. 2012a). Despite Plasmodium vivax can cause maquine toxicity have been
its rarity in very large series from Thailand and Indonesia con-genital malaria reported over the past
(Nosten et al. 1999; Poespoprodjo et al. 2008; McG-ready et al. (McGready et al. 2004;
2012b), severe vivax-associated maternal malaria, including Valecha et al. 2007; Vottier et
severe anaemia, has been reported in al. 2008; Del Punta et al.
2010; Poe-spoprodjo et al.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 87
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
parasitaemias, all others have
been less than 100 000/ll
(about 2% parasitaemia):
2011) and death (Kochar et al. 2005;
60 years (Recht et al. 2013) despite over 11 million documented (Manning et al. 2011; Alexandre et al. 2010)
exposures (mainly in the course of mass drug administrations). Yadav et al. 2012). (Kochar et al. 2009), (Kochar
et al. 2010; Barber et al.
2012). Nevertheless, an
Risk factors for severe vivax malaria Pathogenesis of disease in association between disease
vivax malaria severity and semi-quanti-
As in falciparum malaria (Miller et al. 2002), host, para-site and
socio-geographical factors likely contribute to risk of severe Comparative pathobiology of tative parasitaemia (1+ to 4+)
disease and death in vivax malaria, as well as specific severe Plasmodium vivax has been reported (Lanca et
manifestations. al. 2012; Nurleila et al. 2012).
There are significant It has been hypothes-ised that
differences in pathobiology total parasite biomass in
Host and parasite genetics. P. vivax uses the red cell Duffy
between P. vivax and P. uncomplicated and severe
antigen as its main receptor for red cell invasion, so people who
falciparum that are important
are Duffy negative (such as those in most of sub-Saharan Africa) malaria may be higher than
in under-standing vivax
are largely protected against vivax malaria. Genetic that represented by peripheral
pathophysiology (Kitchen
polymorphisms have been associated with both increased risk parasitaemia due to
1949b; Anstey et al. 2009).
[alpha- and beta-thalassaemia (Williams et al. 1996; ODonnell accumulation of parasi-tised
et al. 2009)] and decreased risk [Duffy antigen negativity (Miller red cells in organs such as the
et al. 1976), G6PD deficiency (Leslie et al. 2010) and ovalocy- spleen (Machado Siqueira et
Parasite biomass. In contrast
tosis (Rosanas-Urgell et al. 2012) ] of P. vivax parasita-emia. al. 2012; Baird 2013);
to the invasion of red cells of
The role of ovalocytosis in protecting against vivax anaemia and however, this requires further
all ages by P. falciparum, P.
other severe disease syndromes is less well defined. Alpha- investigation.
vivax has a very strong
thalassaemia has been associated with reduced risk of severe
predilection for infecting red
anaemia from P. falciparum (Fow-kes et al. 2008), attributed to a
blood cells that have emerged
lesser reduction in hae-moglobin from the loss of microcytic from the bone marrow within
cells, and has been hypothesised to protect against vivax the preceding Relapse. A fundamental
anaemia through a similar mechanism (Fowkes et al. 2008). difference from P. falciparum
2 weeks (Kitchen 1949b;
Whether natu-rally acquired P. vivax strains vary in virulence is that P. vivax can relapse
Simpson et al. 1999), particu-
and risk of severe vivax malaria is unknown. from dormant hypnozoites to
larly early in the course of
infection (Kitchen 1938). cause repeated episodes of
This property contributes to clinical and subclinical infec-
Chloroquine resistance. A high prevalence of chloro-quine- the lower parasite biomass tions. Frequent recurrent
resistant P. vivax (Sumawinata & Bernadeta Leksana 2003; seen in P. vivax infections. infections may result in
Ratcliff et al. 2007) has been associated with a high risk of Unlike P. falciparum infec- insuffi-cient time for
severe vivax anaemia (Tjitra et al. 2008). The prevalence of tions, parasitaemia densities adequate haematological
chloroquine-resistant P. vivax is increasing across vivax-endemic recovery from each episode.
in vivax malaria rarely exceed
areas (Douglas et al. 2010), and its role in contributing to severe Multiple recurrences are
2% of circulating
vivax disease warrants further investigation (Price et al. 2009). associated with greater
erythrocytes (Ross &
anaemia (Douglas et al.
Thomson 1910; Kitchen
Mixed Plasmodium infections. In areas of low malaria 2013). In contrast, in
1949b; Field & Shute 1956).
endemicity such as Thailand, mixed infections with temperate areas, relapses are
Although a high P. vivax
P. vivax appear to attenuate P. falciparum disease severity fewer and delayed, and the
parasite burden (140 000/ll)
(Luxemburger et al. 1997; Price et al. 2001; Mayxay et al. haematological impact of
has been reported in fatal
2004; Snounou & White 2004). Con-versely, in areas with each recurrence is less (Song
vivax malaria (Valecha et al.
higher endemicity of both species, mixed infections are et al. 2003; Goller et al.
2009), this is very unusual.
associated with an increased risk of severe malaria (Genton et 2007; Price et al. 2009).
Although series reporting
al. 2008; Tjitra et al. 2008), including severe anaemia (Genton
parasite counts in severe
et al. 2008; Tjitra
vivax malaria have
et al. 2008; Douglas et al. 2013), coma (Manning et al.
documented moder-ately high
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
88 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
(Hemmer et al. 2006), vWF
(De Mast et al. 2009) and
ADAMTS-13 deficiency (De
consistent finding in P. vivax Mast et al. 2009) occur in
Inflammatory responses. Plasmodium vivax has a lower malaria, although its role in uncomplicated vivax malaria;
pyrogenic threshold than P. falciparum (Ross & Thom-son vivax pathophysiology is however, the role of altered
1910; Kitchen 1949a). Cytokine production (Karun-aweera et unknown. haemostatic pathways,
al. 1992; Hemmer et al. 2006; Yeo et al. intravascular coagula-tion and
2010b; Goncalves et al. 2012), degree of endothelial acti-vation Deformability and fragility of endothelial inflammation
(Yeo et al. 2010b) and pulmonary inflammatory responses parasitised erythrocytes. In through increased for-mation
(Anstey et al. 2007) are higher during and after P. vivax contrast to P. falciparum of ultra-large VWF and
infections than in P. falciparum infections with similar (Dondorp et al. 1999), the de- platelet aggregates in severe
parasitaemias. Although the inflammatory corre-lates of the formability of vivax-infected vivax malaria is not known.
lower pyrogenic threshold have been described, the underlying RBCs is increased (Suwana-
mechanism(s) have not. Hypothesised reasons include rusk et al. 2004; Handayani et
differences between the two species in candidate malaria al. 2009). This may enable P.
toxin(s) (Anstey et al. 2012). A lipid unique to P. vivax vivax to pass through the Pathophysiology of
narrow interendothelial slits specific syndromes of
(Karunaweera et al. 2003, 2007) may also contribute to the severe vivax malaria
greater pyroge-nicity of P. vivax. It is possible that Plasmodium of the splenic sinusoids
spp. priming of the innate immune response to bacterial prod- (Handayani et al. 2009; Severe vivax anaemia. The
ucts (Franklin et al. 2009) may be greater in P. vivax than in P. Deplaine et al. 2011). aetiology of vivax-
falciparum infections, although this remains to be demonstrated. Increased deformability may, associated anaemia is
Although P. vivax is capable of eliciting greater concentrations of however, be accompanied by complex. Anaemia results
both pro- and anti-inflamma-tory cytokines than P. falciparum increased fragility of both P. from loss of both vivax-
(Hemmer et al. 2006; Yeo et al. 2010b; Goncalves et al. 2012), vivax-infected and non- infected and uninfected red
relationships with disease severity may be different in vivax infected RBCs (Handayani et cells from the circula-tion
malaria. al. 2009), although the extent and impaired RBC
to which this is an artefact of production (Wickramasinghe
the ex vivo microfluidic et al. 1989; Anstey et al.
system used is unknown. 2009; Douglas et al. 2012).
Cytoadherence and rosetting. As all stages of P. vivax are visible
in peripheral blood, albeit with partial deple-tion of mature Malaria therapy data
stages (Rudolf & Ramsay 1927; Field & Shute 1956), Endothelial activation and demonstrated that removal of
sequestration is not thought to occur to a significant degree in altered thrombostasis. Con- red cells from the circulation
vivax malaria; so microvascular obstruction causing end-organ centrations of circulating is particularly pronounced
dur-ing acute infection
dysfunction as in P. falci-parum is not thought to occur (Anstey endothelial activation markers
are as high (ICAM-1 and E- (Kitchen 1938; Collins et al.
et al. 2009). Despite in vitro evidence of cytoadherence to
selectin) or higher 2003), over and above the
ICAM-1 (Carvalho et al. 2010) and chondroitin sulphate A
(angiopoie-tin-2), in rate modelled from
(CSA) (Chotivanich et al. 2012), evidence for sequestration-
reticulocyte loss and impaired
mediated pathology in vivax malaria in vivo is absent (Valecha et uncomplicated vivax malaria
supply of mature red cells
al. 2009) or at best modest (Ewing 1901; Billings & Post 1915; than in falciparum malaria
(McQueen & McKenzie
Bruetsch 1932; Anstey et al. 2007; Lacerda et al. 2012; Anstey et (Jakobsen et al. 1994; Yeo et
2004; Antia et al. 2008). The
al. 2012 for review), although splenic accumulation of infected al. 2010b). Endo-thelial
dysfunction and impaired NO removal of red cells occurs
and uninfected red cells as in falciparum malaria seems likely
from both extravascular loss
(Machado Siqueira et al. 2012; Baird 2013). Published placental bioavailability may be
significant contributors to in the spleen and from
his-tology is even more limited, but has shown an absence
severe falciparum malaria intravascular red cell loss
(McGready et al. 2004) or limited presence (Mayor et al. 2012)
(Yeo et al. 2007, 2009, (Douglas et al. 2012). Despite
of placental P. vivax-infected red cells. Taken together,
2010a), but their role in the lower parasite biomass of
histological findings suggest that significant microvascular
severe vivax malaria is P. vivax rel-ative to P.
obstruction from sequestration of parasi-tised red cells does not
unknown. Endothelial falciparum, red cell removal
occur in vivax malaria, although it is possible that in some
activation and damage have is comparable
circumstances and in some organs, more limited cytoadherence
been described in fatal vivax-
to endothelial cells may occur. Rosetting, adherence of non-
associated ARDS (Valecha et
infected to infected RBCs in vitro (Udomsanpetch et al. 1995) is
al. 2009). Increased
a
procoagulant activity
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 89
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
malaria (De Mast et al. 2009)
although they are linked to
disease severity in falciparum
sons 2006; Tan et al. 2008; malaria (Larkin et al. 2009)
because of the greater proportional removal of uninfected red Valecha et al. 2009). Onset and so might conceivably
cells following P. vivax infection. In vivax malaria, of most but not all vivax- underlie vivax thrombotic
approximately 34 uninfected red cells are removed for every associated ARDS occurs microangi-opathy in these
infected red cell (Collins et al. 2003; Douglas et al. 2012) after starting antimalarial patients.
compared to approximately 8 uninfected red cells for every treatment (Anstey et al.
infected red cell in falciparum malaria (Jakeman et al. 1999; 2009; Taylor et al. 2012b)
Price et al. 2001). Mechanisms for this differ-ence are not clear. with gas transfer studies
Although greatest during the early stages of infection, enhanced showing progressive Coma. The true incidence
removal of uninfected red blood cells has been shown to persist deterioration in alveolar and the aetiology of the coma
for at least 5 weeks after antimalarial treatment (Woodruff et al. capillary function following associated with P. vivax are
1979; Looa-reesuwan et al. 1987). An additional contributory treatment (Lomar et al. not known, and the role of
factor in the anaemia of P. vivax is relapse. In tropical latitudes, 2005; Anstey et al. 2007). co-infections remains unclear
relapses at 3- to 4-week intervals are associated with pro-gressive (Anstey et al. 2009; Lam-pah
anaemia from recurrent episodes of haemolysis and et al. 2011). The rarity of
dyserythropoiesis before haematological recovery from Acute kidney injury. Both the coma in P. vivax relative to P.
preceding infections can occur (Price et al. 2009). In some true incidence and the falciparum and its absence in
regions, severe vivax anaemia is common in chil-dren less than 2 mechanisms underlying AKI P. knowlesi (Danesh-var et
months of age (Poespoprodjo et al. 2009); multiple relapses in vivax malaria are not clear. al. 2009; William et al. 2011;
cannot explain severe anaemia at such an early age. Sustained In prospective studies of adult Barber et al. 2012) makes it
parasitaemia, initially sub-clinical, from congenital malaria may severe malaria con-ducted in unlikely that the
the explanation. In areas of chloroquine resistance, anaemia is South-East Asia, with the cerebrovascular sequestration
exacerbated further by delayed parasite clearance, and exception of haemoglobinuric of parasitised red cells
recrudescent and chronic infections (Price et al. 2007). Impaired renal failure in G6PD characteristic of P.
pro-duction of red cells is also likely to contribute to vivax- deficiency, acute renal failure falciparum occurs in the
related anaemia, particularly with chronic and repeated has never been observed in same way with these other
infections, but mechanisms are unclear. Cytokine-related vivax malaria (Trang et al. parasites. This contention is
dyserythropoiesis has been demonstrated in P. vivax malaria in 1994; T.T. Hien & N. J. supported by the absence of
adults (Wickramasinghe et al. 1989). In adults, erythroblasts can White, unpub-lished P. vivax DNA, albeit post-
be infected by P. vivax in vivo (Ru et al. 2009). observations). Whether acute treatment, in a single
tubular necrosis underlies Brazilian autopsy case of
AKI in vivax malaria in the coma attributed to P. vivax
setting of multior-gan (Lacerda et al. 2012) and
Acute lung injury. Even in uncomplicated vivax malaria, clinical dysfunction or acute cortical brain aspirates from three
pulmonary function testing shows increased pul-monary necrosis, as reported in one PNG children with fatal
phagocytic cell activity associated with reduced gas transfer at series (Kute et al. 2012b), coma associated with mixed
the alveolarcapillary membrane (Anstey et al. 2002, 2007). requires further study. Over a P. falciparum P. vivax
Autopsy findings in P. vivax ARDS have shown heavy third of fatal cases in Manaus, infection (Manning et al.
intravascular monocytic infiltrates with diffuse endothelial and Brazil, had AKI (as part of 2012).
alveolar damage (Valecha et al. 2009) or interstitial infiltrates multiorgan dysfunction)
with predominantly neutrophils (Lacerda et al. 2012). While (Lacerda et al. 2012). The
alveolarcapil-lary parasites after peripheral blood clearance extent to which thrombotic Multiorgan dysfunction and
have been reported at autopsy in vivax-associated acute lung microangiopathy causes shock. The extent to which
injury (Lacerda et al. 2012), another severe vivax ARDS autopsy vivax-associated AKI multiorgan dysfunction and
did not show sequestration of parasitised red blood cells in the (Sharma et al. 1993; Saharan shock are attributable to
pulmonary vasculature (Valecha et al. 2009). As in acute lung et al. 2008; Sinha et al. 2012) sepsis-like inflammatory
injury in other disease settings, ARDS in vivax malaria probably is also not known. Elevated responses to P. vivax,
results from soluble mediators, diffuse alveolar-endothelial vWF and low levels of the concur-rent bacteraemia (Sur
capillary damage, exacerbated by shock, with increases in vWF-cleaving protein et al. 2006; Piyaphanee et al.
alveolar perme-ability and altered alveolar fluid clearance ADAM-TS13 occur even in 2007; Barber et al. 2012), or
(Suratt & Par- uncomplicated in vivax both, requires further
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
90 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
difficulties of discriminating
between P. vivax and P. fal-
ciparum, the relative safety of
species infections (Mayxay artesunate compared with
study. Negative blood cultures reported in some series are limited et al. 2001, Lampah et al. quinine, the high sensitivity
by widespread pre-hospitalisation use of anti-biotics in the 2011), with PCR used as a of P. vivax to artemisinins and
community, and the known insensitivity of pre-antibiotic blood delayed gold standard in ease of use and the
cultures in bacterial sepsis (Davis excluding misdiagnosis and operational benefits of a
et al. 2011). mixed infections. unified approach to the
Aggressive microbiological treatment of vivax and
Pregnancy-associated malaria and low birth- and radiological falciparum malaria (Douglas
weight. There are few reports of placental histopathology, investigations for alter- et al. 2010), the current
showing absent (McGready et al. 2004) or modest (Mayor et al. native causes (both unified policy of intravenous
2012) placental parasite burden. Placental histopa-thology shows infectious and non- artesunate for severe malaria
little (McGready et al. 2004) or no (Mayor et al. 2012) hemozoin infectious) of severe disease from all Plasmodium species
deposition, and largely absent inflammatory changes (McGready are essential. is pragmatic and appropriate
et al. 2004). Pathologi-cal mechanisms are unknown, but vivax- (Price et al. 2011). Other
associated microvascular dysfunction may cause deleterious Management of severe vivax supportive care for severe
utero-placental haemodynamic effects and foetal growth restric- malaria malarial manifestations,
tion (McGready et al. 2004; Rogerson et al. 2007; Umbers et al. including transfusion,
2011; Rijken et al. 2012b). Maternal anaemia, com-mon in vivax In the absence of comparative intravenous antibi-otics,
malaria (Poespoprodjo et al. 2008; Rijken drug trials in severe vivax vasopressor support, dialysis
et al. 2012a), is likely to be an additional contributor to low malaria, when it does occur, and invasive ventila-tion as
birthweight (Rogerson et al. 2007). severe disease in vivax needed, should be given as
malaria has been managed in per recommendations for
the same way as severe fal- severe falciparum malaria.
Diagnosis and definition of severe vivax malaria
ciparum malaria (World
The recent series from Brazil suggests that criteria in pre-vious Health Organization 2010a;
WHO Guidelines for severe falciparum malaria (World Health Price et al. 2011). Both
Organization 2000, 2010a) are sensitive in identifying children quinine (Tjitra et al. 2008)
requiring intensive care admission (Lanca et al. 2012) and in and artesunate (Tjitra et al. Epidemiological or
research definition of
identifying patients at risk of death (Lacerda et al. 2012). Criteria 2008; Kochar et al. 2010;
severe vivax malaria
for severe vivax malaria (Box) are the same as for severe Lampah et al. 2011; Barber et
falciparum malaria with the exclusion of parasite density al. 2012) have been used
successfully. Therapeutic As for the criteria for
thresholds. This is because of the unclear association to date
responses in uncomplicated adults and children
between parasitaemia and disease severity and outcome in
with severe falciparum
P. vivax malaria, and the greater propensity for P. vivax to vivax malaria are
malaria but with no
destroy uninfected red cells. significantly faster following
parasitaemia
Microscopy remains the gold standard for the immedi-ate artesunate. Given the
thresholds and without
diagnosis of P. vivax infection in severe disease. The sensitivity importance of starting highly a criterion of
of parasite LDH-based rapid antigen tests for P. vivax has effective schizon-tocidal
hyperparasitaemia.
improved recently (who.int/tdr/publications/ tdr-research- treatment as quickly as
publications/rdt_round3/pdf/rdt3.pdf), with high sensitivity possible in severe falcipa-rum
reported in severe vivax malaria (Barber et al. 2013a). P. malaria, the magnitude of the
falciparum -specific HRP2 rapid antigen tests have proved benefit of artesunate
useful in identifying occult mixed compared to quinine in severe
falciparum malaria, the
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 91
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
et al. 2009). In a retrospective
tertiary referral centre study
in Sabah, 39% of P. knowlesi
et al. 2012; Rajahram admissions had severe
et al. 2012). Most malaria, with a case-fatality
Section 14: Severe knowlesi malaria cases of P. knowlesi rate in severe disease of 27%
have been reported in (William
The simian parasite, Plasmodium knowlesi, was first shown to
adults, although
be transmissible to humans in 1932 (Knowles & Das Gupta
uncomplicated malaria and
1932) and has more recently been identi-fied as a common cause et al. 2011). Reported case-
severe anaemia have also
of human malaria in Malaysian Borneo (Singh et al. 2004; Cox- fatality rates in quinine-trea-
been described in children
Singh et al. 2008; Daneshvar et al. 2009; William et al. 2011; ted severe disease of 2027%
(Barber et al. 2011). Clinical
World Health Organization 2011a,b; Barber et al. 2012; Rajah- are comparable to those
features of uncomplicated
ram et al. 2012), with isolated reports from elsewhere in South- reported in severe falciparum
knowlesi malaria are indistin-
East Asia. The potential of P. knowlesi to cause severe disease malaria (South East Asian
guishable from other species
was originally suggested by experimental simian and human Quinine Artesunate Malaria
(Daneshvar et al. 2009; Bar-
infections (Ciuca et al. 1955, 1964; Chin et al. 1968; Coatney et Trial (SEAQUAMAT) Group
ber et al. 2012).
al. 1971; White 2008). The full asexual life cycle takes only 1 2005). While age, female
day, so expansion of the infection can be very rapid. In total, 86 gender, parasitaemia,
human cases of severe and/or fatal knowlesi malaria have been schizonta-emia and severity
reported since 2008 (Cox-Singh et al. 2008, 2010; Daneshvar et Severe malaria in adults of thrombocytopenia have
al. 2009; Lee et al. 2010a; William et al. 2011; Barber et al. been associ-ated with a higher
Of the 86 cases of naturally
2012, 2011; Fatih et al. 2012; Rajah-ram et al. 2012). risk of both severe disease
acquired severe human
and death (Daneshvar et al.
P. knowlesi infection reported 2009; Lee et al. 2010a; Cox-
between 2008 and 2012, all Singh
were from Malaysia of which
19 were fatal (Cox-Singh et et al. 2011; William et al.
Transmission and epidemiology 2011; World Health Organiza-
al. 2008, 2010; Daneshvar et
The natural monkey hosts (long-tailed and pig-tailed macaques) al. 2009; Lee et al. 2010a; tion 2011a,b; Barber et al.
William et al. 2011; Barber et 2012; Rajahram et al. 2012);
and mosquito vectors (Anopheles leucosphyrus group) for P.
on multivariate analysis, only
knowlesi extend across South-East Asia from eastern India and al. 2012; Fatih
parasitaemia and schizonta-
southern China to Indonesia (Singh & Daneshvar 2013). While et al. 2012; Rajahram et al.
emia >10% were independent
this area has a population of approximately 500 million people 2012), with progression to
predictors of severe disease
poten-tially at risk of P. knowlesi infection, and thousands of death occurring in as little as
(Barber et al. 2012). Risk of
cases have been reported from Malaysia, the true burden of 3 days after symptom onset
severe disease from
disease is not known. Human P. knowlesi infections have also (Cox-Singh et al. 2008).
been reported from ChinaMyanmar (Jiang Knowlesi malaria is P. knowlesi occurs at
lower parasitaemias than
et al. 2010), Thailand (Jongwutiwes et al. 2004; Putap-orntip et associated with a high risk of
with P. falciparum,
al. 2009; Jongwutiwes et al. 2011; Sermwittayawong et al. 2012), severe disease. In the largest
increasing 11-fold with
Vietnam (van den Eede et al. 2009), Cambodia (Khim et al. prospec-tive series, from a
parasitaemia >20 000/ll
2011), Philippines (Luchavez et al. 2008), peninsular Malaysia referral hospital in Sabah, and 28-fold with
(Fong et al. 1971; Cox-Singh et al. 2008; Lee et al. 2010a), 29% of knowlesi infections parasitaemia >100 000/ll
Indonesia (Figtree et al. 2010; Sulistyaningsih et al. 2010) and were severe and P. knowlesi (Barber et al. 2012).
Sin-gapore (Ng et al. 2008), although concerns have been raised infection was associated with
Multiorgan failure is
regarding specificity of the PCR assays used in the studies of a threefold greater risk of
common in severe knowlesi
archival samples (Imwong et al. 2009). severe malaria than P.
malaria (Cox-Singh et al.
falciparum (Barber et al.
2008, 2010; Daneshvar et al.
2012). In a prospective
2009; William et al. 2011;
district hospital-based study
Clinical spectrum Barber et al. 2012; Rajahram
in Sarawak, 9% of patients et al. 2012). In one series,
Plasmodium knowlesi causes disease ranging from with P. knowlesi developed 59% had respiratory distress;
uncomplicated to severe and fatal malaria (Cox-Singh et al. severe malaria, with a case- 55%, acute renal failure; and
2008, 2010; Daneshvar et al. 2009; Lee et al. 2010a; William fatality rate of 2% (95% CI 55% shock (William et al.
et al. 2011; Barber et al. 2012; Fatih 0.26.6%) over-all and 20%
in severe disease (Daneshvar
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
92 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Non-severe knowlesi
malaria has a lower median
para-sitaemia than non-
tological examination severe P. falciparum,
2011). In non-artemisinin-treated patients, the propor-tions with (Praba-Egge et al. 2002). A indicating a lower fever
hypoxaemia-associated respiratory distress and ARDS (5970%) similar histopathological threshold (pyrogenic density)
(Daneshvar et al. 2009; William et al. 2011) and shock (William appearance of widespread with P. knowlesi than with P.
et al. 2011) are higher than that reported in larger series of adult microvascu-lar accumulation falciparum (Barber et al.
severe falciparum malaria (Lichtman et al. 1990; Aursudkij et al. of parasitised and non- 2012), which may sug-gest a
1998; Bruneel et al. 2003; Krishnan & Karnad 2003; Yeo et al. parasitised ery-throcytes greater inflammatory
2007; Dondorp et al. 2008a). However, ARDS is significantly without platelet aggregation response per parasitised red
less common in knowlesi malaria series trea-ted with has been reported in multiple cell, as seen with P. vivax
artemisinins (Barber et al. 2012). Severe anae-mia is seen in both organs, including the brain, (Ross & Thomson 1910; Yeo
adults (Barber et al. 2012) and children (Barber et al. 2011). in a single autopsy report of et al. 2010a). In keeping with
Metabolic acidosis, black-water fever, jaundice and an adult human who died this, the neutrophil count is
hypoglycaemia have also been reported (William et al. 2011; from positively associated with
Barber et al. 2012). P. knowlesi multiorgan failure both P. knowlesi parasitaemia
without coma (Cox-Singh et (Cox-Singh et al. 2008;
al. 2010). Although P. William et al. 2011; Barber et
knowlesi-infected al.
Clinical spectrum in children
erythrocytes have been 2012) and disease severity
A single small series to date describes mostly uncompli-cated shown to bind to ICAM-1 in (Cox-Singh et al. 2008;
disease in older children (Barber et al. 2011). As in adults, vitro (Fatih et al. 2012), William et al. 2011; Barber et
thrombocytopenia is nearly universal, with 94% having ICAM-1 was not detected on al. 2012). Consistent with a
thrombocytopenia at diagnosis and 100% by day one of brain endothelium in this greater inflammatory
treatment. Anaemia is common, with 71% having haemoglobin autopsy, and no electron response to P. knowlesi is a
<10 g/dl. Severe anaemia has also been reported (Barber et al. microscopy studies of greater fre-quency of acute
2011). endothelial cytoadherence respiratory distress syndrome
have yet been reported. Early in non-arte-misinin-treated
microvascular imaging severe knowlesi than in
Pregnancy severe falciparum malaria
studies of severe malaria in
Severe disease has been reported in pregnancy, associated with rhesus monkeys showed (William et al. 2011). Plasma
intrauterine death (William et al. 2011). In one small series, two progressive intravascular concentrations of the pro-
(18%) of women requiring hospital admission with knowlesi agglutination of knowlesi- inflammatory cytokine,
malaria were pregnant (William et al. 2011). Pregnancy may be a infected red cells, with TNFa, are associated with
risk factor for severity as in falciparum malaria, but larger microvascular endo-thelium knowlesi disease severity, but
studies are needed. becoming sticky to and levels of the anti-inflamma-
solidly coated with, leu- tory cytokine IL-10 are not
cocytes (Knisely & (Cox-Singh et al. 2011).
Pathophysiology Peptic ulceration has been
Stratman-Thomas 1945,
reported in severe knowlesi
Little is known about the pathophysiology of human knowlesi 1948). Microvascular
malaria (Cox-Singh et al.
malaria. Plasmodium knowlesi has important differences from P. sludging of blood flow was
associated with greatly 2008; Lee et al. 2010a;
falciparum, including the 24-h blood-stage cycle (Knowles &
slowed capillary circulation Barber et al. 2012) and could
Das Gupta 1932), and conse-quent potential for more rapid
indicate gut ischaemia (White
multiplication and pro-gression to death (Cox-Singh et al. 2008). rates before death (Knisely
& Stratman-Thomas 1945, 2008). Concurrent Gram-
In simian studies, P. knowlesi infection in the long-tailed
negative bacteraemia has also
macaque, a natural host, is associated with mild clinical disease 1948). The absence of coma
in severe knowlesi malaria been reported (William et al.
or asymptomatic carriage, while infections in the non-natu-ral
suggests dif-ferent 2011; Rajahram et al. 2012),
simian hosts such as the rhesus macaques and olive baboons
but the true incidence of co-
result rapidly in death (Coatney et al. 1971; Ibi-woye et al. 1993; mechanisms and/or
infection and its contribution
Praba-Egge et al. 2002). Experimental inoculation of P. knowlesi consequences of parasite
accumulation in brain to severe disease is not
into olive baboons results in increased pro-inflammatory
known.
cytokine concentrations with widespread vascular congestion microvasculature with P.
of the capillaries with cellular necrosis in multiple organs knowlesi compared to the
demonstrated on his- cytoadherence-mediated Thrombocytopenia is
sequestration occurring in associated with the severity
of both falciparum and
severe P. falciparum malaria. knowlesi malaria
(Daneshvar et al.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131 93
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
(SEAQUAMAT) Group
2005), parenteral artesunate
is the treatment of choice for
Treatment of severe knowlesi severe P. knowlesi infection
2009; William et al. 2011; Barber et al. 2012), but patients malaria (Barber et al. 2012). Other
infected with non-severe P. knowlesi have a more profound supportive care, including
Both quinine (Cox-Singh et
thrombocytopenia than patients with non-severe falciparum transfusion, intravenous
al. 2008; Daneshvar et al.
malaria (Daneshvar et al. 2009; William et al. 2011; Barber et antibiotics, vasopressor
2009; William et al. 2011)
al. 2012). Whether this reflects platelet activation contributing support, dialysis and
and more recently, artesunate
to pathophysiol-ogy (William et al. 2011) or consumption as invasive ventilation as
(William et al. 2011; Barber
part of a beneficial antiparasitic response (Cox-Singh et al. needed, should be given as
et al. 2012) have been used.
2011) has not been determined. In one series, the only knowle- per recommendations for
Chloroquine usage following
si-infected patients who did not develop thrombocytope-nia had severe falciparum malaria.
misdiagnosis as P. malariae
had previous splenectomy (Barber et al. 2012), suggesting a and delayed parenteral
role for the spleen in platelet clearance. therapy have both been
associated with fatal
Diagnosis and definition of severe knowlesi malaria outcomes (Cox-Singh et al.
Definition of severe
2008; Rajahram
malaria in P. knowlesi
Mature trophozoites and schizonts of P. knowlesi are et al. 2012). In a retrospective infection
indistinguishable on thick film microscopy from P. mala-riae and review of treatment responses
subtle differences on thin film microscopy can-not distinguish in severe knowlesi malaria, Research definition
the species reliably (Lee et al. 2009b; World Health Organization artesunate-treated patients
As for severe
2011a,b). Ring forms resem-ble P. falciparum leading to further had faster parasite clearance falciparum malaria (see
misdiagnosis (Cox-Singh et al. 2008; Lee et al. 2009b; World times, and the case-fatality Table 4) but with
Health Organization 2011a,b). Misdiagnosis as P. vivax also rate (17%) was lower than in modified parasitaemia
occurs (Cox-Singh et al. 2008; Barber et al. 2013b). All cases of those who received quinine cut-offs:
malaria in knowlesi-endemic areas diagnosed as P. malariae (31%) (William et al. 2011), 1 Parasite density >100
should be treated immediately as P. knowlesi pending PCR-based although the study was not 000/ll
diagnosis at a reference laboratory. Parasite LDH-based rapid 2 Jaundice and
parasitaemia >20 000/ll
powered to demonstrate a
antigen tests are not specific and insufficiently sensitive overall statistically significant Clinical definition
in P. knowlesi infections, although high sensitivity has been mortality advantage. In the requiring treatment with
reported in severe knowlesi malaria (Barber et al. 2013a). largest prospective study of intrave-nous artesunate:
severe knowlesi malaria, 1 Inability to tolerate oral
therapy
The research definition of severe malaria (Box), based on early referral protocols and
those used for severe P. falciparum malaria, is derived from stan-dardised (including pre- 2 Warning signs or
clinical severity
severe knowlesi malaria series to date (Daneshvar et al. 2009; referral) use of intravenous criteria as per
severe falciparum
William et al. 2011; Barber ar-tesunate were associated malaria
et al. 2012), with relatively high specificity. The para-sitaemia with zero mortality (Barber 3 Parasitaemia >20
threshold defining hyperparasitaemia in 000/ll
et al. 2012). Given the clear
P. knowlesi is >100 000/ll (compared to >10% with P. mortality advantage in *In settings where
falciparum) with a parasitaemia threshold of 20 000/ ll for severe falciparum malaria, clinical or laboratory
jaundice (compared to >100 000/ll with P. falci-parum). In criteria of severity
faster parasite clearance
clinical settings where laboratory assessment of severity criteria time than quinine in P. cannot be assessed.
is not readily available, a practical clinical definition for severity knowlesi (William et al.
requiring treatment with intravenous artesunate is inability to 2011), dem-onstrated
tolerate oral ther-apy, any clinical or laboratory severity criteria efficacy in severe knowlesi
used for malaria (William et al. 2011;
falciparum malaria or any parasitaemia >20 000/ll. The latterBarber et al. 2012), safety
parasitaemia cut-off is more sensitive but less spe-cific for severe and ease of use (South East
disease, but nevertheless predicted an 11-fold greater risk of Asian Quinine Artesunate
severe disease in the largest series to date (Barber et al. 2012). Malaria Trial
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
94 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
drolysed rapidly in vivo to the
active metabolite DHA. This
reaction can also occur ex
iron (and other reactive vivo (i.e. after collection)
cations) (Lindegardh et al. both through chemical
Section 15: Pharmacology of 2011, 2008). Thus, inherent hydrolysis and esterase
antimalarials in severe malaria
properties of these drugs mediated hydrolysis and thus
Severe malaria is a medical emergency requiring immediate necessary for their potent bias the analytical results
administration of rapidly effective antimalarial drugs. In the antimalarial activity also (Linde-gardh et al. 2008).
largest randomised trials ever conducted in severe malaria, the create serious problems for Anticoagulants containing
artemisinin derivative artesunate proved to be markedly superior quantification in biological fluoride inhibit esterase
to quinine in the parenteral treatment of severe malaria and is samples. Early methods using hydrolysis but not chemical
therefore now the treatment of choice for all patients (Dondorp et UV detection following post- hydrolysis. All artemisinin
al. 2005a, 2010) (Figure 23). Artesu-nate has also considerably column online derivatisation derivatives are thermolabile
simplified the treatment of severe malaria, as it can be given by reached limits of detection at with improved stability at
intravenous or intramuscular injection, has a simple dose 30 ng/ ml (Edlund et al. lower temperatures (e.g. 4 C
regimen and requires no dose adjustments. If parenteral 1984; Batty et al. 1996). or ice). Stability of these
artesunate is not available, then intramuscular artemether is Electrochemi-cal detection drugs in plasma varies with
second choice and quinine third. For pre-referral treatment in the (ECD) methods, which are source. Some methods have
community, a rectal formulation of artesunate has been notoriously diffi-cult, were carried out the bioanalytical
developed with satisfac-tory absorption kinetics. Given in the used more widely and work on ice to minimise
community before referral to hospital, this reduced the mortality reached detection limits of degradation, while others
of severe malaria in children by 25% (Gomes et al. 2009). As the about 10 ng/ml (Navaratnam have con-ducted analysis at
malaria parasites causing illness are confined to the blood, it is et al. 1997; Na-Bang-chang ambient temperature.
the concentrations of antimalarial drugs in blood that determine et al. 1998). An indirect Artemisinins are relatively
the therapeutic response. Severe malaria affects the absorption, approach using a sensitive stable in haemolysed plasma
disposition, metabolism and elimination of many drugs. Reduced but non-specific bioassay was but are degraded rapidly
visceral blood flow (Molyneux et al. 1987; Pukrittayakamee et also used in early pharma- when they come into contact
al. 1992, 1994) and microvascu-lar sequestration may reduce oral cokinetic studies (Teja- with organic sol-vents during
and intramuscular drug absorption, respectively. Fortunately, the Isavadharm et al. 1996; sample processing
effects on paren-teral artesunate pharmacokinetics are relatively Bethell (Lindegardh et al. 2011). The
small. et al. 1997; Newton et al. result is that analysis of these
2000). None of these methods drugs in haemolysed samples
Mechanism of action provide sufficient sensitivity or samples containing active
and specificity for accurate haemolytic products are
The exact mechanism of antimalarial action of artemisinin drugs characterisation of the biased (concentrations usually
is still unknown, but a reduction of the reactive per-oxide bridge pharmacokinetic properties of underestimated) unless the
and the production of free radicals or other reactive these drugs. The preferred method uses a suitable
intermediates are thought to be essential for anti-malarial method for quantification of internal standard (i.e. stable
activity (Jansen & Soomro 2007; Haynes et al. 2010, 2012, the artemisinins [artesunate, isotope labelled artesunate,
2011). The ferrous ion (Fe++) in haem appears to be important artemether, artemotil and di- artemether or DHA) that
for bioactivation as activity is reduced in the presence of iron hydroartemisinin (DHA)] is compensates fully for this. In
chelators (desferrioxamine). Quinine is thought to interfere with liquid chromatography tan- general, these confounders
haem detoxification (as do other quinolines and structurally dem mass spectrometry (LC- result in underestimation of
related compounds). MS/MS), which reaches the drug concentrations. In
quantification limits of about summary, multiple pitfalls in
1 ng/ml using only 50 ll sample separation, storage,
Drug measurement plasma (Naik et al. 2005; Gu preparation and analysis have
Antimalarial drug measurement has improved substan-tially in et al. 2008; Lindegardh undoubtedly contributed to
recent years. Pharmacokinetic studies in severe malaria need to et al. 2008, 2011; the large intersubject
be interpreted in the light of these advances. Artemisinins have Hanpithakpong et al. 2009; variation in plasma
posed particular measurement challenges. The peroxide bridge Hodel concentration profiles
needed for antimalarial activity renders the artemisinins unstable et al. 2009). Artesunate, the reported, and the derived
and, in particular, susceptible to degradation mediated by most widely used of the arte- pharmacokinetic parameters
misinin derivatives, acts as an quoted for these drugs.
ester pro-drug and is hy-
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 95
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
have lower exposures to both
artesu-nate and DHA given a
standard weight adjusted dose
reportedly well tolerated and of parenteral artesunate than
Quinine has been measured using increasingly sensitive and had estimated bioavailabili- older children and adults
precise methods over the past 70 years. The initial ties of 36% and 40%, and a (Hendriksen et al. 2013b)
spectrophotometric methods developed over sixty years ago mean (SD) time to peak (Figures 28 and 29). In a
could not distinguish the parent compound from the metabolites concentration of 4.1 (2.4) and recent large population,
and substantially overestimated the correct values. The extraction 2.7 (0.4) h, respectively, in pharmacokinetic study of
fluorescence method introduced in 1963 was a significant children with moderately artesu-nate from Tanzania
improvement but still overesti-mated concentrations, as the severe malaria from Niger children weighing between 6
hydroxylated metabolites were not distinguished (this was more (Bar-ennes et al. 1995). In a and
of a problem in uncomplicated than in severe malaria) (White et later study, rectal
al. 1982; Edstein et al. 1983). Then, in the early 1980s, specific bioavailability of quinine in 10 kg body weight had 20%
HPLC methods with fluorescence detection were intro-duced, moderate severity malaria lower DHA exposure than
and finally in recent years, LC-MS methods have been used. was shown to be dose- children between 21 to 25 kg
dependent falling from 96% body weight, suggesting that
with a dose of 8 mg/kg to a higher dose is needed for
52% at 16 mg/kg (Pussard et young children (Hendrik-sen
Antimalarial drug absorption
al. 2004). et al. 2013b). In contrast, in
In severe malaria, the oral route is unreliable and in children with severe malaria
unconscious patients may be dangerous as aspiration of gastric Antimalarial drug disposition less than 2 years old, quinine
contents may occur. Fortunately, the absorption of artesunate concentrations were higher
or quinine after intramuscular injection is good even in severe The apparent volume of than in older children and
malaria (Waller et al. 1990; van Hensbroek et al. 1996; distribution of the artemisinin adults (van Hensbroek et al.
Krishna et al. 2001a; Nealon et al. 2002; Hien et al. 2004; derivatives is not greatly 1996).
Hendriksen et al. 2013c), affected by malaria, whereas
and this is an acceptable alternative route to intravenous for quinine, there is a marked
administration for these drugs. Parenteral artemether and contraction in proportion to
Antimalarial drug clearance
artemotil are oil-based injectates which can be given only by disease severity (White et al.
intramuscular injection. Absorption is slow and erratic and may 1982). This is explained in Artesunate, artemether,
be dangerously slow in some patients with severe malaria part by increased plasma artemotil are all converted in
(Murphy et al. 1997; Hien et al. 2004; Li et al. 2004). This protein binding of the basic vivo to the active metabolite
explains why they are inferior to intra-venous artesunate in qui-nine to the acute phase dihydroartemisinin, which is
severe malaria (Phu et al. 2010). Suppository formulations of reactant a1-acid glycoprotein. then inactivated by
artesunate, artemether and artemisinin are available in some Binding increases from 85 to glucuronidation (principally
countries. In a very large community-based trial, intrarectal 90% to approximately 93% in via UGT1A9 and UGT2B7)
artesunate (recto-cap ) given at a community level before referral severe malaria (Silamut et al. (Ilett et al. 2002a). The
to hospi-tal reduced malaria mortality in children by 25%, 1985; Mansor et al. 1991). principal route of artemisinin
particularly in patients who took many hours to reach hospital Thus, the free fraction in clearance is by
(Gomes et al. 2009). Rectal bioavailability of artesunate given as severe malaria is often less biotransformation to inactive
a gel-filled capsule (artesunate recto-cap ) averages than half that in healthy metabolites. Cytochrome
approximately 50% although there is con-siderable subjects. Concentrations of P450 3A4 activity is impaired
interindividual variability (see below) (Krishna et al. 2001b; quinine and DHA in in malaria, which reduces
Simpson et al. 2006). Intrarectal administra-tion of artesunate in cerebrospinal fluid in cerebral conversion of arteme-ther and
a gel-filled capsule is simple, safe and well tolerated. Quinine malaria are both <10% of artemotil to DHA and also
and Quinimax (a buffered mixture of Cinchona alkaloids corresponding plasma reduces metabolic clearance
comprising 96.1% qui-nine, 2.5% quinidine, 0.68% cinchonine concen-trations (White et al. of quinine (Pukrittayakamee
and 0.67% cinchonidine) have been also administered 1982; Davis et al. 2003). et al. 1997). Renal
intrarectally. Unbuffered quinine is irritant when instilled Drug exposure in young impairment does not affect
rectally, whereas Quinimax is generally well tolerated; rectal children with severe malaria clearance of the artemisinins
quinine gluconate as a cream and the commercial mixture of is lower than that in older
Cinchona alkaloids, Quinimax , in solution, was children and adults. Young
children with severe malaria
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
96 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
a relatively small
geographical area at present,
but if artemisinin resistance is
means that this class of drug suspected, then both
but reduces elimination of quinine and its main biologi-cally is not appropriate for severe artesunate and quinine should
active metabolite 3-OH quinine. In renal failure, 3-OH quinine malaria management. be given together in full doses
concentrations reach 45% of those of the parent compound, Although quinine resistance (Newton et al. 2001a).
thereby contributing 12% of the anti-malarial activity (Newton has been discussed for over a
et al. 1999). century, and there is Pharmacology of
undoubtedly reduced antimalarial drugs
Antimalarial pharmacodynamics susceptibility to quinine in P.
falciparum in parts of South- Artemisinin, also known as
The primary objective of antimalarial treatment in severe malaria East Asia and South America, qinghaosu, is a sesquiterpene
is to inhibit the development of, or to kill, a suffi-cient number of there is no hard evi-dence that lactone extracted from the
parasites to prevent death. After antimalar-ial drug treatment, the this has translated into an leaves of Artemisia annua
reduction in parasite numbers is fractional thus provided increase in quinine-treated (sweet wormwood). It has
minimum parasiticidal concen-trations are exceeded, a fixed mortality in severe malaria. In been used in China for the
fraction of the parasite bio-mass is killed per asexual cycle; a Thailand, where multidrug- treatment of fever for more
first-order process (White 1997, 2011). However, in severe resistant P. falciparum is than 2000 years. It is a potent
malaria, it is the drug effects on the current asexual cycle that are prevalent, coma recov-ery and rapidly acting blood
paramount, and drug effects on subsequent cycles are of less times and parasite clearance schizontocide and is active
importance. The pharmacodynamic properties of the antimalarial times were noted to lengthen against all Plasmodium
drugs can be described in terms of the stage specificity of their between 1981 and 1992, but species. It has an unusually
antiparasitic action during the asexual life cycle. The con- mortality did not increase broad activity against asexual
centrationeffect relationships and their maximal effects differ (Pukrittayakamee et al. 1994). malaria parasites (ter Kuile et
between the drugs. All antimalarial drugs kill the mature Occasional early treatment al. 1993), killing all stages
trophozoite stages of susceptible plasmodia. Once schizonts are failures do occur, but usually from young rings to schizo-
formed, their effects are much less. Only the artemisinins kill the can be explained by unusual nts. In P. falciparum malaria,
young circulating ring stages and thereby prevent their pharmacokinetics resulting in artemisinin also kills the
sequestration (ter Kuile et al. 1993; Watkins et al. 1993; low drug concen-trations gametocytes including the
Udomsangpetch et al. 1996). Evidence from the recent large (Looareesuwan et al. 1990; stage 4 and early stage 5 ga-
SEAQUAMAT and AQUAMAT trials indicates that the Newton et al. 2005b). There metocytes, which are
substantial life-saving advantage of ar-tesunate over quinine is is no convincing evidence for otherwise sensitive only to
explained by its parasiticidal effects on circulating ring-stage high-grade resistance primaqu-ine. The peroxide
parasites, preventing their develop-ment and sequestration anywhere in the world, so bridge is essential for
(Dondorp et al. 2005a, 2010; Caramello et al. 2012). The action quinine can still be relied antimalarial activity, but the
of both drugs on the sequestered parasites is similar, although upon everywhere in the exact mechanism of action
artesunate may also have a greater effect on mature schizonts. treatment of severe malaria. remains unknown.
The critical advantage of artesunate is reflected in the shape of The suscep-tibility of P. Artemisinin is the parent
the para-site clearance curve. Following artesunate, the decline in falciparum in Western compound, and it is still
parasitaemia is more rapid compared with quinine and any Cambodia and along the available in some areas in a
increase or plateau phase before the log-linear decline in parasite ThailandMyanmar border to suppository formulation and
numbers is attenuated (White 1997, 2011). This advantage is lost artemisinins has declined, and is still used orally in some
in artemisinin resistant parasites (Dondorp et al. 2009). In this is manifested by reduced ACTs, but it has now lar-gely
addition, the artemisinin derivatives gener-ally have a wide parasiticidal effects against given way to the more potent
therapeutic index, whereas the quinoline antimalarial drugs have younger circulating parasites dihydroartemisinin (DHA)
a narrow therapeutic index. (Saralamba and its derivatives,
et al. 2011; Phyo et al. 2012), artemether, artemotil and
which suggests that the life- artesunate. All three are
saving benefit of artesunate formulated for parenteral
Antimalarial drug resistance could be compromised. How- admin-istration in severe
ever, the extent to which this malaria. The DHA derivatives
Chloroquine resistance fatally compromised the efficacy of this are all
previously highly effective drug in severe malaria. Aside from compromises artesunate in
widespread resistance, the very late-stage activ-ity of antifols severe malaria has not been
(affecting the formation of the early schizont) determined. Fortunately,
resis-tance is still confined to
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 97
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
methods have generally given
more reliable assays and
therefore more reliable
acid with a separate pharma-cokinetic estimates.
converted back in vivo to DHA. For artesunate, this back ampoule of 5% Artesunate is rapidly
conversion is very rapid and DHA accounts for the majority of sodium bicar-bonate absorbed, with peak plasma
antimalarial activity in severe malaria. solution. levels occurring 0.5 h after
1 Rectal capsules intramuscular and 2 h after
containing 100 or 400 rectal administration (Nealon
Artesunate mg of sodium
artesunate. et al. 2002; Hendriksen et al.
Artesunate is the treatment of choice for severe malaria; it is the 2013a). Intramuscular
sodium salt of the hemisuccinate ester of dihyd-roartemisinin. Pharmacokinetics and bioavailability in Gabonese
Artesunate is soluble in water but has poor stability in aqueous pharmacodynamics. Early children with severe malaria
solutions at neutral or acid pH. In the most widely used meth-ods of assay for was estimated at a median of
injectable formulation, artesunate is formed by the addition of artesunate, artemether and 86%. Following rectal
sodium bicarbonate solution to freeze-dried artesunic acid dihydroarte-misinin were administration, bio-
immediately before dilution in isotonic dextrose or saline and difficult and techniques for availability is variable but
given by intravenous or intramuscular injection. Other sample preparation did not averages approximately 50%.
formulations are in devel-opment. Artesunate can be given orally, satisfactorily limit haem- Artesunate is rapidly and
rectally or by the intramuscular or intravenous routes. mediated degradation. As a almost entirely converted by
result, concentration
Formulations. measurements were
sometimes inaccurate. More
1 Ampoules for intramuscular or intravenous injection recent studies employ-ing
containing 30, 60 or 120 mg of anhydrous artesunic LC-MS/MS-based assay
5,000 5,00
0 0
0 2 4 6 8
Intravenous
artesunate
2.4mg/kg given to
childre
n
0 2 4 6 8
metabolite, dihydroartemisinin
Artesunate (ARS) was
(DHA),
assumed
following
to be
derived
rectal
converted
from
or immediate
age-weig
Time (h) Time (h)
intravenous administration
completely to DHA.
of artesunate
Weight (Simpson
distributions
individuals
et al.
for2006).
each
(Taylor
age gro
et a
Figure 28
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
98 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
elimination half-life from 2 to
8 min across the differ-ent
study populations of healthy
volunteers, adults with vivax
malaria, adults with
falciparum malaria, children
with severe malaria and
Figure 29 Prediction-corrected venous log pregnant and post-partum
plasma concentrations based on a study of the
women. For DHA
population pharmacokinetics of artesunate and
dihydroartemisinin in 70 Tanzanian children concentrations following
with severe malaria (Hendriksen et al. 2013a). intravenous administration of
Open circles, observed data points; solid lines, artesunate, the median
5th, 50th and 95th percentiles of the observed volume of distribution ranged
data; shaded area, 95% confidence interval of from 9 to 108 l, the median
simulated
clearance from 9 to 62 l/h and
(n = 2000) 5th, 50th and 95th percentiles.
the elimination half-life from
Awad et al. 2004; Hien et al. 18 to 69 min across the
2004; Sirivichayakul different study populations.
blood esterases to DHA, the active metabolite. Thus, DHA
accounts for nearly all the antimalarial effect. DHA plasma et al. 2007; McGready et al.
protein binding is estimated at approximately 75%. Red cell 2012c; Hendriksen et al.
concentrations are lower than correspond-ing plasma 2013a,b). The median times Implications for dosing. No
concentrations (Lindegardh et al. 2011). DHA is eliminated to achieve maximum ar- dose modifications are nec-
mainly by conversion to inactive glu-curonides. Elimination of tesunate concentrations were essary in renal or hepatic
within a few minutes, 7 10
artesunate is very rapid, and antimalarial activity is determined impairment. The
min and 0.51 h (Halpaap et
by dihydroartemisinin elimination (half-life approximately 45 pharmacoki-netic properties
al. 1998; Siri-vichayakul et
min) (Simpson of intravenous artesunate are
al. 2007) and to reach
et al. 2006). This rapid rate of elimination means that also relatively unaffected by
maximum plasma, DHA
concentrations may fall below the minimum parasitical pregnancy. In a study of 70
concentrations were within
concentration for the infecting parasites during the dose interval. 12 min, 2540 min and 13 h Tanzanian children aged
This does not matter for sensitive parasites, as maximum killing for intravenous, between 6 months and 11
effects are obtained with approximately 4 h exposure, but in the intramuscular and rectal years who presented with
presence of artemisinin resistance may lead to submaximal administration, respectively. severe falciparum malaria,
effects if the majority of parasites are circulating young rings body weight significantly
The median artesunate AUC0-
with reduced susceptibility (Saralamba et al. 2011). This affected clearance and
was similar for all three apparent volume of
emphasises the importance of the second dose given at 12 h as an inf
routes of administra-tion; distribution (P < 0.001),
insurance policy in case the parasites were relatively refractory
5551269 ng 9 h/ml for resulting in lower
12 h earlier when the first dose was given. Evidence suggests
intravenous, 535
that severe malaria has relatively little effect on the disposition of
parenteral artesunate. Artesunate does not penetrate to the CSF
999 ng 9 h/ml for
whereas DHA concentrations averaged 8% of those in plasma intramuscular and 548
(Davis et al. 2003).
1076 ng 9 h/ml for rectal
Summarising the literature after intravenous artesu-nate doses administration. The median
of between 1.2 and 4 mg/kg, the observed median (or mean) AUC0-inf values for DHA
maximum plasma concentrations of artesunate ranged from 13 varied widely (partly because
685 to 29 677 ng/ml and for DHA ranged from 1280 to 3277 of different dosing). The
ng/ml. After intra-muscular doses of 1. to 2.4 mg/kg, plasma ranges of median DHA
artesunate ranged from 615 to 2195 ng/ml and plasma DHA ran- AUC0-inf values were 737 to
ged from 341 to 1166 ng/ml, and following rectal doses of 2 to 3 3298 ng 9 h/ml for
intravenous, 3962474 ng 9
mg/kg, 10 mg/kg and 20 mg/kg plasma artesunate ranged from h/ml for intramuscular and
90 to 561 ng/ml and plasma DHA ranged from 180 to 1535 726 to 9576 ng 9 h/ml for
ng/ml (Batty et al. 1998a,b; Halpaap et al. 1998; Navaratnam et rectal artesunate. The median
al. 1998; Sabchareon et al. 1998; Davis et al. 2001; Krishna vol-ume of distribution for
artesunate ranged from 5 to
et al. 2001b; Ilett et al. 2002b; Nealon et al. 2002; 53 l, the median clearance
from 35 to 213 l/h and the
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 99
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
CYP3A4. Autoinduction of
metabolism is less than with
artemisinin. After
Artemether intramuscular administra-
artesunate and dihydroartemisinin exposure in smaller children
(Hendriksen et al. 2013a) (Figures 26 and 29). This suggests that Artemether is the methyl Artemether (nmol/L)
weight-based dosing should be adjusted and doses increased in ether of DHA. It is more 20
young children (Table 10). lipid soluble than
artemisinin or artesunate. It
can be given as an oil-based
Toxicity. Artemisinin and its derivatives are safe and remarkably
intramuscular injection or 16
well tolerated. There have been reports of mild gastrointestinal
orally. It is also co-
disturbances, dizziness, tinnitus, re-ticulocytopenia, neutropenia, formulated with
elevated liver enzyme val-ues, allergic reactions, and lumefantrine (previously
electrocardiographic abnormalities, including bradycardia and called benf-lumetol) for 12
prolongation of the QT interval, although most studies have not combination therapy.
found any electrocardiographic abnormalities (Price et al. 1999;
Maude et al. 2009a). The only potentially serious adverse effect Formulations. 8
reported with this class of drugs is type 1 hypersen-sitivity
reactions in approximately 1 in 3000 patients (Leonardi et al. 1 Ampoules of injectable 4
2001). Neurotoxicity has been reported in animal studies oil for intramuscular
(Genovese & Newman 2008), particu-larly with very high doses injection containing 80
mg of artemether in 1 0
of intramuscular artemotil and artemether, but has not been ml for adults or 40 mg
substantiated in humans (Kissinger et al. 2000; Van Vugt et al. of artemether in 1 ml 0 4 8
for paediatric use.
2000; Hien et al. 2003). Similarly, evidence of death of embryos 12 16
and mor-phological abnormalities in early pregnancy has been
20 24
demonstrated in animal studies (Longo et al. 2006; Clark 2009). Pharmacokinetics and
Embryolethality occurs within a narrow time win-dow in early pharmacodynamics. T
pregnancy and is related to specific toxicity to primitive red Following intramuscular i
blood cell precursors. In experimental studies, limb injection in severe malaria, m
developmental abnormalities were observed in rodents, but not in absorption is very variable, e
primates (Clark 2009). There is no evidence these drugs cause especially in children with (
poor peripheral perfusion: h
abortion, stillbirth or develop-mental abnormalities in humans
peak plasma concentrations )
(McGready et al. 2012b).
generally occur after around 6
h, but absorption is slow and Figure 30 Individual
erratic and times to peak can concentrationtime profiles for
At doses higher than currently recommended the artemisinins be 18 h or longer in some artemether after the first
(6 mg/kg/day for 7 days) may cause tempo-rary neutropenia cases (Murphy et al. 1997; intramuscular dose of 10.7 lmol
(Bethell et al. 2010). Following the treatment of severe malaria Hien et al. 2004; Mithwani et (3.2 mg) of ARM/kg to 10
with artesunate, particularly in hyperparasitaemic patients, there al. 2004) (Figure 30). The patients with severe falciparum
malaria (Hien
may be a delayed but severe anaemia (Zoller et al. 2011; intrinsic activity of et al. 1996). Oval highlights
Kreeftmeijer-Vegter et al. 2012; Rolling et al. 2012). This is artemether is less than that of critical early period in which
attributed, at least partly, to the accelerated destruction of once DHA, which combined with some patients may absorb very
parasi-tised erythrocytes red cells which contained a parasite the very variable absorption little drug.
which was killed and then removed by the spleen (pit-ting) in severe malaria makes it an
(Angus et al. 1997; Newton et al. 2001b). Thus, this apparent inferior treatment to artesu-
adverse effect is a direct function of the life-saving effect of nate, but probably still better
artesunate in killing young parasites in circulating red cells than quinine in severe malaria
before they can cytoadhere (Udom-sangpetch et al. 1996). (Dondorp et al. 2010; Phu et
al. 2010). Artemether is
metabolised to DHA, the
Drug interactions. Artemisinin and, to a lesser extent, artemether active metabolite.
induce their own metabolism. There are no significant Biotransfor-mation is
interactions with other drugs. The antimalarial action of these mediated predominantly via
drugs is antagonised by desferrioxamine. the cytochrome P450 enzyme
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
100 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
available and extensively
used, and it needs to be kept
available in case artemisinin
1 These include: resistance worsens. The
tion, artemether predominates in the blood (Teja-Isavad-harm Suppositories mechanisms of quinines
containing 100, 200,
et al. 1996; Hien et al. 2004), whereas after oral administration 300, 400 or 500 mg antimalarial actions are
DHA predominates. Artemether is 95% bound to plasma of artemisinin. thought to involve inhibition
proteins. The elimination half-life is approximately 1 h, but of parasite haem
following intramuscular adminis-tration, the elimination phase Pharmacokinetics. Peak detoxification in the food
is prolonged considerably because of continued absorption. No plasma concentrations occur vacuole, but are not well
dose modifications are necessary in renal or hepatic around 3 h after oral and understood. Quinine can be
impairment. around 11 h after rectal given orally, rectally (if
administration. Artemisinin buffered), and by intra-
Toxicity. In all species of animals tested, intramuscular is converted to inactive muscular injection (to the
artemether and artemotil cause an unusual selective pattern of metabolites via the anterior thigh, preferably
neuronal damage to certain brain stem nuclei (Brewer et al. cytochrome P450 mixed diluted to a concentration of
1994). Neurotoxicity in experimental animals is related to the function oxi-dases notably 60100 mg/ml)) or by con-
sustained blood concentrations that follow intramuscular CYP2B6 and several other stant rate intravenous
administration, because it is much less frequent when the same enzymes. Arte-misinin is a infusion. Quinine should not
doses are given orally or with similar doses of water-soluble potent inducer of its own
be given subcutaneously
drugs such as ar-tesunate. Clinical, neurophysiological and metabolism. The elimination
because this can result in skin
pathological studies in humans have not shown similar findings half-life is approximately 1 h necrosis.
(Simonsson
with therapeutic use of these compounds (Kissinger et al. 2000;
Van Vugt et al. 2000 Hien et al. 2003). Toxicity is otherwise et al. 2003; Asimus et al.
2007).
similar to that of artemisinin.
Formulations.
Toxicity. As for artesunate.
Artemotil 1 Injectable solutions of
Drug interactions. None quinine hydrochloride,
known apart from quinine dihydrochloride
Artemotil is the beta ethyl ether of dihydro artemisinin and quinine sulphate
(arteether) and is very closely related to the more widely used autoinduc-tion. containing 82%, 82%
artemether. It is oil-based so is also water insoluble. A mixture of and 82.6% quinine base,
respectively.
a and b ethers is also available in India for intramuscular
administration. Artemotil and a b arteether are given by Quinine
intramuscular injection only. Pharmacokinetics and
Quinine is an alkaloid pharmacodynamics. The
derived from the bark of the pharma-cokinetic properties
Formulations.
Cin-chona tree. Four of quinine are altered
1 Ampoules containing 150 mg of artemotil in 2 ml of antimalarial alkaloids can be significantly by malaria
injectable solution. infection, with reductions in
derived from the bark:
apparent volume of
quinine (the main alkaloid by
Pharmacokinetics. There is substantially less published distribution and clearance in
weight), quinidine,
information on artemotil than for artemether. Absorption is proportion to disease sever-
cinchonine and cinchonidine.
slower and more erratic, with some patients having undetectable ity. In children under 2 years
Quinine is the L-stereoisomer of age with severe malaria,
plasma artemotil until more than 24 h after administration
of quinidine, which was used
(Afolabi & Okoromah 2004; Li et al. 2004; Pareek et al. 2006;
as an alter-native treatment of
Mukim et al. 2011).
severe malaria in temperate
countries where quinine was
Toxicity. As for artemisinin.
not readily available. Quinine
has been the mainstay of
Drug interactions. None known.
antimalarial treatment of
severe malaria for 350 years
Artemisinin but has now been overtaken
by the artemisinin
Formulations. A wide variety of formulations for oral,
parenteral and rectal use is available. derivatives. Nevertheless,
quinine is still widely
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 101
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
compartment model. The
mean (SD) volume of the
central compartment (Vc) is
mean (SD) time to peak also contracted from 0.7 (0.3)
Plasma quinine (g/L) concentration of 4.1 (2.4) and in healthy Thai adults to 0.17
1600 2.7 (0.4) h, respectively, in (0.1) l/kg in cerebral malaria
children with moderately (Davis et al. 1988). In
severe malaria from Niger Kenyan children with
(Barennes et al. 1995). These cerebral malaria, the
1200 solutions were reportedly estimated volume of the
well tolerated. Rectal absorp- central compartment was
tion is dose-dependent even smaller; 0.27 (0.1) l/kg
800 (Pussard et al. 1999, 2004). or 40% lower than the value
Rec-tal quinine proved in adults (Winstanley et al.
effective in childhood 1993). This explains why
400 cerebral malaria in a recent intravenous injections (as
trial although much larger opposed to infusions) of
trials would be needed for quinine are potentially so
definitive information, and
1 2 3 dangerous in severe
before this could be
Days infections. Quinine is
recommended widely. (Achan
distributed throughout most
et al. 2007).
Figure 31 Mean plasma quinine concentration profiles in adult patients of the body fluids. The mean
with severe falciparum malaria receiving a loading dose of quinine (20 concentration in erythro-cytes
mg salt/kg over 4 h) in the upper panel (blue), the predicted plasma is approximately one-third of
concentrations based on derived pharmacoki-netic parameters without a
Disposition. A single that in plasma, rising to one
loading dose (10 mg/kg/8 h) (green) and the predicted levels in the once
compartment model is
advocated 5 mg/kg/8 h regi-men (red). Note the decline in plasma half (presumably because of
adequate to define the concentration within malaria
concentrations after the first days of treatment as systemic clearance
disposition of quinine after
improves, and the volume of distribution expands (White et al. 1983c). parasites) in severe malaria
intravenous infu-sion. The (White et al. 1983a).
concentrations are slightly higher than in older children and total apparent volume of Concentrations in saliva and
adults (van Hensbroek et al. 1996). There is no evi-dence for distribution (Vdss) in healthy in breast milk are about 30%
dose-dependent kinetics. adult subjects ranges from 1.5 of those in plasma (Salako &
to 3.5 l/kg (White et al. Sowunmi 1992, Phil-lips et
Absorption. Quinine is preferably given by rate con-trolled 1982). This is contracted in al. 1986b). Cerebrospinal
intravenous infusion to patients with severe malaria (Figure 31) malaria proportional to the fluid concentrations are 7 3%
(White et al. 1982). Quinine is also well absorbed after severity of disease (to of those in plasma in cerebral
intramuscular injection in severe malaria. Intramuscular quinine approximately 1.7 l/kg in malaria (White
has good bioavailability even in very young children (<2 years) Thai adults with
with severe malaria (Shann et al. 1985; van Hensbroek et al. uncomplicated falciparum et al. 1982). These values are
1996; Hendriksen et al. 2013c). Overall, there is good agree- malaria and 1.2 l/ kg in adults approximately half those of
ment between recent studies in African children with moderately with cerebral malaria). free (unbound) quinine in
severe to severe falciparum malaria. The overall mean (SD) peak Similar changes are seen in plasma, which suggests that
plasma quinine concentration after the 20 mg/kg loading dose is global malnutrition (Pussard quinine does not freely
15.6 (5.2) mg/l et al. 1999). Plasma traverse the bloodbrain
concentrations for a given barrier (Silamut et al. 1985).
(N = 57) (White 1995b). This compares with an overall mean dose are therefore highest in Quinine is a base and the
(SD) peak quinine concentration after intravenous administration severe malaria. In Kenyan principal plasma protein to
of 15.2 (3.6) mg/l (N = 74). Absorption is more rapid and the children with severe malaria, which it binds is the acute
intramuscular injection is less painful if quinine dihydrochloride estimated mean Vdss values phase pro-tein, a1-acid
(usual concentration 300 mg/ml) is diluted 1:2 to 1:5 before were lower; 1.22 l/kg and glycoprotein (Mihaly et al.
injection. The plasma concentration profile after intramuscular 0.87 l/kg in severe and 0.45 1987; Silamut
admin-istration may be biphasic in some patients. Rectal qui- l/kg (Winstanley et al. 1993), et al. 1991). Plasma protein
nine gluconate as a cream and the commercial mixture of and 0.75 l/kg (Winstanley et binding is therefore increased
from approximately 85% in
Cinchona alkaloids, Quinimax , in solution, had estimated al. 1994) in cerebral malaria.
healthy subjects to 9093%
bioavailabilities of 36% and 40%, and a Quinine pharmacokinetics
can be described by a two
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
102 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
available evidence suggests a
therapeutic range of free
quinine con-centrations
3A4 such as between 0.5 and 2.0 mg/l
in severe malaria (i.e. the free fraction is reduced by one-third to phenobarbitone and (corresponding roughly to
one half). Thus, although total plasma concentra-tions are higher rifampicin (Pukritta- total plasma concentrations of
in severe malaria, free concentrations may be no different from yakamee et al. 2003). 520 mg/l (White 1995b).
those in patients with uncom-plicated infections or healthy Modelling suggested an in
subjects. Increased protein binding may explain why relatively Children and pregnant vivo minimum parasiticidal
high total plasma qui-nine concentrations (1020 mg/l) do not women. Absorption of concentration for Thai P.
cause major tox-icity in the treatment of severe malaria. The quinine is similar in children falciparum isolates of 3.5
relationship between quinine binding (expressed as the and adults. The total apparent mg/l (Pukrittayakamee et al.
association constant) and pH is hyperbolic such that binding falls volume of distribution and 2003). Total plasma
with pH to a nadir around pH 7 (Winstanley et al. 1993). There is the volume of the central concentrations between 8 and
no clinical evidence for increased toxicity of quinine in acidosis. compart-ment are smaller in 20 mg/l in severe malaria are
children (Waller et al. 1990; usually safe and effective
Pasvol et al. 1991; (White 1987, 1995b, White et
Elimination. Extensive metabolism via the cytochrome P450 Winstanley et al. 1993), and al. 1983c).
enzyme CYP3A4 occurs in the liver (Zhao et al. 1996), and pregnant women
elimination of more polar metabolites is mainly renal. The initial (Looareesuwan et al. 1985;
metabolite 3-hydroxyquinine may accumulate in renal failure. In Phillips et al. 1985) than in Pharmacodynamics. Quinine
healthy subjects and patients with malaria, quinine is adults with disease of acts principally on the
predominantly (80%) biotransformed (White et al. 1982) first to comparable severity, but mature trophozoite stage of
3 and 2 hy-droxyquinine and then to a series of more polar elimination is more rapid in parasite development and
water-soluble metabolites. Plasma concentrations of 3-hydrox- both groups. Systemic clear- does not prevent
yquinine are approximately one-third to one-fifth of those of the ance values are therefore sequestration or further
parent compound, with a lower ratio in malaria indicating similar. Cord blood development of circulating
impairment of hepatic biotransformation. 3-hy-droxyquinine concentra-tions and breast ring stages of P. falciparum.
contributes approximately 5% of antima-larial activity in acute milk concentrations are Like other struc-turally
malaria rising to 10% in convalescence (Nontprasert et al. 1996; approximately one-third of similar antimalarials, quinine
Pukrittayakamee et al. 1997) and 12% in renal failure (Newton et those in simultaneously also kills the sexual stages of
al. 1999). sampled maternal plasma P. vivax, P. malariae and P.
(Phillips et al. 1986b). ovale, but not mature
gametocytes of P.
Approximately 20% of the quinine dose is eliminated by the falciparum. It does not kill
kidneys and the remaining 80% by hepatic bio-transformation. Areas of uncertainty. It has the pre-erythrocytic stages of
Small amounts appear in the bile and saliva. Total systemic been suggested that there be a malaria parasites.
clearance is reduced in uncompli-cated malaria, and further ceiling dose above which
reduced in severe malaria (White et al. 1982; White 1987). quinine should not be given, Toxicity. Administration of
Renal clearance and hepatic clearance are reduced in parallel. but there is no evidence to quinine or its salts regularly
support this. In obese causes a complex of
The observa-tion that plasma quinine concentrations are high in
patients, dosing should be symptoms known as
patients with acute renal failure probably relates more to the
based on ideal rather than cinchonism, which is
overall severity of disease and the consequent pharmacokinetic
observed body weight characterised in its mild form
changes, rather than to a reduction in glomerular filtration rate
(Viriyayudhakorn et al. by tinnitus, impaired high-
per se. The mean terminal elimination half-life in healthy adult
2000). Studies in malnutrition tone hearing, headache,
subjects is 11 h, compared with 16 h in uncomplicated malaria,
have given variable findings, nausea, dizziness and dyspho-
and
but overall sug-gest that no ria, and sometimes disturbed
dose alterations should be vision. More severe manifes-
18 h in cerebral malaria. The clearance of quinine is reduced, made (Salako tations include vomiting,
and the elimination half-life prolonged from 11 to 18 h in the
et al. 1989; Treluyer et al. abdominal pain, diarrhoea
elderly (age 6574 were studied) (Wan-wimolruk et al. 1991).
1996; Pussard et al. 1999). and severe vertigo.
Quinine elimination is more rapid in smokers (Wanwimolruk et
The relationship between Hypersensitivity reactions to
al. 1993), although the relevance of this to severe malaria is
plasma concentrations and quinine range
uncertain. Qui-nine clearance is increased by drugs which induce
par-asiticidal effects in severe
CYP
malaria is unclear, but
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 103
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
7-day course with artesunate,
artemether or quinine. It
should never be used alone to
nine is actually generally treat malaria. It is available
from urticaria, bronchospasm, flushing of the skin and fever, well tolerated in the as the hydro-chloride salt or
through antibody-mediated thrombocytopenia and haemolytic treatment of malaria. phosphate complex, or as a
anaemia, to life-threatening haemolyticurae-mic syndrome complex pre-pared from the
(which is very rare). Massive haemolysis with renal failure Drug interactions. There is a hydrochloride and calcium
(black water fever) has been linked epi-demiologically and theoretical concern that drugs chloride.
historically to quinine, but its aetiology remains uncertain. that may prolong the QT
Severe concentration-related toxicity, including hypotension, interval should not be given Formulations.
myocardial conduction and repo-larisation disturbances, with quinine, although
blindness, deafness and coma, is very unusual in the treatment of whether or not quinine 1 Capsules and tablets
containing 100 mg of
malaria with plasma con-centrations under 20 mg/l increases the risk of doxycy-cline salt as
(Pukrittayakamee et al. 1994; White 1995b). Hypoglycaemia is a iatrogenic ventricular hydrochloride.
more commonly encountered problem. Quinine is a potent tachyarrhythmia has not been
stimulus to pan-creatic insulin secretion (White et al. 1983b), and established. Antiarrhythmics, Pharmacokinetics.
hyperins-ulinaemic hypoglycaemia is particularly likely in such as flecainide and Doxycycline is readily and
pregnant women (Looareesuwan et al. 1985) who have amplified amiodarone, should probably almost completely absorbed
responses to islet cell stimulation, or patients who remain be avoided. Quinine increases from the gastrointestinal
severely ill for several days. Half of quinine-treated women with the plasma concentrations of tract, and absorption is not
severe malaria in late pregnancy develop hypoglyca-emia during digoxin (Doering 1981; affected significantly by the
treatment. Intravenous injections may cause acute cardiovascular Wilkerson 1981). Cimetidine presence of food. Peak
plasma concentrations occur
toxicity, especially after rapid intrave-nous injection, presumably inhibits quinine metab-olism,
causing increased quinine 2 h after admin-istration.
because transiently toxic blood concentrations occur before
levels and rifampicin, phe- Some 8095% is protein-
adequate distribution (Davis et al. 1988). Quinine causes an
bound and the elimi-nation
approximately 10% pro-longation of the electrocardiograph QT nobarbitone, ritonavir and
half-life is 1024 h. It is
interval mainly as a result of slight QRS widening. The effect other enzyme inducers
increase metabolic clearance widely distributed in body
on ventricular repolarisation is much less than that with
tissues and fluids. In patients
quinidine. Intra-venous quinine should be given only by infusion, leading to low plasma
with normal renal function,
never injection. Overdosage of quinine may cause oculotoxicity, concentrations and an
increased therapeutic failure 40% of doxycycline is
including blindness from direct retinal toxicity, and cardio-
rate. Combination with other excreted in the urine,
toxicity, and can be fatal. Postural hypotension is common in
antimalarials, such as the although more if the urine is
acute malaria, and this is exacerbated by quinine.
artemisinins, lumefan-trine, alkalinised. It may accumu-
Thrombocytopenia, Coombs positive haemolytic anaemia,
late in renal failure.
haemolyticuraemic syndrome and other allergic manifes-tations mefloquine and tetracyclines,
appears to be safe. However, the majority of the
are all rare in malaria treatment.
dose is excreted in the
faeces. Pharmacokinetic
Intramuscular quinine is certainly painful if concen-trated Doxycycline studies in severe malaria
acidic solutions are administered (undiluted qui-nine renal failure indicate that
dihydrochloride 300 mg/ml has a pH of 2), and in the past, these Doxycycline is a tetracycline
twice daily dosing would be
have been associated with sterile abscess formation. derivative with uses similar
preferable to the current
Intramuscular injections of undiluted quinine dihydrochloride to those of tetracycline. It
once-a-day regimen
cause pain, focal necrosis and in some cases abscess formation may be preferred to
(Newton et al. 2005b).
and in endemic areas are a com-mon cause of sciatic nerve tetracycline because of its
palsy. Tetanus associated with intramuscular quinine injections longer half-life, more reliable
is usually fatal (Yen absorption and better safety
profile in patients with renal
et al. 1994). In animals, toxic concentrations of quinine are
insuffi-ciency, where it may
oxytocic and induce premature labour. Quinine was once widely
used as an abortifacient. This has led to con-cern over the use of be used with caution. It is
quinine in pregnancy, but prospective studies (Looareesuwan et relatively water insoluble but
al. 1985) show no evidence of an oxytocic effect. Indeed very lipid soluble. It may be
administration of quinine was associated with a reduction in given orally or intravenously
uterine irritability. Despite an apparently long list of potential and is often given as a
adverse effects, qui- follow-on treatment of
severe malaria to complete a
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
104 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
area of The Gambia, West
Africa: 2 Mortality and
morbidity from malaria in the
study area. Transactions of the
Akech S, Ledermann H &
Royal Society of Tropical
Toxicity. Doxycyclines gastrointestinal effects are fewer than Maitland K (2010) Choice
Medicine and Hygiene
with tetracycline, although oesophageal ulceration can still be a of fluids for resuscitation in
87(Suppl 2), 1317.
problem if insufficient water is taken with tab-lets or capsules. children with severe
infection and shock: Alonso A, Lau J & Jaber BL
There is less accumulation in patients with renal impairment. (2008) Biocompatible
systematic review. British
Doxycycline should not be given to preg-nant or lactating Medical Journal 341, c4416. hemodialysis membranes for
women, or children younger than 8 years. Akhtar S & Mukherjee S (1993) acute renal failure. The
Chloroquine induced mania. Cochrane Database of
International Journal of Systematic Reviews,
Drug interactions. Doxycycline has a lower affinity for binding
Psychiatry in Medicine 23, CD005283.
with calcium than other tetracyclines, so may be taken with food
349356. Alexandre MA, Amaragiri SV & Lees TA
or milk. However, antacids and iron may still affect absorption. (2000) Elastic compression
Ferreira CO, Siqueira AM, et
Metabolism may be acceler-ated by drugs that induce hepatic al. (2010) Severe stockings for prevention of
enzymes, such as carba-mazepine, phenytoin, phenobarbital and Plasmodium vivax deep vein thrombosis. The
rifampicin, and by chronic alcohol use. malaria, Brazilian Cochrane Data-base of
Amazon. Emerging Systematic Reviews,
Infectious Diseases 16, CD001484.
16111614. Anand AC & Puri P (2005)
References Alkizim FO, Matheka D & Jaundice in malaria. Journal of
Mwanda OW (2011) Case Gas-troenterology and
Abdulla MN, Sokrab TE, Zaidan ZA, Siddig HE & Ali ME (1997) report - malaria complicated Hepatology 20, 13221332.
Post-malarial cerebellar ataxia in adult Sudanese patients. East by gangrene: a case Anand AC, Ramji C, Narula
African Medical Journal 74, 570572. presentation and review. Pan AS & Singh W (1992)
Abrams ET, Brown H, Chensue SW, et al. (2003) Host response to African Medical Journal 10, Malarial hepatitis: a
malaria during pregnancy: placental monocyte recruitment is e46. heterogeneous syndrome?
associated with elevated beta chemokine expression. Journal of Allegranzi B, Sax H, Bengaly The National Medical
Immunology 170, 27592764. L, et al. (2010) Successful Journal of India 5, 5962.
Abu Sayeed A, Maude RJ, Hasan MU, et al. (2011) Malarial ret-inopathy imple-mentation of the Anderson WK (1927)
in Bangladeshi adults. American Journal of Tropical Medicine and World Health Organization Malaria Psychoses and
Hygiene 84, 141147. hand hygiene improvement Neuroses Their Medical,
Abubakar A, Van De Vijver FJ, Mithwani S, et al. (2007) Assessing strategy in a referral hospital Sociological and Legal
developmental outcomes in children from Kilifi, Kenya, following in Mali, Africa. Aspects. London: Oxford,
prophylaxis for seizures in cerebral malaria. Infection Control and Medical Publications
Journal of Health Psychology 12, 417430. Hospital Epidemiology 31, 251254.
Abu-Raddad LJ, Patnaik P & Kublin JG (2006) Dual infection with HIV 133141. Allegranzi B, Anderson RJ, Linas SL,
and malaria fuels the spread of both diseases in sub-Saharan Africa. Bagheri Nejad S, Combescure Berns AS, et al. (1977)
Science 314, 16031606. C, et al. (2011) Nonoliguric acute renal
Burden of endemic health- failure. New England
Achan J, Byarugaba J, Barennes H & Tumwine JK (2007) Rectal versus
care-associated infection in Journal of Medicine 296,
intravenous quinine for the treatment of childhood cerebral malaria in
devel-oping countries: 11341138.
Kampala, Uganda: a randomized, double-blind clinical trial. Clinical
Infectious Diseases 45, 14461452. systematic review and meta- Andrade BB, Reis-Filho A,
analysis. Lancet 377, 228 Souza-Neto SM, et al. (2010)
241. Severe Plasmodium vivax
Afolabi B & Okoromah C (2004) Intramuscular arteether for treating
Allen SJ, ODonnell A, malaria exhibits marked
severe malaria. The Cochrane Database of Systematic Reviews 18,
Alexander ND, et al. (1997) inflammatory imbalance.
CD004391.
alpha+-Thalassemia protects Malaria Journal 9, 13.
Agarwal R, Nath A & Gupta D (2007) Noninvasive ventilation in Angus BJ, Chotivanich K,
children against disease caused
Plasmodium vivax related ALI/ARDS. Internal Medicine (Tokyo,
by other infections as well as Udomsangpetch R & White
Japan) 46, 20072011.
malaria. Proceedings of the NJ (1997) In vivo removal
Agarwal B, Kovari F, Saha R, Shaw S & Davenport A (2011) Do of malaria parasites from
National Academy of Sciences
bicarbonate-based solutions for continuous renal replacement red blood cells without
of the United States of Amer-
therapy offer better control of metabolic acidosis than lactate- their destruction in acute
ica 94, 1473614741.
containing fluids? Nephron Clinical Practice 118, c392c398. falciparum malaria. Blood
Aikawa M, Iseki M, Barnwell JW, Taylor D, Oo MM & Howard RJ 90, 20372040.
Alonso PL, Lindsay SW,
(1990) The pathology of human cerebral malaria. American Journal Anochie IC & Eke FU (2005)
Schellenberg JRMA, et al.
of Tropical Medicine and Hygiene 43, 3037. Acute renal failure in
(1993) A malaria control trial
Akachi Y & Atun R (2011) Effect of investment in malaria con-trol on Nigerian children: Port
using insecticide-treated bed
child mortality in sub-Saharan Africa in 2002-2008. PLoS ONE 6, Harcourt experience.
nets and tar-geted
e21309. Pediatric Nephrology 20,
chemoprophylaxis in a rural
16101614.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 105
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
of a pLDH-based and an
aldolase-based rapid
diagnostic test for diagnosis
of uncomplicated and severe
tal administration in healthy
malaria caused by PCR-
Anstey NM & Price RN (2007) Improving case definitions for severe Sudanese volunteers.
Tropical Doctor 34, 132 confirmed
malaria. PLoS Medicine 4, e267.
135. Plasmodium knowlesi,
Anstey NM, Weinberg JB, Hassanali MY, et al. (1996) Nitric oxide in
Axton JH & Siebert SL (1982) Plasmodium falciparum, and
Tanzanian children with malaria: inverse relationship between Plasmo-dium vivax. Journal
malaria severity and nitric oxide production/nitric oxide synthase type Aetiology of convulsions in of Clinical Microbiology 51,
2 expression. Journal of Experimental Medicine 184, 557567. Zim-babwe children three
11181123.
months to eight years old. The
Anstey NM, Jacups SP, Cain T, et al. (2002) Pulmonary mani-festations Barber BE, William T, Grigg
Central African Journal of
of uncomplicated falciparum and vivax malaria: cough, small airways MJ, Yeo TW & Anstey NM
Medicine 28, 246249.
obstruction, impaired gas transfer, and increased pulmonary (2013b) Limitations of
Bagshaw SM, Uchino S, Bellomo
phagocytic activity. Journal of Infectious Diseases 185, 13261334. microscopy to differentiate
R, et al. (2009) Timing of renal
Anstey NM, Handojo T, Pain MC, et al. (2007) Lung injury in vivax Plasmo-dium species in a
replacement therapy and clinical
malaria: pathophysiological evidence for pulmonary vascular region co-endemic for
outcomes in critically ill patients
sequestration and posttreatment alveolar-capil- Plasmodium falcipa-rum,
with severe acute kidney injury.
lary inflammation. Journal of Infectious Diseases 195, 589596. Plasmodium vivax and
Journal of Critical Care 24, 129
Anstey NM, Russell B, Yeo TW & Price RN (2009) The patho- Plasmodium knowlesi.
140.
physiology of vivax malaria. Trends in Parasitology 25, 220 227. Malaria Journal 12, 8.
Baird JK (2007) Neglect of
Plasmodium vivax malaria.
Anstey NM, Douglas NM, Poespoprodjo JR & Price RN (2012) Trends in Parasitology 23, Barcus MJ, Basri H, Picarima H,
Plasmodium vivax: clinical spectrum, risk factors and patho-genesis. 533539. et al. (2007) Demographic risk
Advances in Parasitology 80, 151201. Baird JK (2009) Severe and fatal factors for severe and fatal
Antia R, Yates A & De Roode JC (2008) The dynamics of acute malaria vivax malaria challenges vivax and falciparum malaria
infections. I. Effect of the parasites red blood cell preference. benign tertian malaria dogma. among hospital admissions in
Proceedings. Biological Sciences 275, 1449 1458. Annals of Tropical Paediatrics northeastern Indonesian Papua.
29, 251252. Ameri-can Journal of Tropical
Medicine and Hygiene 77,
Apisarnthanarak A, Thongphubeth K, Sirinvaravong S, et al. (2007) Baird JK (2013) Evidence and
984991.
Effectiveness of multifaceted hospitalwide quality improvement implications of mortality associ-
programs featuring an intervention to remove unnecessary urinary ated with acute Plasmodium Barennes H, Kahiatani F, Pussard
catheters at a tertiary care center in Thai-land. Infection Control and vivax malaria. Clinical E, et al. (1995) Intrarectal
Hospital Epidemiology 28, 791 798. Microbiol-ogy Reviews 26, 36 Quinimax (an association of
57. Cinchona alkaloids) for the
Baird JK & Surjadjaja C (2010) treat-ment of Plasmodium
Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W,
Consideration of ethics in pri- falciparum malaria in children
Adjei AA, Gyasi RK, Tettey Y, Wiredu EK, Tongren JE,
in Niger: efficacy and
Udhayakumar V & Stiles JK (2007) Cerebrosp-inal fluid and serum maquine therapy against malaria
transmission. Trends in Para- pharmacokinetics. Transactions
biomarkers of cerebral malaria mortality in Ghanaian children.
sitology 27, 1116. of the Royal Soci-ety of
Malaria Journal 6, 147.
Barber BE, William T, Jikal M, et Tropical Medicine and Hygiene
Asimus S, Elsherbiny D, Hai TN, et al. (2007) Artemisinin anti-malarials 89, 418421.
al. (2011) Plasmodium knowlesi
moderately affect cytochrome P450 enzyme activity in healthy
malaria in children. Emerging Barnes KI, Durrheim DN, Little
subjects. Fundamental & Clinical Pharmacology 21, 307316. Infectious Diseases 17, 814820. F, et al. (2005) Effect of
Asindi AA, Ekanem EE, Ibia EO & Nwangwa MA (1993) Upsurge of Barber BE, William T, Grigg M, et arteme-ther-lumefantrine policy
malaria-related convulsions in a paediatric emer-gency room in al. (2012) A prospective and improved vector control on
Nigeria. Consequence of emergence of chloro-quine-resistant comparative study of knowlesi, malaria burden in KwaZulu-
Plasmodium falciparum. Tropical and Geographical Medicine 45, falciparum and vivax malaria in Natal. South Africa. PLoS
110113. Sabah, Malaysia: high Medi-cine 2, e330.
Aursudkij B, Wilairatana P, Vannaphan S, Walsh DS, Gordeux VR & proportion with severe disease
Looareesuwan S (1998) Pulmonary edema in cerebral malaria patients from Plasmodium knowlesi and Barsoum RS (2000) Malarial
in Thailand. The South East Asian Journal of Tropical Medicine and P. vivax but no mortality with acute renal failure. Journal of
Public Health 29, 541545. early referral and artesunate the American Society of
Avril M, Brazier AJ, Melcher M, Sampath S & Smith JD (2013) DC8 therapy. Clinical Infectious Nephrology 11, 21472154.
and DC13 var genes associated with severe malaria bind avidly to Diseases 56, 383397. Bassat Q & Alonso PL (2011)
diverse endothelial cells. PLoS Pathogens 9, e1003430. Barber BE, William T, Grigg Defying malaria: Fathoming
MJ, Piera K, Yeo TW & severe Plasmodium vivax
Awad MI, Eltayeb IB, Baraka OZ, Behrens RH & Alkadru AM (2004) Anstey NM (2013a) disease. Nature Medicine 17,
Pharmacokinetics of artesunate following oral and rec- 4849.
Evaluation of the sensitivity
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
106 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
al. (2007) Impact of artemisi-
nin-based combination therapy
and insecticide-treated nets on
malaria burden in Zanzibar.
Berkley JA, Lowe BS, Mwangi I, PLoS Medicine 4, e309.
Bassat Q, Guinovart C, Sigauque B, et al. (2008) Malaria in rural et al. (2005) Bacteremia among
Mozambique. Part II: children admitted to hospital. Biemba G, Dolmans D, Thuma
children admitted to a rural
hospital in Kenya. New PE, Weiss G & Gordeuk VR
Malaria Journal 7, 37.
England Journal of Medicine (2000) Severe anaemia in
Batty KT, Davis TM, Thu LT, Binh TQ, Anh TK & Ilett KF (1996)
352, 3947. Zambian children with
Selective high-performance liquid chromatographic determination of
Plasmodium falciparum
artesunate and alpha- and beta-dihydroartemisinin in patients with Berkley JA, Bejon P, Mwangi T,
malaria. Tropical Medicine and
falciparum malaria. Jour-nal of Chromatography B, Biomedical et al. (2009) HIV infection,
malnutrition, and invasive International Health 5, 916.
Applications 677, 345350.
bacterial infection among
children with severe malaria. Billings F & Post W (1915)
Batty KT, Le AT, Ilett KF, et al. (1998a) A pharmacokinetic and Fatal malaria due to the
pharmacodynamic study of artesunate for vivax malaria. Clinical Infectious Diseases
49, 336343. tertian parasite. Transactions.
American Journal of Tropical Medicine and Hygiene 59, 823 827. Chicago Pathological Society
Bertin GI, Lavstsen T,
Batty KT, Thu LT, Davis TM, et al. (1998b) A pharmacokinetic and 9, 209 215.
Guillonneau F, et al. (2013)
pharmacodynamic study of intravenous vs oral artesunate in
Expression of the domain
uncomplicated falciparum malaria. British Journal of Clini-cal Birbeck GL, Beare N, Lewallen
cassette 8 Plasmodium
Pharmacology 45, 123129. S, et al. (2010a) Identification
falciparum erythrocyte
Beare NA, Southern C, Lochhead J, Molyneux ME, Lewallen S & membrane protein 1 is of malaria retinopathy
Harding SP (2002) Inter-observer concordance in grading retinopathy in associated with cerebral malaria improves the specificity of the
cerebral malaria. Annals of Tropical Medicine and Parasitology 96, in Benin. PLoS ONE 8, e68368. clinical diagnosis of cerebral
105108. malaria: findings from a
Bethell DB, Phuong PT, Phuong
Beare NA, Southern C, Chalira C, Taylor TE, Molyneux ME & Harding SP CX, et al. (1996) Electrocardio- prospective cohort study.
(2004) Prognostic significance and course of reti-nopathy in children graphic monitoring in severe American Journal of Tropical
with severe malaria. Archives of Ophthal-mology 122, 11411147. falciparum malaria. Medicine and Hygiene 82,
Beare NA, Taylor TE, Harding SP, Lewallen S & Molyneux ME (2006) Transactions of the Royal 231234.
Malarial retinopathy: a newly established diagnostic sign in severe Society of Tropical Medicine Birbeck GL, Molyneux ME,
malaria. American Journal of Tropical Medicine and Hygiene 75, 790 and Hygiene 90, 266269. Kaplan PW, et al. (2010b)
797. Blantyre Malaria Project
Beare NA, Lewallen S, Taylor TE & Molyneux ME (2011) Redefining Bethell DB, Teja-Isavadharm P, Epilepsy Study (BMPES) of
cerebral malaria by including malaria retinopathy. Cao XT, et al. (1997) Pharma- neurological out-comes in
Future Microbiology 6, 349355. cokinetics of oral artesunate in retinopathy-positive paediatric
Beg M, Khan R, Baig S, Gulzar Z, Hussain R & Smego R (2002) children with moderately cerebral malaria survi-vors: a
Cerebral involvement in benign tertian malaria. severe Plasmodium falciparum prospective cohort study. Lancet
American Journal of Tropical Medicine and Hygiene 67, 230 232. malaria. Transactions of the Neurology 9, 1173 1181.
Bejon P, Berkley JA, Mwangi T, et al. (2007) Defining childhood severe Royal Society of Tropical
falciparum malaria for intervention studies. PLoS Medi-cine 4, e251. Medicine and Hygiene 91, Bircan Z, Kervancioglu M,
Bellomo R & Ronco C (1998) Indications and criteria for initiat-ing renal 195 198. Soran M, Gonlusen G &
replacement therapy in the intensive care unit. Kid-ney International Tuncer I (1997) Two cases of
Supplements 66, S106S109. Bethell D, Se Y, Lon C, et al. nephrotic syndrome and
(2010) Dose-dependent risk of tertian malaria in south-
Bellomo R, Chapman M, Finfer S, Hickling K & Myburgh J (2000)
neutropenia after 7-day eastern Anatolia. Pediatric
Low-dose dopamine in patients with early renal dys-function: a
Nephrology 11, 7879.
placebo-controlled randomised trial. Australian and New Zealand courses of artesunate
monotherapy in Cambodian Black RE, Cousens S, Johnson
Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356,
patients with acute HL, et al. (2010) Global,
21392143.
regio-nal, and national causes
Berg A, Patel S, Langeland N & Blomberg B (2008) Falciparum malaria Plasmodium falciparum of child mortality in 2008: a
and HIV-1 in hospitalized adults in Maputo, Mozam-bique: does HIV- malaria. Clinical Infectious system-atic analysis. Lancet
infection obscure the malaria diagnosis? Diseases 51, e105e114.
375, 19691987.
Malaria Journal 7, 252. Bhattacharya SK, Sur D,
Dutta S, et al. (2013) Vivax Bloland PB, Redd SC, Kazembe
Berkley JA, Mwarumba S, Bramham K, Lowe B & Marsh K (1999) P, Tembenu R, Wirima JJ &
malaria and bacteraemia: a
Bacteraemia complicating severe malaria in children. Campbell CC (1991) Co-
prospective study in
Transactions of the Royal Society of Tropical Medicine and Hygiene Kolkata, India. trimoxazole for childhood
93, 283286. Malaria Journal 12, 176. febrile ill-ness in malaria-
Bhattarai A, Ali AS, Kachur SP, et endemic regions. Lancet 337,
518520.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 107
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
pathogenesis of Plasmodium
falciparum malaria in humans:
insights from splenic
physiology. Blood 117, 381
Brower RG (2009) 392.
Boivin MJ (2002) Effects of early cerebral malaria on cognitive ability Consequences of bed rest.
Critical Care Med-icine 37, Bulmer JN, Rasheed FN,
in Senegalese children. Journal of Developmental and Behavioral
S422S428. Francis N, Morrison L &
Pediatrics 23, 353364. Greenwood BM (1993)
Boivin MJ, Bangirana P, Byarugaba J, et al. (2007) Cognitive Brown H, Hien TT, Day N, et al. Placental malaria. I.
impairment after cerebral malaria in children: a prospective study. (1999) Evidence of blood- Pathological classification.
Pediatrics 119, e360e366. brain barrier dysfunction in Histopathology 22, 211218.
human cerebral malaria.
Boivin MJ, Gladstone MJ, Vokhiwa M, et al. (2011) Develop-mental Calis JC, Phiri KS, Faragher
Neuropa-thology and Applied
outcomes in Malawian children with retinopathy-posi-tive cerebral EB, et al. (2008) Severe
Neurobiology 25, 331340.
malaria. Tropical Medicine and International Health 16, 263271. anemia in Malawian
Brown HC, Chau TT, Mai NT, et children. New England
al. (2000) Blood-brain barrier
Bojang KA, van Hensbroek MB, Palmer A, Banya WA, Jaffar S & function in cerebral malaria Journal of Medicine 358,
Greenwood BM (1997) Predictors of mortality in Gambian children and CNS infections in 888899.
with severe malaria anaemia. Annals of Tropical Pae-diatrics 17, 355 Vietnam. Camara B, Diagne-Gueye NR,
359. Neurology 55, 104111. Faye PM, et al. (2011)
Bondi FS (1992) The incidence and outcome of neurological Bruce-Chwatt LJ (1987) Malaria severity criteria and
abnormalities in childhood cerebral malaria: a long-term follow-up Quinine and the mystery of prognostic factors among
of 62 survivors. Transactions of the Royal Society of Tropical blackwater fever. Acta children in Da-kar. Medecine
Medicine and Hygiene 86, 1719. Leidensia 55, 181196. et Maladies Infectieuses 41,
Boonpucknavig V & Sitprija V (1979) Renal disease in acute Bruetsch W (1932) The 6367.
Plasmodium falciparum infection in man. Kidney International histopathology of Caniza MA, Duenas L, Lopez B,
16, 4452. therapeutic (tertian) et al. (2009) A practical guide
malaria. American Journal to alcohol-based hand hygiene
Boonpucknavig V & Soontornniyomkij V (2003) Pathology of renal of Psychiatry 12, 1965. infrastructure in a resource-
diseases in the tropics. Seminars in Nephrology 23, 88 106.
Bruneel F, Hocqueloux L, poor pediatric hospital.
Alberti C, et al. (2003) The American Journal of Infection
Bouyou-Akotet MK, Dzeing-Ella A, Kendjo E, et al. (2009) Impact of Control
clinical spectrum of severe
Plasmodium falciparum infection on the frequency of moderate to 37, 851854.
imported falciparum malaria
severe anaemia in children below 10 years of age in Gabon. Malaria
in the intensive care unit: Cao XT, Bethell DB, Pham TP,
Journal 8, 166.
report of 188 cases in adults. et al. (1997) Comparison of
Brabin BJ (2007) Congenital malariaa recurrent problem.
American Journal of ar-temisinin suppositories,
Annals of Tropical Paediatrics 27, 9598.
Respiratory and Critical Care intramuscular artesunate and
Brewer TG, Peggins JO, Grate SJ, et al. (1994) Neurotoxicity in animals Medicine 167, 684 689. intrave-nous quinine for the
due to arteether and artemether. Transactions of the Royal Society of treatment of severe childhood
Tropical Medicine and Hygiene 88(Suppl. 1), S33S36. malaria.
Bruneel F, Tubach F, Corne P, et
al. (2010) Severe imported fal- Transactions of the Royal
Brewster DR, Kwiatkowski D & White NJ (1990) Neurological ciparum malaria: a cohort Society of Tropical
sequelae of cerebral malaria in children. Lancet 336, 1039 1043. study in 400 critically ill Medicine and Hygiene 91,
adults. PLoS ONE 5, e13236. 335342.
Bridges DJ, Bunn J, Van Mourik JA, et al. (2010) Rapid activa-tion of Brunkhorst FM, Engel C, Bloos Caramello P, Balbiano R, De
endothelial cells enables Plasmodium falciparum adhe-sion to platelet- F, et al. (2008) Intensive Blasi T, Chiriotto M,
decorated von Willebrand factor strings. Blood 115, 14721474. insulin therapy and Deagostini M & Calleri G
(2012) Severe malaria,
Bronzan RN, Taylor TE, Mwenechanya J, et al. (2007) Bactere-mia in pentastarch resuscitation in
artesunate and haemolysis.
Malawian children with severe malaria: prevalence, eti-ology, HIV severe sepsis. New England
Journal of Antimicrobial
coinfection, and outcome. Journal of Infectious Diseases 195, 895 Journal of Medicine 358,
Chemotherapy 67, 20532054.
904. 125139.
Cariou A, Vinsonneau C &
Brooker S, Akhwale W, Pullan R, et al. (2007) Epidemiology of Buck RL, Alcantara AK, Dhainaut JF (2004) Adjunctive
Plasmodium-helminth co-infection in Africa: populations at risk, Uylangco CV & Cross JH ther-
potential impact on anemia, and prospects for combining control. (1983) Malaria at San
apies in sepsis: an evidence-
American Journal of Tropical Medicine and Hygiene Lazaro Hospital, Manila,
based review. Critical Care
77, 8898. Philippines, 1979 1981.
Medi-cine 32, S562S570.
Brooks MH, Kiel FW, Sheehy TW & Barry KG (1968) Acute pul- American Journal of Carlson J, Helmby H, Hill AV,
monary edema in falciparum malaria: a clinicopathological cor- Tropical Medicine and Brewster D, Greenwood BM
relation. New England Journal of Medicine 279, 732737. Hygiene
& Wahlgren M (1990) Human
32, 212216. cerebral malaria: association
Brooks MH, Kiel FW, Sheehy TW & Barry KG (1969) Detec-tion of
hypervolemia. New England Journal of Medicine 280, 110. Buffet PA, Safeukui I, Deplaine with
G, et al. (2011) The
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
108 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
of the artemisinin antimalarials
and potential consequences for
use in women in the first tri-
mester. Reproductive
Chotivanich KT, Dondorp AM, Toxicology 28, 285296.
erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet White NJ, et al. (2000) The
336, 14571460. Clemens R, Pramoolsinsap C,
resistance to physiological
Lorenz R, Pukrittayakamee
Carneiro I, Roca-Feltrer A, Griffin JT, et al. (2010) Age-patterns of shear stresses of the
S, Bock HL & White NJ
malaria vary with severity, transmission intensity and sea-sonality in erythrocytic rosettes formed
by cells infected with (1994) Activation of the
Sub-Saharan Africa: a systematic review and pooled analysis. PLoS
Plasmodium falciparum. coagulation cascade in
ONE 5, e8988.
severe falciparum malaria
Carrara VI, Sirilak S, Thonglairuam J, et al. (2006) Deployment of early Annals of Tropical Medicine
through the intrinsic
diagnosis and mefloquine-artesunate treatment of fal-ciparum malaria and Parasitology 94, 219226. pathway. British Journal of
in Thailand: the Tak Malaria Initiative. PLoS Medicine 3, e183. Chotivanich K, Udomsangpetch
R, Suwanarusk R, et al. (2012) Haematology 87, 100105.
Carter JA, Neville BG, White S, et al. (2004) Increased preva-lence of Coatney GR, Collins WE,
epilepsy associated with severe falciparum malaria in children. Plasmodium vivax adherence
to placental Warren M & Contacos PG
Epilepsia 45, 978981. (1971). The Primate Malarias.
glycosaminoglycans. PLoS
Carter JA, Mungala-Odera V, Neville BG, et al. (2005a) Persis-tent ONE 7, e34509. National Institutes of Health,
neurocognitive impairments associated with severe falcipa-rum Bethesda, MD.
Christophers S (1911).
malaria in Kenyan children. Journal of Neurology, Neurosurgery, and
Scientific Memoirs by
Psychiatry 76, 476481. Officers of the Medical Colin JF, Rottcher KH & Dhali
Carter JA, Ross AJ, Neville BG, et al. (2005b) Developmental and Sanitary DP (1975) Letter: venous
impairments following severe falciparum malaria in children. Departments of the throm-bosis in Africans.
Tropical Medicine and International Health 10, 310. Carter JA, Government of India. Lancet 1, 408.
Lees JA, Gona JK, et al. (2006) Severe falciparum Government of India Collins WE, Jeffery GM &
malaria and acquired childhood language disorder. Develop-mental Press, Delhi. Roberts JM (2003) A
Medicine and Child Neurology 48, 5157. Chung BH, Lee SW, Lee SE, retrospective examination of
Carvalho BO, Lopes SC, Nogueira PA, et al. (2010) On the cy- Hwang TJ & Shin HS (2008) anemia during infection of
toadhesion of Plasmodium vivax-infected erythrocytes. Journal of Predic-tors of Plasmodium humans with Plas-modium
Infectious Diseases 202, 638647. vivax malaria-induced vivax. American Journal of
Centers for Disease Control and Prevention (2013) Published reports of nephropathy in young Korean Tropical Medicine and
delayed hemolytic anemia after treatment with ar-tesunate for severe men. Nephron. Clinical Hygiene 68, 410412.
malaria-worldwide, 2010-2012. Morbidity and Mortality Weekly Practice 110, c172c177. Collomb H (1977) Putting the
Report 62, 58. Ciuca M, Chelarescu M, family to death. La Psychiatrie
de lenfant 20, 245299.
Chakravarty A, Ghosh B, Bhattacharyya R, Sengupta S & Muk-herjee S Sofletea A, et al. (1955)
(2004) Acute inflammatory demyelinating polyneurop-athy following Contribution experimentale a Commey JOO, Mills-Tetteh D
Plasmodium vivax malaria. Neurology India letude de limmunite dans le & Phillips BJ (1980)
paludisme. Edi-tions Acad Cerebral malaria in Accra,
52, 130131.
Rep Pop Roumaine, 1108. Ghana. Ghana Medical
Chalwe V, Van Geertruyden JP, Mukwamataba D, et al. (2009) Journal 19, 68 72.
Increased risk for severe malaria in HIV-1-infected adults, Zambia. Ciuca M, Lupasco G, Negulici E
Emerging Infectious Disease, 15, 749; quiz 858. & Constaninesco P (1964)
Research on the experimental Conroy AL, Glover SJ, Hawkes
Chau TTH, Day NP, Van Chuong L, et al. (1996) Blackwater fever in
transmission of Plasmodium M, et al. (2012) Angiopoietin-
southern Vietnam: a prospective descriptive study of 50 cases.
malariae to man [in French]. 2 levels are associated with
Clinical Infectious Diseases 23, 12741281.
Archives Roumaines de retinopathy and predict
Chimalizeni Y, Kawaza K, Taylor T & Molyneux M (2010) The mortality in Malawian
Patholo-gie Experimentales et
platelet count in cerebral malaria, is it useful to the clinician? children with cerebral malaria:
de Microbiologie 23, 763
American Journal of Tropical Medicine and Hygiene 83, 4850. Chin 776. a retrospective case-control
W, Contacos PG, Collins WE, Jeter MH & Alpert E study. Critical Care Medicine
Claessens A, Adams Y,
(1968) Experimental mosquito-transmission of Plasmodium 40, 952959.
Ghumra A, et al. (2012) A
knowlesi to man and monkey. American Journal of Tropical Cooke BM, Berendt AR, Craig
subset of group A-like var
Medicine and Hygiene 17, 355358. AG, MacGregor J, Newbold CI
genes encodes the malaria
Choi HJ, Lee SY, Yang H & Bang JK (2004) Retinal haemor-rhage in parasite ligands for binding & Nash GB (1994) Rolling and
vivax malaria. Transactions of the Royal Society of Tropical to human brain endothelial stationary cytoadhesion of red
Medicine and Hygiene 98, 387389. cells. Proceedings of the blood cells parasitized by
Cholera R, Brittain NJ, Gillrie MR, et al. (2008) Impaired cyto- National Academy of Plasmodium falciparum:
adherence of Plasmodium falciparum-infected erythrocytes Sciences of the United separate roles for ICAM-1,
containing sickle hemoglobin. Proceedings of the National Academy States of America 109, CD36 and thrombospondin.
of Sciences of the United States of America 105, 991996. E1772E1781. British Journal of
Clark RL (2009) Embryotoxicity Haematology 87, 162170.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 109
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
of parasites and pigment-
containing leukocytes in
severe malaria. Blood 88,
46944700.
Dasari P, Reiss K, Lingelbach K,
Day NP, Phu NH, Bethell DP, et
Cordoliani YS, Sarrazin JL, Felten D, Caumes E, Leveque C & Fisch A et al. (2011) Digestive vacuoles
al. (1996b) The effects of dopa-
(1998) MRT of cerebral malaria. American Journal of Neuroradiology of Plasmodium falciparum are
mine and adrenaline infusions
19, 871874. selectively phagocytosed by and
on acid-base balance and sys-
Cox-Singh J, Davis TM, Lee KS, et al. (2008) Plasmodium knowl-esi impair killing function of
temic haemodynamics in severe
malaria in humans is widely distributed and potentially life threatening. polymorphonuclear leukocytes. infection. Lancet 348, 219223.
Clinical Infectious Diseases 46, 165171. Blood 118, 49464956.
Day NP, Phu NH, Mai NT, et al.
Cox-Singh J, Hiu J, Lucas SB, et al. (2010) Severe malaria - a case of fatalDavid J, Shanbag P & More (2000a) Effects of dopamine
Plasmodium knowlesi infection with post-mortem findings: a case report. V (2009) Plasmodium and epinephrine infusions on
Malaria Journal 9, 10. vivax malaria presenting as
the nephrotic syndrome in renal hemodynamics in severe
Cox-Singh J, Singh B, Daneshvar C, Planche T, Parker-Williams J & an infant. malaria and severe sepsis.
Krishna S (2011) Anti-inflammatory cytokines predominate in acute Critical Care Medicine 28,
Tropical Doctor 39, 127128.
human Plasmodium knowlesi infections. PLoS ONE 6, e20541. 13531362.
Davis TM, White NJ,
Craig A & Scherf A (2001) Molecules on the surface of the Plas-modium Day NP, Phu NH, Mai NT, et al.
Looareesuwan S, Silamut K &
falciparum infected erythrocyte and their role in malaria pathogenesis and (2000b) The pathophysiologic
Warrell DA (1988) Quinine
immune evasion. Molecular and Bio-chemical Parasitology 115, 129 and prognostic significance of
pharmacokinetics in cerebral acidosis in severe adult
143.
malaria: pre-dicted plasma malaria.
Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C & Marsh K (1996) concentrations after rapid
Seizures and status epilepticus in childhood cerebral malaria. Quarterly intravenous loading using a Critical Care Medicine 28,
18331840.
Journal of Medicine 89, 591597. two-compartment model. De Mast Q, Groot E, Asih PB, et
Crawley J, Waruiru C, Mithwani S, et al. (2000) Effect of phe-nobarbital Transactions of the Royal al. (2009) ADAMTS13 defi-
on seizure frequency and mortality in childhood cerebral malaria: a Society of Tropical Medicine ciency with elevated levels of
randomised, controlled intervention study. Lancet 355, 701706. and Hygiene 82, 542547. ultra-large and active von
Cunnington AJ, De Souza JB, Walther M & Riley EM (2012a) MalariaDavis TM, Pukrittayakamee S, Wille-brand factor in P.
impairs resistance to Salmonella through heme- and heme oxygenase- Woodhead JS, Holloway P, falciparum and P. vivax
dependent dysfunctional granulocyte mobili-zation. Nature Medicine Chaivi-suth B & White NJ malaria. American Journal of
18, 120127. (1991) Calcium and phosphate Tropical Medicine and Hygiene
Cunnington AJ, Njie M, Correa S, Takem EN, Riley EM & Walther M metabolism in acute falciparum 80, 492498.
(2012b) Prolonged neutrophil dysfunction after Plasmodium malaria. Clinical Science 81, De Silva HJ, Goonetilleke AK,
falciparum malaria is related to hemolysis and heme oxygenase-1 297304. Senaratna N, et al. (1988)
induction. Journal of Immunology 189, 53365346. Davis TM, Phuong HL, Ilett KF, Skele-tal muscle necrosis in
Curley JM, Mody RM & Gasser RA (2011) Malaria caused by et al. (2001) Pharmacokinetics severe falciparum malaria.
Plasmodium vivax complicated by acalculous cholecystitis. and pharmacodynamics of British Medi-cal Journal
American Journal of Tropical Medicine and Hygiene 85, 42 49. intravenous artesunate in severe (Clinical Research ed.) 296,
fal-ciparum malaria. 1039.
Cyrklaff M, Sanchez CP, Kilian N, et al. (2011) Hemoglobins S and C Antimicrobial Agents and Del Punta V, Gulletta M, Matteelli
interfere with actin remodeling in Plasmodium falcipa-rum-infected Chemotherapy 45, 181186. A, Spinoni V, Regazzoli A &
erythrocytes. Science 334, 12831286. Castelli F (2010) Congenital
DAlessandro U, Ubben D, Hamed K, et al. (2012) Malaria in infants agedDavis TM, Binh TQ, Ilett KF, et Plasmodium vivax malaria
less than six months - is it an area of unmet medi-cal need? Malaria al. (2003) Penetration of dihyd- mim-icking neonatal sepsis: a
Journal 11, 400. roartemisinin into cerebrospinal case report. Malaria Journal 9,
63.
Daneshvar C, Davis TM, Cox-Singh J, et al. (2009) Clinical and laboratory fluid after administration of
features of human Plasmodium knowlesi infection. intravenous artesunate in severe Dellinger RP, Levy MM, Carlet
Clinical Infectious Diseases 49, 852860. falciparum malaria. Antimi- JM, et al. (2008) Surviving
crobial Agents and Sep-sis Campaign:
Darouiche RO, Wall MJ, Itani KM, et al. (2010) Chlorhexidine-alcohol
versus povidone-iodine for surgical-site antisepsis. Chemotherapy 47, 368370. international guidelines for
New England Journal of Medicine 362, 1826. Davis JS, Cheng AC, McMillan management of severe sepsis
and septic shock: 2008.
Das BS, Satpathy SK, Mohanty D, et al. (1988) Hypoglycaemia in severe M, Humphrey AB, Stephens DP
Intensive Care Medicine 34,
falciparum malaria. Transactions of the Royal Soci-ety of Tropical & Anstey NM (2011) Sepsis in
the tropical Top End of 1760.
Medicine and Hygiene 82, 197201.
Australias Northern Territory:
Das SN, Mohapatra B, Mohanty R, Dash PC, Kar K & Dash PK (2007)
disease burden and impact on Deplaine G, Safeukui I, Jeddi F,
Malarial hepatitis as a component of multiorgan failurea bad
Indigenous Australians. The et al. (2011) The sensing of
prognostic sign. Journal of the Indian Medical Association 105, 247
Medical Journal of Australia poorly deformable red blood
250.
194, 519524. cells by the human spleen can
Day NP, Pham TD, Phan TL, et be mimicked in vitro. Blood
al. (1996a) Clearance kinetics 117, e88e95.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
110 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
557574.
Edlund PO, Westerlund D,
Carlqvist J, Wu BL & Jin YH
Dorovini-Zis K, Schmidt K, (1984) Determination of
Huynh H, et al. (2011) The artesunate and
Desai M, Ter Kuile FO, Nosten F, et al. (2007) Epidemiology and
burden of malaria in pregnancy. Lancet Infectious Dis-eases 7, 93 neuro-pathology of fatal dihydroartemisinine in plasma
104. cerebral malaria in by liquid chromatography with
Malawian children. post-column derivatization and
Desakorn V, Dondorp AM, Silamut K, et al. (2005) Stage-depen-dent
American Journal of UV-detection. Acta
production and release of histidine-rich protein 2 by Plas-modium
Pathology 178, 2146 Pharmaceutica Suecica 21,
falciparum. Transactions of the Royal Society of Tropical Medicine and
2158. Douglas NM, Anstey 223234.
Hygiene 99, 517524.
NM, Angus BJ, Nosten F Edstein M, Stace J & Shann F
Devakul K, Harinasuta T & Reid HA (1966) 125-I-labelled fibrinogen & Price RN (1983) Quantification of
in cerebral malaria. Lancet 2, 886888. (2010) Artemisinin quinine in human serum by
Dhingra N, Jha P, Sharma VP, et al. (2010) Adult and child malaria combination therapy for vivax high-performance liquid
mortality in India: a nationally representative mortal-ity survey. Lancet malaria. chromatography.
376, 17681774. Lancet Infectious Diseases 10, Journal of Chromatography
Doering W (1981) Is there a clinically relevant interaction between 405416. 278, 445451.
quinine and digoxin in human beings? American Journal of Douglas NM, Anstey NM, Eiam-Ong S (2003) Malarial
Cardiology 48, 975976. Buffet PA, et al. (2012) The nephropathy. Seminars in
Dondorp AM, Angus BJ, Hardeman MR, et al. (1997) Prognos-tic anaemia of Plasmodium Nephrol-ogy 23, 2133.
significance of reduced red blood cell deformability in severe falciparum vivax malaria. Malaria Ekanem AD, Anah MU & Udo JJ
malaria. American Journal of Tropical Med-icine and Hygiene 57, 507 Journal 11, 135. (2008) The prevalence of con-
511. Douglas NM, Lampah DA, genital malaria among
Kenangalem E, et al. (2013) neonates with suspected sepsis
Dondorp AM, Angus BJ, Chotivanich K, et al. (1999) Red blood cell
Major burden of severe in Cala-bar, Nigeria. Tropical
deformability as a predictor of anemia in severe falciparum malaria.
anemia from non-falciparum Doctor 38, 7376.
American Journal of Tropical Medicine and Hygiene 60, 733737.
species: a hospi-tal-based Elesha SO, Adepoju FB &
study. PLoS Medicine 10, Banjo AA (1993) Rising
Dondorp AM, Nyanoti M, Kager PA, Mithwani S, Vreeken J & Marsh K e1001575. incidence of cerebral malaria
(2002) The role of reduced red cell deformability in the pathogenesis of
Duarte MIS, Corbett CEP, in Lagos, Nigeria: a
severe falciparum malaria and its restora-tion by blood transfusion.
Boulos M & Amato Neto V postmoterm study. East
Transactions of the Royal Society of Tropical Medicine and Hygiene 96, African Medical Journal 70,
(1985) Ultrastructure of the
282286. 302306.
lung in falciparum malaria.
Dondorp AM, Chau TT, Phu NH, et al. (2004a) Unidentified acids of strong American Journal of Elhassan E & Schrier R
prognostic significance in severe malaria. Criti-cal Care Medicine 32, Tropical Medicine and (2011) Acute Kidney
16831688. Hygiene 34, 3135. Injury. In Text-book of
Dondorp AM, Pongponratn E & White NJ (2004b) Reduced mi- Dugbartey AT, Dugbartey MT Critical Care Medicine,
crocirculatory flow in severe falciparum malaria: pathophysiol-ogy and & Apedo MY (1998) (eds Moore F, Vincent J-L,
electron-microscopic pathology. Acta Tropica 89, 309317. Delayed neuropsychiatric Abraham E, Kochanek P &
effects of malaria in Ghana. Fink M) Elsevier,
Dondorp A, Nosten F, Stepniewska K, Day N & White N (2005a) Journal of Ner-vous and Philadelphia.
Artesunate versus quinine for treatment of severe fal-ciparum malaria: a Mental Disease 186, 183 Eltahir HG, Omer AA, Mohamed
randomised trial. Lancet 366, 717725. 186. AA & Adam I (2010) Com-
Dondorp AM, Desakorn V, Pongtavornpinyo W, et al. (2005b) Estimation Duggan ST & Scott LJ parison of artesunate and
of the total parasite biomass in acute falciparum malaria from plasma (2009) Intravenous quinine in the treatment of
PfHRP2. PLoS Medicine 2, e204. paracetamol (acet- Sudanese children with severe
aminophen). Drugs 69, Plasmodium falciparum
Dondorp AM, Ince C, Charunwatthana P, et al. (2008a) Direct in vivo
assessment of microcirculatory dysfunction in 101113. malaria. Transac-tions of the
severe falciparum malaria. Journal of Infectious Diseases 197, 7984. Dumas M, Leger J-M, Pestre- Royal Society of Tropical
Alexandre M & Malauzat D Medicine and Hygiene
Dondorp AM, Lee SJ, Faiz MA, et al. (2008b) The relationship between age
(1986) Manifestations 104, 684686.
and the manifestations of and mortality associ-ated with severe malaria.
Neurologiques et English M, Punt J, Mwangi I,
Clinical Infectious Diseases 47, 151 157.
Psychiatriques Des McHugh K & Marsh K
Parasitoses. Masson, (1996a) Clinical overlap
Dondorp AM, Nosten F, Yi P, et al. (2009) Artemisinin resis-tance in
Presented at Congre`s de between malaria and severe
Plasmodium falciparum malaria. New England Jour-nal of Medicine
Psychiatrie et de Neurologie pneumonia in Africa children
361, 455467.
de Langue Francaise, session in hospital. Transactions of
Dondorp AM, Fanello CI, Hendriksen IC, et al. (2010) Artesu-nate versus LXXXIV, Le Mans, the Royal Society of Tropical
quinine in the treatment of severe falciparum malaria in African France,1986. Medicine and Hygiene 90,
children (AQUAMAT): an open-label, randomised trial. Lancet 376,
658662.
16471657.
Dunser MW, Festic E, Dondorp English M, Waruiru C, Amukoye
A, et al. (2012) Recommenda- E, et al. (1996b) Deep breath-
tions for sepsis management ing in children with severe
in resource-limited settings. malaria: indicator of metabolic
Inten-sive Care Medicine 38, aci-
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 111
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Adherence of Plasmodium
falcipa-rum to chondroitin
sulfate A in the human
placenta. Science 272, 1502
Figtree M, Lee R, Bain L, et al. 1504.
dosis and poor outcome. American Journal of Tropical Medi-cine and (2010) Plasmodium knowlesi in
Hygiene 55, 521524. Fried M, Nosten F, Brockman A,
Human, Indonesian Borneo.
Brabin BJ & Duffy PE (1998)
English M, Waruiru C & Marsh K (1996c) Transfusion for respi-ratory Emerging Infectious Diseases
Maternal antibodies block
distress in life-threatening childhood malaria. American Journal of 16, 672674.
malaria. Nature 395, 851 852.
Tropical Medicine and Hygiene 55, 525530. Fleming AF (1989) Tropical
English MC, Waruiru C, Lightowler C, Murphy SA, Kirigha G & Marsh obstetrics and gynaecology. 1.
Friedrich JO, Adhikari N,
K (1996d) Hyponatraemia and dehydration in severe malaria. Archives Anae-mia in pregnancy in
tropical Africa. Transactions of Herridge MS & Beyene J
of Disease in Childhood 74, 201205.
(2005) Meta-analysis: low-
English M, Muambi B, Mithwani S & Marsh K (1997) Lactic acidosis the Royal Society of Tropical dose dopamine increases
and oxygen debt in African children with severe anae-mia. Quarterly Medicine and Hygiene 83, 441 urine output but does not
Journal of Medicine 90, 563569. 448.
prevent renal dysfunction or
English M, Ahmed M, Ngando C, Berkley J & Ross A (2002) Blood Flowe B, Armstrong-Jame D,
death. Annals of Inter-nal
Danc C, Bremne F & Doherty
transfusion for severe anaemia in children in a Kenyan hospital. Medicine 142, 510524.
T (2011) Blind, breathless, and
Lancet 359, 494495. Gabriel DP, Caramori JT, Martin
paralysed from benign malaria.
Erdman LK, Dhabangi A, Musoke C, et al. (2011) Combinations of host Lancet 377, 438. LC, Barretti P & Balbi AL
biomarkers predict mortality among Ugandan children with severe (2009) Continuous peritoneal
Fong Y, Cadigan F & Coatneyi G
malaria: a retrospective case-control study. PLoS ONE 6, e17440. dialysis compared with daily
(1971) A presumptive case of
Ernest SK, Anunobi NE & Adeniyi A (2002) Correlates of emer-gency naturally occurring Plasmodium he-modialysis in patients with
response interval and mortality from severe anaemia in childhood. West knowlesi malaria in man in acute kidney injury. Peritoneal
African Journal of Medicine 21, 177179. Esamai F, Ernerudh J, Janols Malaysia. Transactions of the Dialysis International 29(Suppl
H, et al. (2003) Cerebral malaria Royal Society of Tropical Medi- 2), S62S71.
in children: serum and cerebrospinal fluid TNF-alpha and TGF- cine and Hygiene 65, 839840. Gambaro G, Bertaglia G, Puma G
beta levels and their relationship to clinical outcome. & DAngelo A (2002) Diuret-
Fowkes FJ, Allen SJ, Allen A,
Journal of Tropical Pediatrics 49, 216223. ics and dopamine for the
Alpers MP, Weatherall DJ &
Evans JA, Adusei A, Timmann C, et al. (2004) High mortality of infant Day KP (2008) Increased prevention and treatment of
bacteraemia clinically indistinguishable from severe malaria. QJM: microerythrocyte count in acute renal failure: a critical
Monthly Journal of the Association of Physi-cians 97, 591597. homozygous alpha(+)- reappraisal. Journal of
Ewing J (1901) Malarial parasitology. Journal of Experimental thalassaemia contributes to Nephrology 15, 213219.
Medicine 5, 429491. protection against severe
Falade C, Mokuolu O, Okafor H, et al. (2007) Epidemiology of malarial anaemia. PLoS Genovese RF & Newman DB
congenital malaria in Nigeria: a multi-centre study. Tropical Medicine Medicine 5, e56. (2008) Understanding
and International Health 12, 12791287. artemisinin-induced brainstem
Fox LL, Taylor TE, Pensulo P, et
Falade CO, Tongo OO, Ogunkunle OO & Orimadegun AE (2010) neurotoxicity. Archives of
al. (2013) Histidine-rich pro-
Effects of malaria in pregnancy on newborn anthropom-etry. Journal tein 2 plasma levels predict Toxicology 82, 379385.
of Infection in Developing Countries 4, 448453. progression to cerebral malaria Genton B, DAcremont V, Rare
Falchook GS, Malone CM, Upton S & Shandera WX (2003) in Malawian children with L, et al. (2008) Plasmodium
Postmalaria neurological syndrome after treatment of Plasmo-dium Plasmodium falciparum vivax and mixed infections are
falciparum malaria in the United States. Clinical Infec-tious Diseases infection. associated with severe malaria
37, e22e24. Journal of Infectious Diseases in children: a prospective
cohort study from Papua New
Familusi JB & Sinnette CH (1971) Febrile convulsions in Ibadan 208, 500503.
Franklin BS, Parroche P, Gui-nea. PLoS Medicine 5,
children. African Journal of Medicine and Medical Sciences 2, 135
Ataide MA, et al. (2009) e127.
150.
Gerardin P, Rogier C, Ka AS,
Fatih FA, Siner A, Ahmed A, et al. (2012) Cytoadherence and virulence Malaria primes the innate
immune response due to Jouvencel P, Brousse V &
- the case of Plasmodium knowlesi malaria. Malaria Journal 11, 33.
interferon-gamma induced Imbert P (2002) Prognostic
Field JW (1949) Blood examination and prognosis in acute falci-parum
value of thrombocytopenia in
malaria. Transactions of the Royal Society of Tropical Medicine and enhancement of toll-like
receptor expres-sion and African children with
Hygiene 43, 3348.
function. Proceedings of the falciparum malaria. American
Field JW & Niven IC (1937) A note on prognosis in relation to parasite Journal of Tropi-cal Medicine
National Academy of
counts in acute subtertian malaria. Transactions of the Royal Society and Hygiene 66, 686691.
of Tropical Medicine and Hygiene 30, 569574. Sciences of the United
States of America 106,
Field J & Shute P (1956). Plasmodium vivax in the Microscopic
5789 5794.
Diagnosis of Human Malaria. Vol 2. A Morphological Study of the
Erythrocytic Parasites. Institute of Medical Research.
Fried M & Duffy PE (1996)
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
112 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Medicine and Hygiene 85,
597605.
Handayani S, Chiu DT, Tjitra E,
et al. (2009) High deformability
Gu Y, Li Q, Melendez V & Weina
of Plasmodium vivax-infected
Gilles HM & Hendrickse RG (1960) Possible aetiological role of P (2008) Comparison of HPLC
red blood cells under
Plasmodium malariae in nephrotic syndrome in Nigerian children. with electrochemical detection
microfluidic conditions. Journal
Lancet 1, 806807. and LC-MS/MS for the
of Infectious Diseases 199,
Gilles HM & Hendrickse RG (1963) Nephrosis in Nigerian chil-dren. Role separation and validation of 445450.
of Plasmodium malariae, and effect of antimalarial treatment. British artesunate and
Hanpithakpong W, Kamanikom
Medical Journal 2, 2731. dihydroartemisinin in animal
B, Singhasivanon P, White
Gilman RH, Terminel M, Levine MM, Hernandez-Mendoza P & Hornick and human plasma. Journal of
NJ, Day NP & Lindegardh N
RB (1975) Relative efficacy of blood, urine, rectal swab, bone-marrow, Chromatography B, Analytical
(2009) A liquid
and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Technologies in the Biomedical
chromatographic-tandem
Lancet 1, 12111213. and Life Sciences
mass spectrometric method
Goller JL, Jolley D, Ringwald P & Biggs BA (2007) Regional differences in 867, 213218. for determination of ar-
the response of Plasmodium vivax malaria to primaquine as anti-relapseGuerin C, Reignier J, Richard JC, temether and its metabolite
therapy. American Journal of Trop-ical Medicine and Hygiene 76, 203 et al. (2013) Prone positioning dihydroartemisinin in human
207. in severe acute respiratory
plasma. Bioanalysis 1, 3746.
Gomes MF, Faiz MA, Gyapong JO, et al. (2009) Pre-referral rec-tal distress syndrome. New Hanson J, Hossain A,
artesunate to prevent death and disability in severe malaria: a placebo- England Journal of Medicine Charunwatthana P, et al. (2009)
controlled trial. Lancet 373, 557566. 368, 21592168.
Hyponat-remia in severe
Goncalves RM, Scopel KK, Bastos MS & Ferreira MU (2012) CytokineGwer S, Newton CR & Berkley malaria: evidence for an
balance in human malaria: does Plasmodium vivax elicit more JA (2007) Over-diagnosis and appropriate anti-diuretic
inflammatory responses than Plasmodium falcipa-rum? PLoS ONE 7, co-morbidity of severe malaria hormone response to
e44394. in African children: a guide for
hypovolemia. American Journal
clinicians. American Journal of
Gopinathan VP & Subramanian AR (1986) Vivax and falcipa-rum of Tropical Medicine and
Tropical Medicine and Hygiene
malaria seen at an Indian service hospital. Journal of Tropical Medicine Hygiene 80, 141145.
and Hygiene 89, 5155. 77, 613.
Hanson J, Lee SJ, Mohanty S, et
Graham SM, Walsh AL, Molyneux EM, Phiri AJ & Molyneux ME (2000) Gwer SA, Idro RI, Fegan G, et
al. (2010) A simple score to
al. (2013) Fosphenytoin for
Clinical presentation of non-typhoidal Salmonella bacteraemia in predict the outcome of severe
sei-zure prevention in
Malawian children. Transactions of the Royal Society of Tropical malaria in adults. Clinical
childhood coma in Africa: a
Medicine and Hygiene 94, 310 314. Infec-tious Diseases 50, 679
randomized clinical trial.
685.
Journal of Critical Care 28,
Grams ME, Estrella MM, Coresh J, Brower RG & Liu KD (2011) Fluid 10861092. Hanson J, Hasan MM, Royakkers
balance, diuretic use, and mortality in acute kid-ney injury. Clinical AA, et al. (2011a) Laboratory
Gyr K, Speck B, Ritz R, Cornu P
Journal of the American Society of Nephrology 6, 966973. prediction of the requirement
& Buckner CD (1974) Cere-bral
Grau GE, Piguet PF, Vassalli P & Lambert PH (1989) Tumor-necrosis for renal replacement in acute
tropical malaria with blackwater
factor and other cytokines in cerebral malaria: experimental and falciparum malaria. Malaria
fever. A current diagnos-tic and
clinical data. Immunological Reviews 112, 4970. Journal 10, 217.
therapeutic problem].
Grau GE, Mackenzie CD, Carr RA, et al. (2003) Platelet accu-mulation in Schweizerische Medizinische Hanson J, Lam SW, Mohanty S,
brain microvessels in fatal pediatric cerebral malaria. Journal of et al. (2011b) Central venous
Wochenschrift 104, 16281630.
Infectious Diseases 187, 461466. catheter use in severe
Halpaap B, Ndjave M, Paris M, malaria: time to reconsider
Graves PM, Osgood DE, Thomson MC, et al. (2008) Effective-ness of Benakis A & Kremsner PG the World Health
malaria control during changing climate conditions in Eritrea, 1998- (1998) Plasma levels of Organization guidelines?
2003. Tropical Medicine and International Health 13, 218228. artesunate and Malaria Journal 10, 342.
Greenwood BM, Bradley AK, Greenwood AM, et al. (1987) Mortality dihydroartemisinin in children
Hanson J, Lam SW, Mahanta
and morbidity from malaria among children in a rural area of The with Plasmodium falciparum
KC, et al. (2012) Relative
Gambia, West Africa. Transactions of malaria in Gabon after
contri-butions of
the Royal Society of Tropical Medicine and Hygiene 81, 478 486. administration of 50-milligram
macrovascular and
artesunate suppositories.
microvascular dysfunction to
Greenwood B, Marsh K & Snow R (1991) Why do some Afri-can children American Journal of disease severity in falciparum
develop severe malaria? Parasitology Today (Per-sonal ed.) 7, 277281. Tropical Medicine and malaria. Journal of Infectious
Hygiene 58, 365368.
Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M & Gilks CF Diseases 206, 571579.
(2004) HIV infection as a cofactor for severe falciparum malaria in Hamel MJ, Adazu K, Obor D, et
Hanson JP, Lam SW, Mohanty S,
adults living in a region of unstable malaria transmission in South al. (2011) A reversal in reduc-
et al. (2013) Fluid resuscita-
tions of child mortality in
Africa. AIDS 18, 547554. tion of adults with severe
western Kenya, 2003-2009. falciparum malaria: effects on
Ameri-can Journal of Tropical Acid-
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 113
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Chemotherapy 48, 4234
4239.
Ho M, Davis TM, Silamut K,
Hendriksen IC, White LJ, Bunnag D & White NJ (1991)
base status, renal function, and extravascular lung water. Crit-ical Care Veenemans J, et al. (2013c) Rosette formation of
Medicine 41, 972981. Plasmodium falciparum-
Defining falciparum-malaria-
infected erythro-cytes from
Harding SP, Lewallen S, Beare NA, Smith A, Taylor TE & Molyneux ME attributable severe febrile
patients with acute malaria.
(2006) Classifying and grading retinal signs in severe malaria. Tropical illness in moder-ate-to-high
Doctor 36(Suppl 1), 113. Infection and Immu-nity 59,
transmission settings on the
21352139.
Harish R & Gupta S (2009) Plasmodium vivax malaria present-ing with basis of plasma PfHRP2
severe thrombocytopenia, cerebral complications and hydrocephalus. concentration. Journal of Hodel EM, Zanolari B, Mercier T,
Indian Journal of Pediatrics 76, 551552. Infectious Diseases 207, 351 et al. (2009) A single LC-tan-
361. dem mass spectrometry method
Haynes RK, Chan WC, Wong HN, et al. (2010) Facile oxidation of
for the simultaneous determi-
leucomethylene blue and dihydroflavins by artemisinins: relationship with
nation of 14 antimalarial drugs
flavoenzyme function and antimalarial mech-anism of action. Hero M, Harding SP, Riva CE,
and their metabolites in human
ChemMedChem 5, 12821299. Winstanley PA, Peshu N &
plasma. Journal of
Haynes RK, Cheu KW, Tang MM, et al. (2011) Reactions of antimalarial Marsh K (1997) Photographic
and angiographic characteriza- Chromatography B 877, 867
peroxides with each of leucomethylene blue and dihydroflavins: flavin 886.
reductase and the cofactor model exem-plified. ChemMedChem 6, 279 tion of the retina of Kenyan
children with severe malaria. Hoffman SL, Rustama D,
291.
Archives of Ophthalmology Punjabi NH, et al. (1988)
Haynes RK, Cheu KW, Chan HW, et al. (2012) Interactions between High-dose dexamethasone in
115, 9971003.
artemisinins and other antimalarial drugs in relation to the cofactor
Hien TT, Vinh H & Cuong B quinine-treated patients with
modela unifying proposal for drug action.
(1990) Experience in the cerebral malaria: a double-
ChemMedChem 7, 22042226. blind, placebo-controlled
manage-ment of severe
Hebert PC, Wells G, Blajchman MA, et al. (1999) A multicenter, trial. Journal of Infectious
falciparum malaria. The
randomized, controlled clinical trial of transfusion require-ments in Diseases 158, 325331.
Malaria Symposium &
critical care. Transfusion Requirements in Critical Care Investigators, Holding PA, Stevenson J, Peshu N
Workshop on Complications,
Canadian Critical Care Trials Group. New England Journal of Medicine & Marsh K (1999) Cognitive
Management and Prevention
340, 409417. sequelae of severe malaria with
Feb 21-24, 199 Ho Chi Minh
Helbok R, Kendjo E, Issifou S, et al. (2009) The Lambarene Organ City, Vietnam, 2324. impaired consciousness. Trans-
Dysfunction Score (LODS) is a simple clinical predictor of fatal malaria actions of the Royal Society of
Hien TT, Arnold K, Vinh H, et al.
in African children. Journal of Infectious Dis-eases 200, 18341841. Tropical Medicine and Hygiene
(1992) Comparison of arte-
Hemmer CJ, Holst FG, Kern P, Chiwakata CB, Dietrich M & Reisinger EC misinin suppositories with 93, 529534.
(2006) Stronger host response per parasitized erythrocyte in Plasmodium intravenous artesunate and Holst FG, Hemmer CJ, Kern P &
vivax or ovale than in Plasmodium falciparum malaria. Tropical intrave-nous quinine in the Dietrich M (1994) Inappropri-
Medicine and International Health 11, 817823. treatment of cerebral malaria. ate secretion of antidiuretic
Hendriksen IC, Mtove G, Pedro AJ, et al. (2011) Evaluation of a PfHRP2 Transactions of the Royal hormone and hyponatremia in
and a pLDH-based rapid diagnostic test for the diagnosis of severe Society of Tropical severe falciparum malaria.
malaria in 2 populations of African chil-dren. Clinical Infectious Medicine and Hygiene 86, American Journal of Tropical
Diseases 52, 11001107. 582583. Med-icine and Hygiene 50,
Hendriksen IC, Ferr J, Montoya P, et al. (2012a) Diagnosis, clin-ical Hien TT, Phu NH, Mai N, et al. 602607.
presentation, and in-hospital mortality of severe malaria in HIV- (1996) Controlled trial of ar- Horstmann RD, Dietrich M,
coinfected children and adults in Mozambique. Clini-cal Infectious temether or quinine in Bienzle U & Rasche H
Diseases 55, 11441153. Vietnamese adults with severe (1981) Malaria-induced
falcipa-rum malaria. New thrombocytopenia. Blut
Hendriksen IC, Mwanga-Amumpaire J, von Seidlein L, et al. (2012b)
England Journal of Medicine 42, 157164.
Diagnosing severe falciparum malaria in parasitaemic African children: a
335, 7683. Ibiwoye MO, Howard CV,
prospective evaluation of plasma PfHRP2 measurement. PLoS Medicine
Hien TT, Turner GD, Mai NT, et Sibbons P, Hasan M & Van
9, e1001297.
al. (2003) Neuropathological Velzen D (1993) Cerebral
Hendriksen IC, Maiga D, Lemnge MM, et al. (2013a) Popula-tion
assessment of artemether- malaria in the rhesus monkey
pharmacokinetic and pharmacodynamic properties of intramuscular
treated severe malaria. Lancet (Macaca mul-atta): observations
quinine in Tanzanian children with severe Falci-parum malaria. 362, 295296. on host pathology. Journal of
Antimicrobial Agents and Chemotherapy 57, 775783. Comparative Pathology 108,
Hien TT, Davis TM, Chuong LV,
et al. (2004) Comparative 303310.
Hendriksen IC, Mtove G, Kent A, et al. (2013b) Population pharmacokinetics of Idro R, Karamagi C &
pharmacokinetics of intramuscular artesunate in African chil-dren with intramuscular artesunate and Tumwine J (2004) Immediate
severe malaria: implications for a practical dosing regimen. Clinical artemether in patients with outcome and prognostic
Pharmacology & Therapeutics 93, 443 450. severe falciparum malaria. factors for cerebral malaria
Antimicrobial Agents and among children
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
114 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Current Medicinal Chemistry
14, 32433259.
Jarvis JN, Planche T, Bicanic T,
et al. (2006) Lactic acidosis in
Issifou S, Kendjo E, Missinou
MA, et al. (2007) Gabonese children with severe
admitted to Mulago Hospital, Uganda. Annals of Tropical
Paediatrics 24, 1724. Differences in presentation malaria is unrelated to
dehydra-tion. Clinical
Idro R, Jenkins NE & Newton CR (2005a) Pathogenesis, clinical of severe malaria in urban
and rural Gabon. Infectious Diseases 42, 1719
features, and neurological outcome of cerebral malaria. Lancet
American Journal of 1725.
Neurology 4, 827840.
Tropical Medicine and Jat KR, Guglani V & Khairwa A
Idro R, Otieno G, White S, et al. (2005b) Decorticate, decere-brate and Hygiene 77, 1015 (2012) Severe and complicated
opisthotonic posturing and seizures in Kenyan chil-dren with cerebral 1019. Plasmodium vivax malaria
malaria. Malaria Journal 4, 57. in children. Tropical
Jain V, Lucchi NW, Wilson
Idro R, Aloyo J, Mayende L, Bitarakwate E, John CC & Kivum-bi GW NO, et al. (2011) Plasma Doctor 42, 8587.
(2006a) Severe malaria in children in areas with low, moderate and levels of angiopoietin-1 and Jenkins N, Wu Y, Chakravorty
high transmission intensity in Uganda. Tropical Medicine and -2 predict cerebral malaria S, Kai O, Marsh K & Craig
International Health 11, 115124. outcome in Central India. A (2007) Plasmodium
Idro R, Carter JA, Fegan G, Neville BG & Newton CR (2006b) Risk Malaria Journal 10, 383. falciparum intercellular
factors for persisting neurological and cognitive impairments Jakeman GN, Saul A, Hogarth adhesion mole-cule-1-based
following cerebral malaria. Archives of Disease in Childhood 91, 142 WL & Collins WE (1999) cytoadherence-related
148. Anae-mia of acute malaria signaling in human endo-
Idro R, Ndiritu M, Ogutu B, et al. (2007) Burden, features, and outcome infections in non-immune thelial cells. Journal of
of neurological involvement in acute falciparum malaria in Kenyan patients pri-marily results Infectious Diseases 196,
children. Journal of The American Medical Association 297, 2232 from destruction of uninfected 321327.
2240. erythrocytes. Parasitology Jiang N, Chang Q, Sun X, et al.
Idro R, Kakooza-Mwesige A, Balyejjussa S, et al. (2010) Severe 119(Pt 2), 127133. (2010) Co-infections with
neurological sequelae and behaviour problems after cere- Jakobsen PH, Morris-Jones S, Plas-modium knowlesi and
bral malaria in Ugandan children. BMC Research Notes 3, 104. Ilett other malaria parasites,
Ronn A, et al. (1994)
KF, Batty KT, Powell SM, et al. (2002a) The pharmacoki- Myanmar.
Increased plasma
Emerging Infectious Diseases
netic properties of intramuscular artesunate and rectal dihyd- concentrations of sICAM-1,
16, 14761478.
roartemisinin in uncomplicated falciparum malaria. British Journal sVCAM-1 and sELAM-1 in
of Clinical Pharmacology 53, 2330. John CC, Bangirana P,
patients with Plasmodium
Byarugaba J, et al.
Ilett KF, Ethell BT, Maggs JL, et al. (2002b) Glucuronidation of falciparum or Plasmodium
(2008) Cerebral malaria
dihydroartemisinin in vivo and by human liver microsomes and vivax malaria and association
in children is associated
expressed UDP-glucuronosyltransferases. Drug Metabo-lism and with disease severity.
with long-term cognitive
Disposition 30, 10051012. Immunology 83, 665669.
impairment. Pediatrics
Imani PD, Musoke P, Byarugaba J & Tumwine JK (2011) Human 122, e92e99.
immunodeficiency virus infection and cerebral malaria in children in Jallow M, Casals-Pascual C, Jongwutiwes S, Putaporntip C,
Uganda: a case-control study. BMC Pediatrics 11, 5. Ackerman H, et al. (2012) Iwasaki T, Sata T & Kanbara
Clini-cal features of severe H (2004) Naturally acquired
Imbert P, Rapp C & Buffet PA (2009) Pathological rupture of the spleen malaria associated with death: Plasmodium knowlesi malaria
in malaria: analysis of 55 cases (1958-2008). Travel Medicine and a 13-year observational study in human, Thailand.
Infectious Disease 7, 147159. in the Gambia. PLoS ONE 7, Emerging Infectious Diseases
Imwong M, Tanomsing N, Pukrittayakamee S, Day NP, White NJ & e45645. 10, 2211 2213.
Snounou G (2009) Spurious amplification of a Plasmo-dium vivax
small-subunit RNA gene by use of primers cur-rently used to detect James S (1925) The
Jongwutiwes S, Buppan P,
P. knowlesi. Journal of Clinical Microbiology 47, 41734175. disappearance of malaria from
England. Kosuvin R, et al. (2011)
Iqbal J, Siddique A, Jameel M & Hira PR (2004) Persistent histi-dine- Plasmodium knowlesi malaria
Proceedings of the Royal
rich protein 2, parasite lactate dehydrogenase, and pan-malarial in humans and Macaques,
Society of Medicine 23, 7185.
antigen reactivity after clearance of Plasmodium falciparum Thailand. Emerg-ing
James S (1933) Third general
monoinfection. Journal of Clinical Microbiology Infectious Diseases 17, 1799
report of the malaria
42, 42374241. 1806.
commission
Ismail S, Na Bangchang K, Karbwang J, Back DJ & Edwards G (1995) Kapland LI, Read HS & Mullins
of the health organization of
Paracetamol disposition in Thai patients during and after treatment of DF (1946) Spontaneous
the League of Nations.
falciparum malaria. European Journal of Clinical Pharmacology 48, Quarterly Bulletin Health rupture of the spleen during
6569. Organisation of League of malaria therapy; report of a
Ismail MR, Ordi J, Menendez C, Ventura PJ, Aponte JJ, Kahigwa E, Nations 2, 217. case. Annals of Internal
Medicine 24, 707714.
Hirt R, Cardesa A & Alonso PL (2000) Placental pathology in Jansen FH & Soomro SA (2007)
malaria: a histological, immunohistochemical, and quantitative study. Chemical instability Karunaweera ND, Carter R, Grau
Human Pathology 31, 8593. determines the biological GE, Kwiatkowski D, Del Giu-
dice G & Mendis KN (1992)
action of the artemisinins.
Tumour necrosis factor-depen-
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 115
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
malaria? The different burdens
of malaria infection, malaria
disease, and malaria-like
illnesses. American Journal of
Kochar DK, Shubhakaran
Tropical Medi-cine and
dent parasite-killing effects during paroxysms in non-immune Kumawat BL, et al. (2002)
Hygiene 77, 15.
Plasmodium vivax malaria patients. Clinical and Experimental Cerebral malaria in Indian
Immunology 88, 499505. adults: a prospective study of Koram KA, Owusu-Agyei S, Utz
441 patients from Bikaner, G, et al. (2000) Severe anemia
Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN &
north-west India. Journal of in young children after high
Carter R (2003) The paroxysm of Plasmodium vivax malaria.
the Association of Physicians and low malaria transmission
Trends in Parasitology 19, 188193.
seasons in the Kassena-
Karunaweera N, Wanasekara D, Chandrasekharan V, Mendis K & Carter of India 50, 234241. Nankana district of northern
R (2007) Plasmodium vivax: paroxysm-associated lipids mediate Kochar DK, Singh P, Agarwal P,
Ghana. American Journal of
leukocyte aggregation. Malaria Journal 6, 62. Kochar SK, Pokharna R &
Tropical Medicine and
Kasliwal P, Rao MS & Kujur R (2009) Plasmodium vivax malaria: an Sa-reen PK (2003) Malarial
Hygiene 62, 670674.
unusual presentation. Indian Journal of Critical Care Medicine 13, hepatitis. Journal of the
Association of Physicians of Kreeftmeijer-Vegter AR, Van
103105. Genderen PJ, Visser LG, et
India 51, 10691072.
Kastl AJ, Daroff RB & Blocker WW (1968) Psychological testing of al. (2012) Treatment
cerebral malaria patients. Journal of Nervous and Mental Disease 147, Kochar DK, Saxena V, Singh N,
outcome of intravenous
553561. Kochar SK, Kumar SV & Das
artesunate in patients with
A (2005) Plasmodium vivax
Kaushik JS, Gomber S & Dewan P (2012) Clinical and epidemio- severe malaria in the
malaria. Emerging Infectious
logical profiles of severe malaria in children from Delhi, India. Netherlands and Belgium.
Dis-eases 11, 132134.
Journal of Health, Population, and Nutrition 30, 113116. Khim N, Malaria Journal 11, 102.
Siv S, Kim S, et al. (2011) Plasmodium knowlesi infec- Kochar DK, Sirohi P, Kochar
Kremsner PG, Valim C,
SK, et al. (2007) Post-malaria
tion in humans, Cambodia, 20072010. Emerging Infectious Missinou MA, et al. (2009)
neu-rological syndromea case
Diseases 17, 19001902. Prognostic value of
of bilateral facial palsy after
Kibukamusoke JW & Hutt MS (1967) Histological features of the circulating pigmented cells
Plas-modium vivax malaria.
nephrotic syndrome associated with quartan malaria. Jour-nal of in African children with
Journal of Vector Borne
Clinical Pathology 20, 117123. malaria. Journal of
Diseases 44, 227229.
Kihara M, Carter JA, Holding PA, et al. (2009) Impaired every-day Kochar DK, Das A, Kochar SK, Infectious Diseases 199,
memory associated with encephalopathy of severe malaria: the role of et al. (2009) Severe 142150.
seizures and hippocampal damage. Malaria Journal 8, 273. Krishna S, Waller DW, Ter Kuile
Plasmodium vivax malaria: a
F, et al. (1994) Lactic acidosis
report on serial cases from
Kim EM, Cho HJ, Cho CR, Kwak YG, Kim MY & Cho YK (2010) and hypoglycaemia in children
Bikaner in northwestern India.
Abdominal computed tomography findings of malaria infection with with severe malaria:
American Journal of Tropical
Plasmodium vivax. American Journal of Tropi-cal Medicine and pathophysiological and
Medicine and Hygiene 80,
Hygiene 83, 12021205. prognostic significance.
194198.
Transactions of the Royal
Kissinger E, Hien TT, Hung NT, et al. (2000) Clinical and neu- Kochar DK, Tanwar GS, Khatri Society of Tropical Medicine
rophysiological study of the effects of multiple doses of arte-misinin PC, et al. (2010) Clinical fea- and Hygiene 88, 6773.
on brain-stem function in Vietnamese patients. tures of children hospitalized
Krishna S, Nagaraja NV,
American Journal of Tropical Medicine and Hygiene 6, 4855. with malariaa study from
Planche T, et al. (2001a)
Kitchen SF (1938) The infection of reticulocytes by Plasmodium Bika-ner, northwest India.
Population
vivax. American Journal of Tropical Medicine and Hygiene s1-18, American Journal of Tropical
pharmacokinetics of
347359. Medicine and Hygiene 83,
intramuscular quinine in
Kitchen SF (1949a). Symptomatology: General Considerations. In: 981989.
children with severe malaria.
Malariology. (ed MF Boyd) W.B. Saunders, Philadelphia. Koibuchi T, Nakamura T, Miura Antimicrobial Agents and
Kitchen SF (1949b). Vivax malaria. In: Malariology. (ed MF Boyd) T, et al. (2003) Acute dissemi- Chemotherapy 45, 1803
W.B. Saunders, Philadelphia. nated encephalomyelitis
1809.
following Plasmodium vivax
Klahr S & Miller SB (1998) Acute oliguria. New England Jour-nal of Krishna S, Planche T,
malaria.
Medicine 338, 671675. Agbenyega T, et al. (2001b)
Knisely M & Stratman-Thomas W (1945) Knowlesi malaria Journal of Infection and
Chemotherapy 9, 254 Bioavailabil-ity and
in monkeys: microscopic pathological circulatory physiology of preliminary clinical efficacy
256. Kolloffel WJ,
rhesus monkeys during acute Plasmodium knowlesi malaria. of intrarectal artesunate in
Driessen FG & Goldhoorn
Journal of the National Malaria Society (U.S.) 4, 285300. Knisely M PB (1996) Rectal Ghanaian children with
& Stratman-Thomas WK (1948) Microscopic obser-vations of moderate malaria.
administration of paracetamol:
intravascular agglutination of red cells and conse-quent sludging of Antimicrobial Agents and
a comparison of a solution and
blood in rhesus monkeys infected with Chemotherapy 45, 509516.
suppositories in adult
knowlesi malaria. The Anatomical Record 101, 701. Knowles R & volunteers. Pharmacy World &
Das Gupta B (1932) A study of monkey-malaria Science 18, 2629.
and its experimental transmission to man. Indian Medical Koram KA & Molyneux ME
Gazette 67, 301321. (2007) When is malaria
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
116 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Levy MJ, Seelig CB, Robinson
NJ & Ranney JE (1997)
Compar-ison of omeprazole
and ranitidine for stress ulcer
Larkin GL & Thuma PE (1991) prophylaxis.
Krishnan A & Karnad DR (2003) Severe falciparum malaria: an important Congenital malaria in a Digestive Diseases and
cause of multiple organ failure in Indian intensive care unit patients. hype-rendemic area. Sciences 42, 12551259.
Critical Care Medicine 31, 22782284. American Journal of Tropical
Lewallen S, Taylor TE, Molyneux
Kublin JG, Patnaik P, Jere CS, et al. (2005) Effect of Plasmo-dium Medicine and Hygiene 45,
ME, Wills BA & Courtright P
falciparum malaria on concentration of HIV-1-RNA in the blood of 587592.
(1993) Ocular fundus findings
adults in rural Malawi: a prospective cohort study. Lancet 365, 233 Larkin D, De Laat B, Jenkins in Malawian children with cere-
240. PV, et al. (2009) Severe bral malaria. Ophthalmology
Kumar N & Zheng H (1990) Stage-specific gametocytocidal effect in Plasmo-dium falciparum 100, 857861.
vitro of the antimalaria drug qinghaosu on Plasmo-dium falciparum. malaria is associated with
Lewallen S, Bakker H, Taylor TE,
Parasitology Research 76, 214218. circulating ultra-large von
Wills BA, Courtright P &
Willebrand multimers and
Kute VB, Shah PR, Munjappa BC, et al. (2012a) Outcome and prognostic Molyneux ME (1996) Retinal
ADAMTS13 inhibition.
factors of malaria-associated acute kidney injury requiring hemodialysis: findings predictive of outcome
PLoS Pathogens 5, e1000349.
a single center experience. Indian Jour-nal of Nephrology 22, 3338. in cerebral malaria.
Lee AD, Stephen E, Agarwal S & Transactions of the Royal
Kute VB, Trivedi HL, Vanikar AV, et al. (2012b) Plasmodium vivax
Premkumar P (2009a) Venous Society of Trop-ical Medicine
malaria-associated acute kidney injury, India, 2010 2011. Emerging
thrombo-embolism in India. and Hygiene 90, 144146.
Infectious Diseases 18, 842845.
European Journal of Vascular
Kwiatkowski D, Hill AV, Sambou I, et al. (1990) TNF con-centration in Lewallen S, Harding SP, Ajewole
and Endovascular Surgery 37,
fatal cerebral, non-fatal cerebral, and uncom-plicated Plasmodium J, et al. (1999) A review of the
482485.
falciparum malaria. Lancet 336, 1201 1204. spectrum of clinical ocular
Lee KS, Cox-Singh J & Singh B
fundus findings in P.
(2009b) Morphological fea-
Lacerda MV, Fragoso SC, Alecrim MG, et al. (2012) Postmor-tem falciparum malaria in African
tures and differential counts of
characterization of patients with clinical diagnosis of Plas-modium vivax Plasmodium knowlesi para- children with a proposed
malaria: to what extent does this parasite kill? classification and grading
sites in naturally acquired
Clinical Infectious Diseases 55, e67e74. system. Transactions of the
human infections. Malaria
Lackritz EM, Campbell CC, Ruebush TK, et al. (1992) Effect of blood Journal 8, 73. Royal Society of Tropical
transfusion on survival among children in a Kenyan hos-pital. Lancet 340, Medicine and Hygiene 93,
524528. 619623.
Lee C, Adeeba K & Freigang G
Lackritz EM, Ruebush TK, Zucker JR, Adungosi JE, Were JB & Campbell (2010a) Human Plasmodium Lewallen S, Bronzan RN, Beare
CC (1993) Blood transfusion practices and blood-banking services in a knowlesi infections in Klang NA, Harding SP, Molyneux
Kenyan hospital. AIDS 7, 995 999. ME & Taylor TE (2008) Using
Valley, Malaysia: case series.
malarial retinopathy to improve
The Medical Journal of
Malaysia 65, 6365. the classification of children
Lacroix J, Hebert PC, Hutchison JS, et al. (2007) Transfusion strategies
with cerebral malaria. Transac-
for patients in pediatric intensive care units. New England Journal of Lee JH, Chin HS, Chung MH &
Medicine 356, 16091619. tions of the Royal Society of
Moon YS (2010b) Retinal hem-
Tropical Medicine and Hygiene
Ladeia-Andrade S, Ferreira MU, De Carvalho ME, Curado I & Coura JR orrhage in Plasmodium vivax
102, 10891094.
(2009) Age-dependent acquisition of protective immunity to malaria in malaria. American Journal of
riverine populations of the Amazon Basin of Brazil. American Journal Tropical Medicine and Hygiene Li Q, Lugt CB, Looareesuwan S,
of Tropical Medicine and Hygiene 80, 452459. 82, 219222. et al. (2004) Pharmacokinetic
Leonardi E, Gilvary G, White investigation on the therapeutic
Ladhani S, Lowe B, Cole AO, Kowuondo K & Newton CR (2002) Changes
NJ & Nosten F (2001) potential of artemotil (beta-ar-
in white blood cells and platelets in children with falciparum malaria:
Severe allergic reactions to teether) in Thai patients with
relationship to disease outcome. Brit-ish Journal of Haematology 119,
oral artesunate: a report of severe Plasmodium falciparum
839847.
two cases. malaria. American Journal of
Lalloo DG, Trevett AJ, Paul M, et al. (1996) Severe and compli-cated Tropical Medicine and Hygiene
Transactions of the Royal
falciparum malaria in Melanesian adults in Papua New Guinea. American Society of Tropical 71, 723731.
Journal of Tropical Medicine and Hygiene Medicine and Hygiene 95, Lichtman AR, Mohrcken S,
55, 119124. 182183. Engelbrecht M & Bigalke M
Lampah DA, Yeo TW, Hardianto SO, et al. (2011) Coma asso-ciated withLeslie T, Briceno M, Mayan I, et (1990) Pathophysiology of
microscopy-diagnosed Plasmodium vivax: a pro-spective study in al. (2010) The impact of phe- severe forms of falciparum
Papua, Indonesia. PLoS Neglected Tropical Diseases 5, e1032. notypic and genotypic G6PD malaria. Criti-cal Care
Lanca EF, Magalhaes BM, Vitor-Silva S, et al. (2012) Risk fac-tors and deficiency on risk of Medicine 18, 666668.
characterization of Plasmodium vivax-associated admissions to Plasmodium vivax infection: a
pediatric intensive care units in the Brazilian Amazon. PLoS ONE 7, case-control study amongst
e35406. Afghan refugees in Pakistan.
PLoS Medicine 7, e1000283.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 117
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
American Journal of
Epidemiology
154, 459465.
Lowenberg EC, Charunwatthana Lyke KE, Diallo DA, Dicko A, et
Lin E, Kiniboro B, Gray L, et al. (2010) Differential patterns of infection P, Cohen S, et al. (2010) al. (2003) Association of intra-
and disease with P. falciparum and P. vivax in young Papua New Guinean Severe malaria is associated leukocytic Plasmodium
children. PLoS ONE 5, e9047. with a deficiency of von Wille- falciparum malaria pigment
brand factor cleaving protease, with dis-ease severity, clinical
Lindegardh N, Hanpithakpong W, Kamanikom B, et al. (2008) Major
ADAMTS13. Thrombosis and manifestations, and prognosis in
pitfalls in the measurement of artemisinin derivatives in plasma in
Haemostasis 103, 181187. severe malaria. American
clinical studies. Journal of Chromatography B 876, 5460.
Journal of Tropical Medicine
Lubitz J (1949) Pathology of
ruptured spleen in acute and Hygiene
Lindegardh N, Hanpithakpong W, Kamanikom B, et al. (2011)
vivax malaria. Blood 4, 69, 253259.
Quantification of dihydroartemisinin, artesunate and artemisi-nin in
11681176. Lynch M, Korenromp E, Eisele T,
human blood: overcoming the technical challenge of protecting the
Luchavez J, Espino F, et al. (2012) New global esti-
peroxide bridge. Bioanalysis 3, 16131624.
Curameng P, et al. (2008) mates of malaria deaths.
Lins RL, Elseviers MM, Van Der Niepen P, et al. (2009) Inter-mittent Lancet 380, 559.
Human Infec-tions with
versus continuous renal replacement therapy for acute kidney injury Mabeza GF, Moyo VM, Thuma
Plasmodium knowlesi, The
patients admitted to the intensive care unit: results of a randomized PE, et al. (1995) Predictors of
Philippines. Emerging
clinical trial. Nephrology, Dialysis, Transplantation 24, 512518. Infectious Diseases 14, 811 severity of illness on
Liu X, Tao ZY, Fang Q, et al. (2012) A case of congenital Plas-modium 813. presentation in children with
vivax malaria from a temperate region in central China. Malaria JournalLumlertgul D, Keoplung M, cerebral malaria. Annals of
11, 182. Sitprija V, Moollaor P & Tropical Medicine and
Lomar AV, Vidal JE, Lomar FP, Barbas CV, De Matos GJ & Boulos M Suwan-gool P (1989) Parasitology 89, 221228.
(2005) Acute respiratory distress syndrome due to vivax malaria: case Furosemide and dopamine in Macallan DC, Pocock M,
report and literature review. The Brazilian Journal of Infectious Diseases malarial acute renal failure. Robinson GT, Parker-Williams
9, 425430. Nephron 52, 4044. J & Bevan DH (2000) Red cell
Longo M, Zanoncelli S, Torre PD, et al. (2006) In vivo and in vitro Luxemburger C, Ter Kuile FO, exchange, erythrocytapheresis,
investigations of the effects of the antimalarial drug dihydroartemisinin Nosten F, et al. (1994) Single in the treatment of malaria with
(DHA) on rat embryos. Reproductive Toxicology 22, 797810. day mefloquine-artesunate high parasitaemia in returning
Looareesuwan S, Warrell DA, White NJ, et al. (1983a) Retinal hemorrhage, combination in the treatment of travellers. Transactions of the
a common sign of prognostic significance in cere-bral malaria. American multi-drug resistant falciparum Royal Society of Tropical
Journal of Tropical Medicine and Hygiene 32, 911915. malaria. Transactions of the Medi-cine and Hygiene 94,
Looareesuwan S, Warrell DA, White NJ, et al. (1983b) Do patients with Royal Society of Tropical 353356.
cerebral malaria have cerebral oedema? A com-puted tomography study. Medicine and Hygiene 88, Machado Siqueira A, Lopes
Lancet 1, 434437. 213217. Magalhaes BM, Cardoso Melo
Looareesuwan S, Phillips RE, White NJ, et al. (1985) Quinine and severe Luxemburger C, Nosten F, G, et al. (2012) Spleen rupture
falciparum malaria in late pregnancy. Lancet 2, 48. Raimond SD, in a case of untreated Plasmo-
Chongsuphajaisiddhi T & dium vivax infection. PLoS
Looareesuwan S, Merry AH, Phillips RE, et al. (1987) Reduced White NJ (1995) Oral Neglected Tropical Diseases 6,
artesunate in the treatment of e1934.
erythrocyte survival following clearance of malarial parasita-emia in
uncomplicated
Thai patients. British Journal of Haematology 67, 473478.
hyperparasitemic falciparum MacPherson GG, Warrell MJ,
malaria. American Journal of White NJ, Looareesuwan S &
Looareesuwan S, Charoenpan P, Ho M, et al. (1990) Fatal Plas-modium
Tropical Medicine and Hygiene Warrell DA (1985) Human
falciparum malaria after an inadequate response to quinine treatment. 61, 5355. cerebral malaria. A quantitative
Journal of Infectious Diseases 161, 577 580.
Luxemburger C, Ricci F, Nosten ul-trastructural analysis of
F, Raimond D, Bathet S & parasitized erythrocyte
Looareesuwan S, Wilairatana P, Krishna S, et al. (1995) Mag-netic
White NJ (1997) The sequestration.
resonance imaging of the brain in patients with cerebral malaria.
epidemiology of severe malaria American Journal of Pathology
Clinical Infectious Diseases 21, 300309.
in an area of low transmission 119, 385401.
Lopansri BK, Anstey NM, Weinberg JB, et al. (2003) Low plasma in Thailand. Transactions of the Maguire GP, Handojo T, Pain
arginine concentrations in children with cerebral malaria and Royal Society of Tropical MC, et al. (2005) Lung injury
decreased nitric oxide production. Lancet 361, 676678. Medicine and Hygiene 91, in uncomplicated and severe
256262. falciparum malaria: a
Lovegrove FE, Tangpukdee N, Opoka RO, et al. (2009) Serum angiopoietin- Luxemburger C, McGready R, longitudinal study in Papua,
1 and -2 levels discriminate cerebral malaria from uncomplicated malaria Kham A, et al. (2001) Effects Indonesia. Journal of
and predict clinical outcome in African children. PLoS ONE 4, e4912. of malaria during pregnancy Infectious Diseases 192, 1966
on infant mortality in an area 1974.
of low malaria transmission.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
118 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Wiladphaingern J, et al.
(2012b) Adverse effects of
falciparum and vivax malaria
and the safety of anti-malarial
malaria. Transactions of the
treatment in early pregnancy: a
Mahgoub H, Gasim GI, Musa IR & Adam I (2012) Severe Plas-modium Royal Society of Tropical
population-based study. Lancet
vivax malaria among Sudanese children at New Halfa Hospital, Eastern Medi-cine and Hygiene 103,
665671. Infectious Diseases 12, 388
Sudan. Parasites & Vectors 5, 154.
396.
Maitland K & Newton CR (2005) Acidosis of severe falciparum malaria: Maude RJ, Plewes K, Faiz MA,
et al. (2009b) Does McGready R, Phyo AP, Rijken
heading for a shock? Trends in Parasitology 21, 11 16.
artesunate prolong the MJ, et al. (2012c)
electrocardiograph QT Artesunate/di-hydroartemisinin
Maitland K, Williams TN, Peto TE, et al. (1997) Absence of malaria- pharmacokinetics in acute
interval in patients with
specific mortality in children in an area of hyperen-demic malaria. falciparum malaria in
severe malaria? American
Transactions of the Royal Society of Tropical Medicine and Hygiene pregnancy: absorption,
Journal of Tropical Medicine
91, 562566. bioavailability, disposition and
and Hygiene 80, 126132.
Maitland K, Levin M, English M, et al. (2003a) Severe P. falci-parum disease effects. British Journal
malaria in Kenyan children: evidence for hypovolaemia. Maude RJ, Hoque G, Hasan MU,
et al. (2011) Timing of enteral of Clinical Pharmacology
QJM: Monthly Journal of the Association of Physicians 96, 427434. 73, 467477.
feeding in cerebral malaria in
Maitland K, Pamba A, Newton CR & Levin M (2003b) Response to resource-poor settings: a ran- McGregor IA, Gilles HM, Walters
volume resuscitation in children with severe malaria. Pediatric domized trial. PLoS ONE 6, JH, Davies AH & Pearson FA
Critical Care Medicine 4, 426431. e27273. (1956) Effects of heavy and
Maitland K, Pamba A, Newton CR, Lowe B & Levin M (2004) Mayor A, Bardaji A, Felger I, repeated malarial infections on
Hypokalemia in children with severe falciparum malaria. Pedi-atric et al. (2012) Placental Gambian infants and children;
Critical Care Medicine 5, 8185. infection with Plasmodium effects of erythrocytic parasiti-
Maitland K, Kiguli S, Opoka RO, et al. (2011) Mortality after fluid bolus in vivax: a histopathological zation. British Medical Journal
African children with severe infection. New Eng-land Journal of and molecular study. Journal 2, 686692.
Medicine 364, 24832495. of Infectious Diseases 206, McMorrow ML, Masanja MI,
Maitland K, George EC, Evans JA, et al. (2013) Exploring mech-anisms of 19041910. Abdulla SM, Kahigwa E & Ka-
excess mortality with early fluid resuscitation: insights from the FEASTMayxay M, Pukrittayakamee S, chur SP (2008) Challenges in
trial. BMC Medicine 11, 68. Chotivanich K, Looareesuwan S routine implementation and
Malamba S, Hladik W, Reingold A, et al. (2007) The effect of HIV on & White NJ (2001) Persistence quality control of rapid
morbidity and mortality in children with severe malar-ial anaemia. of Plasmodium falciparum diagnostic tests for malaria
Malaria Journal 6, 143. HRP-2 in successfully treated Rufiji Dis-trict, Tanzania.
Mallewa M, Vallely P, Faragher B, et al. (2013) Viral CNS infections in acute falciparum malaria. Trans- American Journal of Tropical
children from a malaria-endemic area of Malawi: a prospective cohort actions of the Royal Society of Medicine and Hygiene 79,
study. Lancet Global Health 1, e153 e160. Tropical Medicine and Hygiene 385390.
95, 179182.
Manning L, Laman M, Law I, et al. (2011) Features and prog-nosis of Mayxay M, Pukrittayakamee S, McQueen PG & McKenzie FE
severe malaria caused by Plasmodium falciparum, Plasmodium vivax Newton PN & White NJ (2004) (2004) Age-structured red
and mixed Plasmodium species in Papua New Guinean children. PLoS Mixed-species malaria blood cell susceptibility and
ONE 6, e29203. infections in humans. Trends in the dynamics of malaria
Parasi-tology 20, 233240. infections. Pro-ceedings of the
Manning L, Rosanas-Urgell A, Laman M, et al. (2012) A histo-pathologic
McGready R, Davison BB, National Academy of Sciences
study of fatal paediatric cerebral malaria caused by mixed Plasmodium
Stepniewska K, et al. (2004) of the United States of America
falciparum/Plasmodium vivax infections.
The effects of Plasmodium 101, 91619166.
Malaria Journal 11, 107.
Medana IM & Turner GD (2006)
Mansor SM, Molyneux ME, Taylor TE, Ward SA, Wirima JJ & Edwards G falciparum and P. vivax
Human cerebral malaria and
(1991) Effect of Plasmodium falciparum malaria infection on the plasma infections on placental the blood-brain barrier.
concentration of alpha 1-acid glyco-protein and the binding of quinine in histopathology in an area of International Journal for
Malawian children. Brit-ish Journal of Clinical Pharmacology 32, 317 low malaria transmis-sion. Parasitology
321. American Journal of Tropical
36, 555568.
Medicine and Hygiene 70,
Marchiafava F & Bignami A (1892) Sulle febbri malariche estiv-o- Medana IM, Day NP, Hien TT, et
398407.
autunnali. Bull del R Acad Med di Roma 297 al. (2002) Axonal injury in
Markley JD & Edmond MB (2009) Post-malaria neurological syndrome: cerebral malaria. American
McGready R, Boel M, Rijken Journal of Pathology 160, 655
a case report and review of the literature. Journal of Travel Medicine
16, 424430. MJ, et al. (2012a) Effect of 666.
early detection and treatment
Marsh K, Forster D, Waruiru C, et al. (1995) Indicators of life-threatening
on malaria related maternal
malaria in African children. New England Journal of Medicine 332,
mortality on the north-Western
13991404.
border of Thailand 1986-2010.
Maude RJ, Beare NA, Abu Sayeed A, et al. (2009a) The spec-trum of PLoS ONE 7, e40244.
retinopathy in adults with Plasmodium falciparum
McGready R, Lee SJ,
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 119
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
following halofantrine intake.
Transactions of the Royal
Society of Tropical
Medicine and Hygiene 88,
Mishra SK, Mohanty S, Satpathy 91.
Medana IM, Day NP, Sachanonta N, et al. (2011) Coma in fatal adult SK & Mohapatra DN (2007b)
human malaria is not caused by cerebral oedema. Mokuolu OA, Falade CO,
Cerebral malaria in adults a
Orogade AA, et al. (2009)
Malaria Journal 10, 267. description of 526 cases admit- Malaria at parturition in
Mehta KS, Halankar AR, Makwana PD, Torane PP, Satija PS & Shah VB ted to Ispat General Hospital in Nigeria: current status and
(2001) Severe acute renal failure in malaria. Journal of Postgraduate Rourkela, India. Annals of delivery outcome.
Medicine 47, 2426. Tropical Medicine and Infectious Diseases in
Melo GC, Reyes-Lecca RC, Vitor-Silva S, et al. (2010) Concur-rent Parasitology 101, 187193. Obstetrics and
helminthic infection protects schoolchildren with Plasmo-dium vivax Mishra SK, Panigrahi P, Mishra R Gynecology 2009,
from anemia. PLoS ONE 5, e11206. & Mohanty S (2007c) Predic- 473971.
Menendez C, Romagosa C, Ismail MR, et al. (2008) An autopsy study of tion of outcome in adults with Molyneux ME, Looareesuwan S,
maternal mortality in Mozambique: the contribution of infectious severe falciparum malaria: a new Menzies IS, et al. (1989a)
diseases. PLoS Medicine 5, e44. scoring system. Malaria Journal Reduced hepatic blood flow
6, 24. and intestinal malabsorption in
Mengistu G, Diro E & Kassu A (2006) Outcomes of pregnancy in severe
malaria wth emphasis on neurological manifestations in Gondar Mithwani S, Aarons L, Kokwaro severe falciparum malaria.
Hospital northwest Ethiopia. Ethiopian Medical Journal 44, 321330. GO, et al. (2004) Population American Journal of Tropical
pharmacokinetics of Med-icine and Hygiene 40,
Michon P, Cole-Tobian JL, Dabod E, et al. (2007) The risk of malarial
artemether and 470476.
infections and disease in Papua New Guinean chil-dren. American
dihydroartemisinin fol-lowing Molyneux ME, Taylor TE,
Journal of Tropical Medicine and Hygiene 76, 9971008.
single intramuscular dosing of Wirima JJ & Borgstein A
Mihaly GW, Ching MS, Klejn MB, Paull J & Smallwood RA (1987)
artemether in African children (1989b) Clinical features and
Differences in the binding of quinine and quinidine to plasma
with severe falciparum prognostic indicators in
proteins. British Journal of Clinical Pharmacology 24, 769774.
malaria. British Journal of paediatric cere-bral malaria: a
Clinical Pharmacology 57, study of 131 comatose
Millan JM, San Millan JM, Munoz M, Navas E & Lopez-Velez R 146152. Malawian children.
(1993) CNS complications in acute malaria: MR findings.
Modiano D, Sawadogo A & Quarterly Journal of Medicine
American Journal of Neuroradiology 14, 493494. 71, 441459.
Pagnoni F (1995) Indicators of
Miller LH, Mason SJ, Clyde DF & McGinniss MH (1976) The life-threatening malaria. New Molyneux E, Walsh A, Phiri A &
resistance factor to Plasmodium vivax in blacks. The Duffy-blood- England Journal of Medicine Molyneux M (1998) Acute
group genotype. FyFy. New England Journal of Medicine 295, 302 333, 1011. bacterial meningitis in children
304. admitted to the Queen Eliza-
Miller KD, White NJ, Lott JA, Roberts JM & Greenwood BM (1989)Modiano D, Sirima BS, beth Central Hospital,
Biochemical evidence of muscle injury in African chil-dren with Sawadogo A, et al. (1998) Blantyre, Malawi in 1996-97.
severe malaria. Journal of Infectious Diseases 159, 139142. Severe malaria in Burkina Tropical Medicine and
Miller L, Baruch D, Marsh K & Doumbo O (2002) The patho-genic Faso: influence of age and International Health 3, 610
basis of malaria. Nature 415, 673679. transmission level on clinical 618.
Milner DA & Taylor TE (2006) The pathology of cerebral malaria: presentation. American Montgomery J, Milner DA, Tse
autopsy studies from Blantyre, Malawi (1996 2006). 11th Journal of Tropical Medicine MT, et al. (2006) Genetic
International Congress of Parasitology, 2006, 147154. and Hygiene 59, 539542. analy-sis of circulating and
Mohanty S, Mishra SK, Patnaik R, sequestered populations of
Milner D, Valim C, Luo R, et al. (2012a) Supraorbital post-mor-tem brainDutt AK, Pradhan S, Das B, Plasmodium falciparum in fatal
sampling for definitive quantitative confirmation of cerebral Patnai J, Mohanty AK, Lee SJ & pediatric malaria. Journal of
sequestration of Plasmodium falciparum parasites. Dondorp AM (2011) Brain Infectious Dis-eases 194, 115
Journal of Infectious Diseases 205, 16011606. swelling and mannitol therapy in 122.
Milner D, Vareta J, Valim C, et al. (2012b) Human cerebral malaria adult cerebral malaria: a ran- Montgomery J, Mphande
and Plasmodium falciparum genotypes in Malawi. domized trial. Clinical Infectious FA, Berriman M, et al.
Malaria Journal 11, 35. Diseases 53, 349355. (2007) Differential var
Mishra SK & Das BS (2008) Malaria and acute kidney injury. Mohammed I, Ibrahim UY, gene expression in the
Seminars in Nephrology 28, 395408. Mukhtar M, et al. (2011) Brain organs of patients dying
Mishra SK & Mahanta KC (2012) Peritoneal dialysis in patients with swelling and mannitol therapy in of falciparum malaria.
malaria and acute kidney injury. Peritoneal Dialysis International 32, adult cerebral malaria: a ran- Molecular Microbiology
656659. domized trial. Clinical Infectious 65, 959967.
Mishra SK, Dietz K, Mohanty S & Pati SS (2007a) Influence of acute Diseases 53, 349355. Moses WR (1945) Splenic
renal failure in patients with cerebral malaria - a hospi-tal-basedMojon M, Wallon M, Gravey A, rupture in therapeutic malaria.
Peaud PY, Sartre J & Peyron F South-ern Medical Journal 38,
study from India. Tropical Doctor 37, 103104.
(1994) Intravascular haemolysis 745.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
120 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
reduce mortality and severe
morbidity from malaria
among children on the
Kenyan coast. Tropical Medi-
malaria in Uganda: a
cine and International Health
Most H & Hayman JM (1946) Uncommon clinical manifesta-tions of vivax randomized clinical
1, 139146.
malaria. Journal of the American Medical Asso-ciation 130, 480485. trial. Malaria Journal 6,
138. Newbold C, Warn P, Black G, et
Moxon CA, Wassmer SC, Milner DA, et al. (2013) Loss of endothelial
Nanda NC, Rath P, Acharya J, al. (1997) Receptor-specific
protein C receptors links coagulation and inflam-mation to parasite adhesion and clinical disease in
sequestration in cerebral malaria in African children. Blood 122, 842 Mishra P & Mishra SK
Plasmodium falciparum.
851. (2011) Falciparum malaria
Ameri-can Journal of Tropical
Mpimbaza A, Ndeezi G, Staedke S, Rosenthal PJ & Byarugaba J (2008) in children-a brief report of Medicine and Hygiene 57,
Comparison of buccal midazolam with rectal diazepam in the treatment 305 patients from rourkela, 389398.
of prolonged seizures in Ugandan children: a randomized clinical trial. eastern India. Indian Journal Newton CR, Kirkham FJ,
Pediatrics 121, e58e64. of Pediatrics 78, 475477.
Winstanley PA, et al. (1991)
Mudenda SS, Kamocha S, Mswia R, et al. (2011) Feasibility of using a Intracra-nial pressure in
Nankabirwa J, Zurovac D,
World Health Organization-standard methodology for Sample Vital African children with cerebral
Njogu JN, et al. (2009)
Registration with Verbal Autopsy (SAVVY) to report leading causes of malaria. Lancet 337, 573576.
Malaria mis-diagnosis in
death in Zambia: results of a pilot in four provinces, 2010. Population Newton CR, Peshu N, Kendall
Ugandaimplications for
Health Metrics 9, 40. B, et al. (1994) Brain
policy change. Malaria
Muehlenbachs A, Fried M, Mcgready R, Harrington WE, Muta-bingwa TK, Journal 8, 66. swelling and ischaemia in
Nosten F & Duffy PE (2010) A novel histological grading scheme for Kenyans with cerebral
Navaratnam V, Mordi MN &
placental malaria applied in areas of high and low malaria transmission. malaria. Archives of Disease
Mansor SM (1997)
The Journal of Infectious Dis-eases 202, 16081616. in Childhood 70, 281287.
Simultaneous determination
Mujuzi G, Magambo B, Okech B & Egwang TG (2006) Pig-mented Newton CR, Chokwe T,
of artesunic acid and
monocytes are negative correlates of protection against severe and Schellenberg JA, et al.
dihydroartemisinin in blood
complicated malaria in Ugandan children. American Journal of Tropical (1997a) Coma scales for
plasma by high-performance
Medicine and Hygiene 74, 724729. children with severe
liquid chromatography for
falciparum malaria. Transac-
Mukim A, Shukla M, Patel J, et al. (2011) A phase III clinical trial of alpha, application in clinical
tions of the Royal Society of
beta-arteether injection 150 mg/ml in patients of P falciparum malaria. pharmacological studies. Tropical Medicine and
Journal of the Indian Medical Associ-ation 109, 597599. Journal of Chromatography Hygiene
Murphy SA, Mberu E, Muhia D, et al. (1997) The disposition of B 692, 157162. 91, 161165.
intramuscular artemether in children with cerebral malaria: a preliminary Navaratnam V, Mansor SM,
Newton CR, Crawley J,
study. Transactions of the Royal Society of Tropi-cal Medicine and Mordi MN, Akbar A & Sowumni A, et al. (1997b)
Hygiene 91, 331334. Abdullah MN (1998) Intracranial hypertension in
Murray CJ, Rosenfeld LC, Lim SS, et al. (2012) Global malaria mortality Comparative Africans with cerebral
between 1980 and 2010: a systematic analysis. Lancet 379, 413431. pharmacokinetic study of malaria. Archives of Disease
Mwaniki MK, Talbert AW, Mturi FN, et al. (2010) Congenital and oral and rectal formulations in Childhood 76, 219226.
neonatal malaria in a rural Kenyan district hospital: an eight-year of artesunic acid in healthy
Newton P, Keeratithakul D, Teja-
analysis. Malaria Journal 9, 313. volunteers.
Isavadharm P, Pukrittayaka-
Na-Bangchang K, Congpuong K, Hung LN, Molunto P & Kar-bwang J European Journal of
mee S, Kyle D & White N
(1998) Simple high-performance liquid chromato-graphic method with Clinical Pharmacology 54, (1999) Pharmacokinetics of
electrochemical detection for the simultaneous determination of 411414. Nayak KC,
Khatri MP, Gupta BK, et al. quinine and 3-hydroxyquinine
artesunate and dihydroartemisi-nin in biological fluids. Journal of in severe falciparum malaria
(2009) Spectrum of
Chromatography B 708, 201207. with acute renal failure.
vivax malaria in pregnancy
Transactions of the Royal
and its outcome: a hospital-
Nadjm B, Mtove G, Amos B, et al. (2013) Blood glucose as a predictor of based study. Journal of Society of Tropical Medicine
mortality in children admitted to the hospital with febrile illness in Vector Borne Diseases 46, and Hygiene 93, 6972.
Tanzania. American Journal of Tropical Medi-cine and Hygiene 89, 232 299302. Newton P, Suputtamongkol Y,
237. Nealon C, Dzeing A, Muller- Teja-Isavadharm P, et al.
Naik H, Murry DJ, Kirsch LE & Fleckenstein L (2005) Develop-ment and Romer U, et al. (2002) (2000) Antimalarial
validation of a high-performance liquid chromatog-raphy-mass Intramuscu-lar bioavailability bioavailability and disposition
spectroscopy assay for determination of artesunate and and clinical efficacy of of artesunate in acute
dihydroartemisinin in human plasma. Journal of Chroma-tography B 816, artesunate in gabonese falciparum malaria.
233242. children with severe malaria. Antimicrobial Agents and
Namutangula B, Ndeezi G, Byarugaba JS & Tumwine JK (2007) Antimicrobial Agents and Chemo-therapy 44, 972977.
Mannitol as adjunct therapy for childhood cerebral Chemotherapy 46, 3933 Newton PN, Chierakul W,
3939. Ruangveerayuth R, et al.
Nevill CG, Some ES, (2001a) A comparison of
artesunate alone with
Mungala VO, et al. (1996)
combined artesunate and
Insecticide-treated bednets
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 121
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Shako D & Mashako M (1983)
Hemiplegia in pernicious
attacks of Plasmodium
falciparum in children. Annales
Ochola LB, Siddondo BR, de Pediatrie 30, 294296.
quinine in the parenteral treatment of acute falciparum malaria. Ocholla H, et al. (2011)
OMeara WP, Bejon P, Mwangi
Transactions of the Royal Society of Tropical Medi-cine and Hygiene Specific receptor usage in
TW, et al. (2008) Effect of a fall
95, 519523. Plasmodium falciparum
in malaria transmission on
Newton PN, Chotivanich K, Chierakul W, et al. (2001b) A com-parison of cytoadherence is associated morbidity and mortality in
the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte with disease outcome. Kilifi, Kenya. Lancet 372,
surface antigen-positive and -negative ery-throcytes. Blood 98, 450457. PLoS ONE 6, e14741. 15551562.
Newton PN, Angus BJ, Chierakul W, et al. (2003) Randomized comparisonODempsey TJ, McArdle TF, Opoka RO, Bangirana P, Boivin
of artesunate and quinine in the treatment of severe falciparum malaria. Laurence BE, Lamont AC, Todd MJ, John CC & Byarugaba J
Clinical Infectious Diseases 37, 716. JE & Greenwood BM (1993)
(2009) Seizure activity and
Newton CR, Valim C, Krishna S, et al. (2005a) The prognostic value of Overlap in the clinical features neurological sequelae in
measures of acid/base balance in pediatric falciparum malaria, compared of pneumonia and malaria in Ugandan children who have
with other clinical and laboratory parame-ters. Clinical Infectious African children. Transactions survived an episode of
Diseases 41, 948957. of the Royal Society of Tropical cerebral malaria.
Medicine and Hygiene 87, 662 African Health Sciences 9, 75
Newton PN, Chaulet JF, Brockman A, et al. (2005b) Pharmaco-kinetics of
665. 81.
oral doxycycline during combination treatment of severe falciparum
malaria. Antimicrobial Agents and Chemo-therapy 49, 16221625. Orimadegun AE, Fawole O,
ODonnell A, Premawardhena A, Okereke JO, Akinbami FO &
Newton PN, Stepniewska K, Dondorp A, et al. (2013) Prognos-tic
indicators in adults hospitalized with falciparum malaria in Western Arambepola M, et al. (2009) Sode-inde O (2007) Increasing
Thailand. Malaria Journal 12, 229. Interaction of malaria with a burden of childhood severe
common form of severe malaria in a Nigerian tertiary
Ng OT, Ooi EE, Lee CC, et al. (2008) Naturally acquired human
thalasse-mia in an Asian hospital: implication for
Plasmodium knowlesi infection, Singapore. Emerging Infectious
population. Proceedings of the control. Journal of Tropical
Diseases 14, 814816.
National Academy of Sciences Pediatrics 53, 185189.
Ngoungou EB, Dulac O, Poudiougou B, et al. (2006a) Epilepsy as a
of the United States of America Orogade AA, Falade CO, Okafor
consequence of cerebral malaria in area in which malaria is endemic in
106, 1871618721. HU, et al. (2008) Clinical and
Mali, West Africa. Epilepsia 47, 873879.
laboratory features of
Ngoungou EB, Koko J, Druet-Cabanac M, et al. (2006b) Cere-bral malaria
Oduro AR, Koram KA, Rogers congenital malaria in Nigeria.
and sequelar epilepsy: first matched case-control study in Gabon.
W, et al. (2007) Severe Journal of Pediatric Infectious
Epilepsia 47, 21472153.
falcipa-rum malaria in young Diseases 3, 181187.
Nguansangiam S, Day NP, Hien TT, et al. (2007) A quantitative children of the Kassena- Osime U, Lawrie J & Lawrie H
ultrastructural study of renal pathology in fatal Plasmodium falciparum Nankana dis-trict of northern
(1976) Post-operative deep
malaria. Tropical Medicine and International Health 12, 10371050. Ghana. Malaria Journal 6, 96. vein thrombosis incidence in
Nguyen PH, Day N, Pram TD, Ferguson DJ & White NJ (1995) Ogetii GN, Akech S, Jemutai J, et Nigerians. Nigerian Medical
Intraleucocytic malaria pigment and prognosis in severe malaria. al. (2010) Hypoglycaemia in Journal 6, 2628.
Transactions of the Royal Society of Tropical Medi-cine and Hygiene 89, severe malaria, clinical
Otieno RO, Ouma C,
200204. associations and relationship to Ongecha JM, et al. (2006)
Nguyen TH, Day NP, Ly VC, et al. (1996) Post-malaria neuro-logical quinine dosage. BMC Infectious Increased severe anemia in
syndrome. Lancet 348, 917921. Diseases 10, 334. HIV-1-exposed and HIV-1-
Nontprasert A, Pukrittayakamee S, Kyle DE, Vanijanonta S & White NJ Ogutu BR, Newton CR, Crawley positive infants and
(1996) Antimalarial activity and interactions between quinine, J, et al. (2002) Pharmacokinet- children during acute
dihydroquinine and 3-hydroxyquinine against Plasmodium falciparum in ics and anticonvulsant effects of malaria. AIDS 20, 275
vitro. Transactions of the Royal Society of Tropical Medicine and diazepam in children with 280.
Hygiene 90, 553555. severe falciparum malaria and
Nosten F, Mcgready R, Simpson JA, et al. (1999) Effects of Plas-modium convulsions. British Journal of Pain A, Ferguson DJ, Kai O, et al.
vivax malaria in pregnancy. Lancet 354, 546549. Clinical Pharmacology 53, 49 (2001) Platelet-mediated
Nurleila S, Syafruddin D, Elyazar IR & Baird JK (2012) Serious and fatal 57. clumping of Plasmodium
illness associated with falciparum and vivax malaria among patients Okiro EA, Al-Taiar A, Reyburn H, falciparum-infected
admitted to hospital at West Sumba in eastern Indonesia. American Idro R, Berkley JA & Snow erythrocytes is a common
Journal of Tropical Medicine and Hygiene 87, 4149. RW (2009) Age patterns of adhesive phenotype and is
severe paediatric malaria and associated with severe malaria.
Obonyo CO, Vulule J, Akhwale WS & Grobbee DE (2007) In-hospital their relationship to Proceedings of the National
morbidity and mortality due to severe malarial ane-mia in western Plasmodium falciparum Academy of Sciences of the
Kenya. American Journal of Tropical Medicine and Hygiene 77, 2328. transmission intensity. United States of America 98,
Malaria Journal 8, 4. 18051810.
Omanga U, Ntihinyurwa M,
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
122 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
punc-ture in bacterial
meningitis necessary?
Harefuah 124(5468), 599.
Phillips RE, Looareesuwan S,
Pittet D, Hugonnet S, Harbarth
Parakh A, Agarwal N, Aggarwal A & Aneja A (2009) Plasmo-dium vivax Warrell DA, et al. (1986a)
malaria in children: uncommon manifestations. S, et al. (2000) Effectiveness
The importance of anaemia in
of a hospital-wide programme
Annals of Tropical Paediatrics 29, 253256. cerebral and uncomplicated
falcipa-rum malaria: role of to improve compliance with
Pareek A, Nandy A, Kochar D, Patel KH, Mishra SK & Mathur PC (2006)
complications, hand hygiene. Infection
Efficacy and safety of beta-arteether and alpha/ beta-arteether for
dyserythropoiesis and iron Control Programme. Lancet
treatment of acute Plasmodium falciparum malaria. American Journal of
sequestration. Quarterly 356, 1307 1312.
Tropical Medicine and Hygiene
75, 139142. Journal of Medicine 58, 305
323. Pittet D, Allegranzi B & Boyce J
Pasvol G, Newton CR, Winstanley PA, et al. (1991) Quinine treatment of (2009) The World Health
severe falciparum malaria in African children: a randomized Phillips RE, Looareesuwan S,
White NJ, Silamut K, Organization Guidelines on
comparison of three regimens. American Journal of Tropical Medicine Hand Hygiene in Health Care
and Hygiene 45, 702713. Kietinun S & Warrell DA
(1986b) Quinine and their consensus
Patankar TF, Karnad DR, Shetty PG, Desai AP & Prasad SR (2002) Adult recommendations. Infection
pharmacokinetics and toxicity
cerebral malaria: prognostic importance of imag-ing findings and Control and Hos-pital
in pregnant and lactating
correlation with postmortem findings. Radiol-ogy 224, 811816. Epidemiology 30, 611622.
women with falciparum
Patel CC (1971) Acute febrile encephalopathy in Ugandan chil-dren. malaria. Piyaphanee W, Issarachaikul R,
African Journal of Medicine and Medical Sciences 2, 127134. Soontarach P & Silachamroon
British Journal of Clinical
Patel MP, Kute VB, Gumber MR, et al. (2012) An unusual case of Pharmacology 21, 677683. U (2007) Concurrent
Plasmodium vivax malaria monoinfection associated with crescentic Phiri HT, Bridges DJ, Glover salmonella bacteremia in P.
glomerulonephritis: a need for vigilance. Parasitol-ogy Research 112, SJ, et al. (2011) Elevated vivax infec-tiona report of 2
427430. plasma cases at the Hospital for
Patnaik JK, Das BS, Mishra SK, Mohanty S, Satpathy SK & Mohanty D von Willebrand factor and Tropical Diseases, Thailand.
(1994) Vascular clogging, mononuclear cell mar-gination, and enhanced propeptide levels in The South East Asian Journal
vascular permeability in the pathogen-esis of human cerebral malaria. Malawian chil-dren with of Tropical Medicine and
American Journal of Tropical Medicine and Hygiene 51, 642647. malaria. PLoS ONE 6, Public Health 38, 616618.
e25626. Plum F & Posner JB (1972) The
Patnaik P, Jere CS, Miller WC, et al. (2005) Effects of HIV-1 se-rostatus,
HIV-1 RNA concentration, and CD4 cell count on the incidence of Phu NH, Hien TT, Mai NT, et diagnosis of stupor and coma.
malaria infection in a cohort of adults in rural Malawi. Journal of al. (2002) Hemofiltration and Contemporary Neurology
Infectious Diseases 192, 984991. peritoneal dialysis in Series 10, 1286.
infection-associated acute Poespoprodjo JR, Fobia W,
Pedro R, Akech S, Fegan G & Maitland K (2010) Changing trends in
renal failure in Vietnam. Kenangalem E, et al. (2008)
blood transfusion in children and neonates admitted in Kilifi District
New England Journal of Adverse pregnancy outcomes
Hospital, Kenya. Malaria Journal 9, 307.
Medicine 347, 895902. in an area where multidrug-
Perel P, Roberts I & Pearson M (2007) Colloids versus crystal-loids for
Phu NH, Tuan PQ, Day N, et al. resistant Plas-modium vivax
fluid resuscitation in critically ill patients. Cochrane Database of
(2010) Randomized and Plasmodium falciparum
Systematic Reviews 4, CD000567.
controlled trial of artesunate infections are endemic. Clinical
Petithory JC, Lebeau G, Galeazzi G & Chauty A (1983) Hypo-calcemia in or artemether in Vietnamese Infectious Diseases 46, 1374
malaria. Study of correlations with other parame-ters. Bulletin de la adults with severe falciparum 1381.
Societe de Pathologie Exotique et de ses Filiales 76, 455462. malaria. Malaria Journal 9, Poespoprodjo JR, Fobia W,
Pfeiffer K, Some F, Muller O, et al. (2008) Clinical diagnosis of malaria and 97. Kenangalem E, et al. (2009)
the risk of chloroquine self-medication in rural health centres in Burkina Phyo AP, Nkhoma S, Vivax malaria: a major cause
Faso. Tropical Medicine and Interna-tional Health 13, 418426. Stepniewska K, et al. (2012) of morbidity in early infancy.
Pham-Hung G, Truffert A, Delvallee G, Michel G, Laporte JP & Duval G Emergence of artemisinin- Clinical Infectious Diseases
(1990) Cerebral infarction in pernicious malaria. Diagnostic value of resistant malaria on the 48, 17041712.
computed tomography. Annales Francaises dAnesthesie et de western border of Thai-land: Poespoprodjo JR, Hasanuddin
Reanimation 9, 185187. a longitudinal study. Lancet A, Fobia W, et al. (2010)
Phillips RE & Warrell DA (1986) The pathophysiology of severe falciparum 379, 19601966. Severe congenital malaria
malaria. Parasitology Today 2, 271282. Pineros~-Jimenez JG, Arboleda acquired in utero. American
Phillips RE, Warrell DA, White NJ, Looareesuwan S & Karbw-ang J M, Jaramillo JC & Blair S Journal of Tropical Medicine
(1985) Intravenous quinidine for the treatment of severe falciparum (2008) [Report of five cases and Hygiene 82, 563565.
malaria. Clinical and pharmacokinetic studies. of severe neonatal Poespoprodjo JR, Fobia W,
New England Journal of Medicine 312, 12731278. Plasmodium vivax malaria in Kenangalem E, et al. (2011)
Uraba, Colombia]. Highly effective therapy for
Biomedica: Revista Del maternal malaria associated
Instituto Nacional De Salud with a lower risk of vertical
28, 471479. transmission. Journal of
Pinhas-Hamiel O, Paret G & Infectious Diseases 204,
Barzilay Z (1993) Is lumbar 16131619.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 123
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Wanwimolruk S,
Stepniewska K, et al. (2003)
Quinine pharmacokinetic-
pharmacodynamic relation-
falciparum malaria. The
ships in uncomplicated
Pongponratn E, Riganti M, Punpoowong B & Aikawa M (1991) South East Asian Journal of
Tropical Medicine and falciparum malaria.
Microvascular sequestration of parasitized erythrocytes in human
Public Health 36, 1359 Antimicrobial Agents and
falciparum malaria: a pathological study. American Journal of Tropical
1370. Chemotherapy 47, 3458
Medicine and Hygiene 44, 168175.
Pronovost P, Berenholtz S, 3463.
Pongponratn E, Turner GD, Day NP, et al. (2003) An ultrastruc-tural study
Punyagupta S, Srichaikul T,
of the brain in fatal Plasmodium falciparum malaria. American Journal of Dorman T, Lipsett PA,
Simmonds T & Haraden C Nitiyanant P & Petchclai B
Tropical Medicine and Hygiene
(2003) Improving (1974) Acute pulmonary
69, 345359.
communication in the ICU insufficiency in falciparum
Ponsford M, Medana I, Prapansilp P, et al. (2012) Sequestration and using daily goals. Journal of malaria: summary of 12 cases
microvascular congestion are associated with coma in human cerebral Critical Care 18, 7175. with evidence of disseminated
malaria. Journal of Infectious Diseases 205, 663671. intravascular coagu-lation.
Pronovost P, Needham D,
Berenholtz S, et al. American Journal of Tropical
Poschl B, Waneesorn J, Thekisoe O, Chutipongvivate S & Kar-anis P (2006) An intervention to Medicine and Hygiene
(2010) Comparative diagnosis of malaria infections by microscopy, decrease catheter-related 23, 551559.
nested PCR, and LAMP in northern Thailand. bloodstream infec-tions Pussard E, Barennes H, Daouda
American Journal of Tropical Medicine and Hygiene 83, 56 60. in the ICU. New England H, et al. (1999) Quinine
Journal of Medicine 355, disposition in globally
Potchen MJ, Birbeck GL, Demarco JK, et al. (2010) Neuroimag-ing 27252732. malnourished children with
findings in children with retinopathy-confirmed cerebral malaria. cerebral malaria. Clinical
European Journal of Radiology 74, 262268. Pukrittayakamee S, White NJ, Pharmacology and
Potchen MJ, Kampondeni SD, Seydel KB, et al. (2012) Acute brain MRI Davis TM, et al. (1992) Therapeutics 65, 500510.
findings in 120 Malawian children with cerebral malaria: new insights Hepatic blood flow and Pussard E, Straczek C, Kabore
into an ancient disease. American Jour-nal of Neuroradiology 33, 1740 metabolism in severe I, et al. (2004) Dose-
1746. falciparum malaria: clearance dependent resorption of
Praba-Egge AD, Montenegro S, Cogswell FB, Hopper T & James MA of intravenously administered quinine after intrarectal
(2002) Cytokine responses during acute simian galactose. Clinical Sci-ence administration to chil-dren
Plasmodium cynomolgi and Plasmodium knowlesi infections. American 82, 6370. with moderate Plasmodium
Journal of Tropical Medicine and Hygiene 67, 586 596. falciparum malaria. Antimi-
Pukrittayakamee S, crobial Agents and
Prakash MV & Stein G (1990) Malaria presenting as atypical depression. Supanaranond W, Chemotherapy 48, 4422
The British Journal of Psychiatry 156, 594595. Looareesuwan S, Vani- 4426.
Prakash J, Singh AK, Kumar NS & Saxena RK (2003) Acute renal janonta S & White NJ Putaporntip C, Hongsrimuang T,
failure in Plasmodium vivax malaria. Journal of the Association of (1994) Quinine in severe Seethamchai S, et al. (2009)
Physicians of India 51, 265267. falciparum malaria: Differential prevalence of
Prendki V, Elziere C, Durand R, et al. (2008) Post-malaria neuro-logical evidence of declining Plasmodium infections and
syndrometwo cases in patients of African origin. Ameri-can Journal of efficacy in Thailand. cryptic Plasmodium knowlesi
Tropical Medicine and Hygiene 78, 699701. Transac-tions of the Royal malaria in humans in
Society of Tropical Thailand. Journal of Infectious
Price R, Van Vugt M, Phaipun L, et al. (1999) Adverse effects in patients
Medicine and Hygiene Diseases 199, 11431150.
with acute falciparum malaria treated with artemisi-nin derivatives.
American Journal of Tropical Medicine and Hygiene 60, 547555. 88, 324327. Putensen C, Theuerkauf N,
Zinserling J, Wrigge H &
Price RN, Simpson JA, Nosten F, et al. (2001) Factors contribut-ing to Pukrittayakamee S,
Pelosi P (2009) Meta-
anemia after uncomplicated falciparum malaria. Ameri-can Journal of Looareesuwan S,
Keeratithakul D, et al. (1997) analysis: ventilation strategies
Tropical Medicine and Hygiene 65, 614622.
A study of the factors and outcomes of the acute
Price RN, Tjitra E, Guerra CA, Yeung S, White NJ & Anstey NM (2007) respiratory distress syndrome
Vivax malaria: neglected and not benign. Ameri-can Journal of Tropical affecting the metabolic
clearance of quinine in and acute lung injury.
Medicine and Hygiene 77, 7987.
malaria. European Journal of Annals of Internal
Price RN, Douglas NM & Anstey NM (2009) New develop-ments in Medicine 151, 566576.
Plasmodium vivax malaria: severe disease and the rise of chloroquine Clinical Pharma-cology 52,
487493. Raghunandan J, Rajeshwari
resistance. Current Opinion in Infectious Diseases 22, 430435. K, Dubey AP & Singh T
Price R, Douglas NM, Anstey NM & von Seidlein L (2011) Plasmodium (2012)
vivax treatments: what are we looking for? Cur-rent Opinion Infectious Pukrittayakamee S,
Peripheral gangrene in an 18-
Diseases 24, 578585. Pitisuttithum P, Zhang H,
month-old boy with
Jantra A, Wan-wimolruk S
Prommano O, Chaisri U, Turner GD, et al. (2005) A quantita-tive Plasmodium vivax malaria.
ultrastructural study of the liver and the spleen in fatal & White NJ (2002) Effects
Paediatrics and International
of cigarette smoking on
Child Health 32, 164166.
quinine pharmacokinetics in
malaria. European Journal Rajahram GS, Barber BE,
William T, Menon J, Anstey
of Clinical Pharmacology
NM & Yeo TW (2012)
58, 315319. Deaths due to Plasmodium
Pukrittayakamee S, knowlesi malaria
124 2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Proceedings of the Royal
Society of London. Series B
83, 159173.
Ru YX, Mao BY, Zhang FK, et al.
dren under the age of 5 years.
(2009) Invasion of erythro-
in Sabah, Malaysia: association with reporting as Plasmodium malariae Tropical Medicine and Interna-
tional Health 13, 771783. blasts by Plasmodium vivax: a
and delayed parenteral artesunate. Malaria Journal 11, 284.
new mechanism contributing to
Rajaratnam JK, Marcus JR, Flaxman AD, et al. (2010) Neona-tal, Rodriguez-Morales AJ, Benitez
malarial anemia. Ultrastructural
postneonatal, childhood, and under-5 mortality for 187 countries, 1970- JA & Arria M (2008) Malaria Pathology 33, 236242.
2010: a systematic analysis of progress towards Millennium mortality in Venezuela: focus
on deaths due to Plasmo-dium Rudolf G & Ramsay J (1927)
Development Goal 4. Lancet 375, 1988 2008.
vivax in children. Journal of Enumeration of parasites in
thera-peutic malaria. Journal of
Ramutton T, Hendriksen IC, Mwanga-Amumpaire J, et al. (2012) Sequence Tropical Pediatrics 54, 94 Tropical Medicine and Hygiene
101.
variation does not confound the measurement of plasma PfHRP2 30, 18.
concentration in African children present-ing with severe malaria. Malaria
Journal 11, 276. Rogerson SJ, Pollina E, Getachew
Runsewe-Abiodun IT,
Ranque S, Poudiougou B, Traore A, et al. (2008) Life-threaten-ing malaria A, Tadesse E, Lema VM & Ogunfowora OB & Fetuga BM
in African children: a prospective study in a me-soendemic urban Molyneux ME (2003) Placental (2006) Neonatal malaria in
setting. Pediatric Infectious Disease Journal monocyte infiltrates in response
Nigeriaa 2 year review. BMC
27, 130135. to Plasmodium falciparum
Pediatrics 6, 19.
malaria infection and their
Ratcliff A, Siswantoro H, Kenangalem E, et al. (2007) Therapeu-tic Rupani AB & Amarapurkar AD
association with adverse
response of multidrug-resistant Plasmodium falciparum and P. vivax to (2009) Hepatic changes in fatal
pregnancy outcomes. American
chloroquine and sulfadoxine-pyrimethamine in southern Papua, malaria: an emerging problem.
Jour-nal of Tropical Medicine
Indonesia. Transactions of the Royal Society of Tropical Medicine and Annals of Tropical Medicine
and Hygiene 68, 115119.
Hygiene 101, 351359. and Parasitology 103, 119127.
Rogerson SJ, Hviid L, Duffy PE,
Reader TW, Flin R, Mearns K & Cuthbertson BH (2009) Devel-oping a Sabchareon A, Attanath P,
Leke RF & Taylor DW (2007)
team performance framework for the intensive care unit. Critical Care Chanthavanich P, et al. (1998)
Malaria in pregnancy:
Medicine 37, 17871793. Com-parative clinical trial of
pathogenesis and immunity.
Recht J, Ashley EA & White NJ (2013). The Safety of 8-Amino-quinoline Lancet Infectious Diseases 7, artesunate suppositories and
Antimalarials. World Health Organization, Geneva. 105117. oral ar-tesunate in combination
Redd SC, Bloland PB, Kazembe PN, Patrick E, Tembenu R & CampbellRolling T, Schmiedel S, with mefloquine in the
CC (1992) Usefulness of clinical case-definitions in guiding therapy for Wichmann D, Wittkopf D, treatment of children with
African children with malaria or pneumo-nia. Lance 340, 11401143. acute falciparum malaria.
Burchard GD & Cramer JP
Reid HA & Nkrumah FK (1972) Fibrin-degradation products in cerebral (2012) Post-treatment American Journal of Tropical
malaria. Lancet 1, 218221. Medicine and Hygiene 58, 11
haemolysis in severe imported
Rey M, Nouhouayi A & Mar ID (1966) Clinical manifesta-tions of 16.
malaria after intravenous
Plasmodium falciparum malaria in African Negro children (according to artesunate: case report of three Safeukui I, Correas JM, Brousse
experiences in a Dakar hospital). Bul-letin de la Societe de Pathologie patients with V, et al. (2008) Retention of
Exotique et de ses Filiales hyperparasitaemia. Malaria Plasmodium falciparum ring-
59, 683704. Journal 11, 169. infected erythrocytes in the
slow, open microcirculation of
Reyburn H, Mbatia R, Drakeley C, et al. (2004) Overdiagnosis of malaria Rosanas-Urgell A, Lin E,
the human spleen. Blood 112,
in patients with severe febrile illness in Tanzania: a prospective study. Manning L, et al. (2012)
2520 2528.
British Medical Journal 329, 1212. Reduced risk of Plasmodium
Saharan S, Kohli U, Lodha
Reyburn H, Mbatia R, Drakeley C, et al. (2005) Association of transmission vivax malaria in Papua New
R, Sharma A & Bagga A
intensity and age with clinical manifestations and case fatality of severe Guinean children with South
(2008) Thrombotic
Plasmodium falciparum malaria. Journal of The American Medical East Asian ovalocytosis in two
microangiopathy
Association 293, 14611470. cohorts and a case-control
associated with
Riddle MS, Jackson JL, Sanders JW & Blazes DL (2002) Exchange study. PLoS Medicine 9,
Plasmodium vivax malaria.
transfusion as an adjunct therapy in severe Plasmo-dium falciparum e1001305.
Pediatric Nephrology 24,
malaria: a meta-analysis. Clinical Infectious Diseases 34, 11921198. Rosenthal VD, Maki DG, 623624.
Rijken MJ, McGready R, Boel ME, et al. (2012a) Malaria in pregnancy Salomao R, et al. (2006)
Salako LA & Sowunmi A (1992)
in the Asia-Pacific region. Lancet Infectious Dis-eases 12, 7588. Device-associ-ated nosocomial
Disposition of quinine in
infections in 55 intensive care
Rijken MJ, Papageorghiou AT, Thiptharakun S, et al. (2012b) Ultrasound plasma, red blood cells and
units of 8 devel-oping
evidence of early fetal growth restriction after maternal malaria saliva after oral and
countries. Annals of Internal
infection. PLoS ONE 7, e31411. intravenous administration to
Medicine 145, 582591.
Roca-Feltrer A, Carneiro I & Armstrong Schellenberg JR (2008) Estimates healthy adult Africans.
of the burden of malaria morbidity in Africa in chil- Ross R & Thomson D (1910)
European Journal of Clinical
Some enumerative studies
Pharmacology 42, 171174.
on malaria fever.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 125
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
(2004) A large focus of natu-
rally acquired Plasmodium
knowlesi infections in human
beings. Lancet 363, 1017
Silamut K, White NJ, 1024.
Salako LA, Sowunmi A & Akinbami FO (1989) Pharmacokinet-ics of Looareesuwan S & Warrell
quinine in African children suffering from kwashiorkor. DA (1985) Binding of quinine Sinha A, Singh G, Bhat AS, et al.
to plasma proteins in (2012) Thrombotic microangi-
British Journal of Clinical Pharmacology 28, 197201. Saralamba
falciparum malaria. opathy and acute kidney injury
S, Pan-Ngum W, Maude RJ, et al. (2011) Intrahost
American Journal of Tropical following vivax malaria. Clini-
modeling of artemisinin resistance in Plasmodium falciparum. cal and Experimental
Medicine and Hygiene 34, 681
Proceedings of the National Academy of Sciences of the Uni-ted 686. Nephrology 17, 6672.
States of America 108, 397402.
Sirivichayakul C, Sabchareon A,
Sarkar S & Bhattacharya P (2008) Cerebral malaria caused by
Silamut K, Molunto P, Ho M, Pengsaa K, et al. (2007) Com-
Plasmodium vivax in adult subjects. Indian Journal of Critical Care Davis TM & White NJ (1991) parative study of the
Medicine 12, 204205. effectiveness and
Alpha 1-acid glycoprotein
Sasi P, Burns SP, Waruiru C, et al. (2007) Metabolic acidosis and other (orosomucoid) and plasma pharmacokinetics of two
determinants of hemoglobin-oxygen dissociation in severe childhood protein binding of quinine in rectal artesunate/oral
Plasmodium falciparum malaria. American Journal of Tropical falciparum malaria. British mefloquine combination
Medicine and Hygiene 77, 256260. Journal of Clinical regimens for the treatment of
Schellenberg D, Schellenberg J, Mushi A, et al. (2003) The silent burden Pharmacology 32, 311315. uncomplicated childhood
of anaemia in Tanzanian children: a community-based study. BulletinSilamut K, Phu NH, Whitty C, et falciparum malaria. Annals of
of the World Health Organization 81, 581 590. al. (1999) A quantitative analy- Tropical Paediatrics 27, 17
sis of the microvascular 24.
Schmutzhard E & Gerstenbrand F (1984) Cerebral malaria in Tanzania. sequestration of malaria Sitprija V (1988)
Its epidemiology, clinical symptoms and neurologi-cal long term parasites in the human brain. Nephropathy in falciparum
sequelae in the light of 66 cases. Transactions of the Royal Society of American Journal of Pathology malaria. Kidney
Tropical Medicine and Hygiene 78, 351 353. 155, 395410. International 34, 867877.
Sim JE, Choi YC & Kim WJ Slutsker L, Taylor TE, Wirima JJ
Schweickert WD, Pohlman MC, Pohlman AS, et al. (2009) Early (2010) Facial diplegia in & Steketee RW (1994) In-hos-
physical and occupational therapy in mechanically ventilated, Plasmo-dium vivax malaria. pital morbidity and mortality
critically ill patients: a randomised controlled trial. Lancet 373, 1874 Journal of Clinical Neurology due to malaria-associated
1882. 6, 102 103. severe anaemia in two areas of
Scott JA, Berkley JA, Mwangi I, et al. (2011) Relation between Malawi with different patterns
falciparum malaria and bacteraemia in Kenyan children: a population- Simonsson US, Jansson B, Hai of malaria infection.
based, case-control study and a longitudinal study. Lancet 378, 1316 TN, Huong DX, Tybring G & Transactions of the Royal
1323. Ashton M (2003) Artemisinin Society of Tropi-cal Medicine
Senanayake N (1987) Delayed cerebellar ataxia: a new complica-tion of autoinduction is caused by and Hygiene 88, 548551.
falciparum malaria? British Medical Journal 294, 12531254. involvement of cytochrome Smith T, Schellenberg JA &
P450 2B6 but not 2C9. Hayes R (1994) Attributable
Clinical Pharmacology and frac-tion estimates and case
Sermwittayawong N, Singh B, Nishibuchi M, Sawangjaroen N &
Therapeutics 74, 3243. definitions for malaria in
Vuddhakul V (2012) Human Plasmodium knowlesi infec-tion in
Ranong province, southwestern border of Thailand. Simpson JA, Silamut K, endemic areas. Statistics in
Chotivanich K, Pukrittayakamee Medicine 13, 23452358.
Malaria Journal 11, 36.
S & White NJ (1999) Red cell Snounou G & White NJ (2004)
Seydel K, Kampondeni SD, Potchen MJ, Birbeck GL, Molyneux M &
selectivity in malaria: a study of The co-existence of Plasmo-
Taylor T (2011) Clinical correlates of magnetic reso-nance imaging in
multiple-infected erythrocytes. dium: sidelights from
pediatric cerebral malaria. American Society of Tropical Medicine and
Transactions of the Royal Soci- falciparum and vivax
Hygiene, 60th Annual Meeting. Seydel KB, Fox LL, Glover SJ, et al.
ety of Tropical Medicine and malaria in Thai-land. Trends
(2012) Plasma concentra-tions of parasite histidine-rich protein 2 Hygiene 93, 165168. in Parasitology 20, 333339.
distinguish between retinopathy-positive and retinopathy-negative
Simpson JA, Agbenyega T, Barnes Snow RW & Marsh K (1998)
cerebral malaria
KI, et al. (2006) Population New insights into the
in Malawian children. Journal of Infectious Diseases 206, 309 pharmacokinetics of artesunate epidemiol-ogy of malaria
318. relevant for disease control.
and dihydroartemisinin follow-
Shann F, Stace J & Edstein M (1985) Pharmacokinetics of qui-nine in ing intra-rectal dosing of British Medical Bulletin 54,
children. Journal of Pediatrics 106, 506510. artesunate in malaria patients. 293309.
Sharma J, Bharadawa K, Shah K & Dave S (1993) Plasmodium vivax PLoS Medicine 3, e444.
malaria presenting as hemolyticuremic syndrome.
Singh B & Daneshvar C (2013)
Indian Pediatrics 30, 369371. Human infections and detection
Silamut K & White NJ (1993) Relation of the stage of parasite of Plasmodium knowlesi.
development in the peripheral blood to prognosis in severe fal- Clinical Microbiology Reviews
ciparum malaria. Transactions of the Royal Society of Tropi-cal 26, 165184.
Medicine and Hygiene 87, 436443. Singh B, Lee K, Matusop A, et al.
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
126 The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.
Tropical Medicine and International Health volume 19 suppl 1 pp 7131 september 2014
Ltd., Amsterdam.
Tan LK, Yacoub S, Scott S,
Bhagani S & Jacobs M (2008)
Acute lung injury and other
Stoppacher R & Adams SP (2003)
serious complications of
Snow RW, Armstrong JR, Forster D, et al. (1992) Childhood deaths in Malaria deaths in the United
Plasmodium vivax malaria.
Africa: uses and limitations of verbal autopsies. Lan-cet 340, 351 States: case report and review
Lancet Infectious Diseases 8,
355. of deaths, 1979-1998. Journal
449454.
Snow RW, Bastos De Azevedo I, Lowe BS, et al. (1994) Severe of Forensic Sciences 48, 404
408. Tan KR, Wiegand RE & Arguin
childhood malaria in two areas of markedly different falciparum
PM (2013) Exchange
transmission in East Africa. Acta Tropica 57, 289 300. Sulistyaningsih E, Fitri L, Loscher transfu-sion for severe
T & Berens-Riha N (2010) malaria: evidence base and
Snow RW, Guerra CA, Noor AM, Myint HY & Hay SI (2005) The Diagnostic difficulties with literature review.
global distribution of clinical episodes of Plasmodium fal-ciparum Plasmodium knowlesi Clinical Infectious Diseases 57,
malaria. Nature 434, 214217. infections in humans. Emerging 923928.
Infectious Diseases 16, 1033
Solomon T, Felix JM, Samuel M, et al. (1994) Hypoglycaemia in Tantipong H, Morkchareonpong
1034.
paediatric admissions in Mozambique. Lancet 343, 149150. C, Jaiyindee S & Thamlikitkul
Song HH, O SO, Kim SH, et al. (2003) Clinical features of Plas-modium Sumawinata IW, Bernadeta V (2008) Randomized
Leksana B, et al. (2003) Very
vivax malaria. Korean Journal of Internal Medicine controlled trial and meta-
high risk of therapeutic failure
18, 220224. with chloroquine for analysis of oral
Song JY, Park CW, Jo YM, et al. (2007) Two cases of Plasmo-dium uncomplicated decontamination with 2%
vivax Malaria with the clinical picture resembling toxic shock. Plasmodium falciparum and chlorhexidine solution for the
American Journal of Tropical Medicine and Hygiene P. vivax malaria in Indonesian prevention of ventilator-
77, 609611. Papua. American Journal of associated pneumonia.
Sotunmbi PT, Idowu AT, Akang EE & Akenova YA (2006) Prevalence Tropical Medicine and Infection Con-trol and
of venous thromboembolism at post-mortem in an African Hygiene Hospital Epidemiology 29,
population: a cause for concern. African Journal of Medicine and 68, 416420. 131136.
Medical Sciences 35, 345348. Sur D, von Seidlein L, Manna B, et Tanwar GS, Khatri PC, Sengar
South East Asian Quinine Artesunate Malaria Trial (SEAQUA-MAT) al. (2006) The malaria and GS, et al. (2011) Clinical
profiles of 13 children with
Group (2005) Artesunate versus quinine for treatment of severe typhoid fever burden in the
slums of Kolkata, India: data Plasmodium vivax cerebral
falciparum malaria: a randomised trial. Lancet 366, 717725.
malaria.
Sowunmi A (1993) Psychosis after cerebral malaria in children. from a prospective community-
Annals of Tropical Paediatrics
Journal of the National Medical Association 85, 695696. based study. Transactions of the
31, 351356.
Sowunmi A, Akindele JA, Omitowoju GO, Omigbodun AO, Royal Society of Tropical
Medicine and Hygiene 100, Tapko JB, Sam O & Diarra-
Oduola AMJ & Salako LA (1993) Intramuscular sulfadoxine- Nama AJ (2007). Status of
725 733.
pyrimethamine in uncomplicated chloroquine-resistant falciparum Blood Safety in the WHO
malaria during pregnancy. Transactions of the Royal Society of African Region: Report of
Tropical Medicine and Hygiene 87, 472. Suratt BT & Parsons PE the 2004 Sur-vey. WHO
(2006) Mechanisms of acute Regional Office for Africa,
Spitz S (1946) The pathology of acute falciparum malaria. The
Military Surgeon 99, 555572. lung injury/acute respiratory Brazzaville.
distress syndrome. Clinics
Srichaikul T (1993) Hemostatic alterations in malaria. The South East Taylor WR & White NJ (2002)
in Chest Medicine 27, 579
Asian Journal of Tropical Medicine and Public Health 24 Malaria and the lung. Clinics
589; abstract viii.
(Suppl 1), 8691. in Chest Medicine 23, 457
Suwanarusk R, Cooke BM, 468.
Stacpoole PW, Wright EC, Baumgartner TG, et al. (1994) Natu-ral
Dondorp AM, et al. (2004) The Taylor TE, Molyneux ME,
history and course of acquired lactic acidosis in adults. DCA-Lactic
de-formability of red blood cells Wirima JJ, Fletcher KA &
Acidosis Study Group. American Journal of Medi-cine 97, 4754.
parasitized by Plasmodium falci- Morris K (1988) Blood glucose
parum and P. vivax. Journal of levels in Malawian children
Stein CM (1987) Leucocytosis in acute Plasmodium falciparum Infectious Diseases 189, 190
malaria. South African Medical Journal 72, 363. before and during the
194. administration of intravenous
Steketee RW & Campbell CC (2010) Impact of national malaria control
scale-up programmes in Africa: magnitude and attribu-tion of effects. quinine for severe fal-ciparum
Swarthout TD, Counihan H, malaria. New England Journal
Malaria Journal 9, 299.
Senga RK & Van Den Broek I of Medicine 319, 10401047.
Steketee RW, Wirima JJ, Slutsker L, et al. (1996) Malaria para-site (2007) Paracheck-Pf accuracy
infection during pregnancy and at delivery in mother, pla-centa, and and recently treated Plasmo- Taylor TE, Borgstein A &
newborn: efficacy of chloroquine and mefloquine in rural Malawi. Molyneux ME (1993) Acid-
dium falciparum infections: is
American Journal of Tropical Medicine and Hygiene 55, 2432. base sta-tus in paediatric
there a risk of over-diagnosis?
Plasmodium falciparum
Malaria Journal 6, 58. malaria. Quarterly Journal of
Stone WJ, Hanchett JE & Knepshield JH (1972) Acute renal Swellengrebel NH & De Buck A Medicine 86, 99109.
insufficiency due to falciparum malaria. Review of 42 cases. (1938). Malaria in The Nether-
Archives of Internal Medicine 129, 620628. lands. Scheltema & Holkema
2014 WHO. Tropical Medicine and International Health is published by John Wiley & Sons., 19 (Suppl. 1), 7131
The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication. 127